HERBICIDAL MALONAMIDES

Information

  • Patent Application
  • 20240365783
  • Publication Number
    20240365783
  • Date Filed
    August 24, 2022
    2 years ago
  • Date Published
    November 07, 2024
    19 days ago
Abstract
The present invention relates to malonamide compounds of the formula (I) where the variables are as defined in the claims and the description, and to compositions comprising these compounds. The invention also relates to the use of said malonamide compounds or the corresponding compositions for controlling unwanted vegetation, and to methods of applying the malonamide compounds or the corresponding compositions.
Description

The present invention relates to specific malonamide compounds and compositions comprising the same. The invention also relates to the use of said malonamide compounds or the corresponding compositions for controlling unwanted vegetation. Furthermore, the invention relates to methods of applying the malonamide compounds or the corresponding compositions.


BACKGROUND OF THE INVENTION

For the purpose of controlling unwanted vegetation, especially in crops, there is an ongoing need for new herbicides that have high activity and selectivity together with a substantial lack of toxicity for humans and animals.


WO 2012/130798, WO 2014/004882, WO 2014/048882, WO 2018/228985, WO 2018/228986, WO 2019/034602, and WO 2019/145245 describe 3-phenylisoxazoline-5-carboxamides and their use as herbicides.


WO 87/05898 describes the use of malonic acid derivatives for retarding plant growth.


Malonic acid derivatives are also described in U.S. Pat. No. 3,072,473 as plant growth regulators.


The prior art compounds often suffer from insufficient herbicidal activity, in particular at low application rates, and/or unsatisfactory selectivity resulting in a low compatibility with crop plants.


Accordingly, it is an object of the present invention to provide further malonamide compounds having a strong herbicidal activity, in particular even at low application rates, a sufficiently low toxicity for humans and animals and/or a high compatibility with crop plants. The malonamide compounds should also show a broad activity spectrum against a large number of different unwanted plants.


These and further objectives are achieved by the compounds of formula (I) defined below including their agriculturally acceptable salts, stereoisomers and tautomers.


SUMMARY OF THE INVENTION

Accordingly, the present invention relates to compounds of formula (I)




embedded image


wherein the substituents have the following meanings:

    • R1 is hydrogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C4)-cycloalkyl, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl, (C2-C3)-haloalkynyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy or (C1-C3)-alkoxy-(C1-C3)-alkoxy;
    • R2 is hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R3 is hydrogen, halogen, nitro, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, hydroxy-(C1-C3)-alkyl, (C3-C5)-cycloalkyl, (C3-C5)-halocycloalkyl, hydroxy-(C3-C5)-cycloalkyl, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl, (C2-C3)-haloalkynyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy, (C1-C3)-alkoxycarbonyl, (C1-C3)-haloalkoxycarbonyl, (C1-C3)-alkylthio, (C1-C3)-haloalkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-haloalkylsulfinyl, (C1-C3)-alkylsulfonyl or (C1-C3)-haloalkylsulfonyl;
    • R4 is hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C3-C4)-cycloalkyl, (C3-C4)-halocycloalkyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl, (C2-C3)-haloalkynyl or (C1-C3)-alkylthio;
    • R5 is hydrogen, halogen, nitro, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, hydroxy-(C1-C3)-alkyl, (C3-C5)-cycloalkyl, (C3-C5)-halocycloalkyl, hydroxy-(C3-C5)-cycloalkyl, (C2-C3)-alkenyl, (C2-C3)-haloalkenyl, (C2-C3)-alkynyl, (C2-C3)-haloalkynyl, (C1-C3)-alkoxy, (C1-C3)-haloalkoxy, (C1-C3)-alkoxycarbonyl, (C1-C3)-haloalkoxycarbonyl, (C1-C3)-alkylthio, (C1-C3)-haloalkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-haloalkylsulfinyl, (C1-C3)-alkylsulfonyl or (C1-C3)-haloalkylsulfonyl;
    • R6 is hydrogen, halogen, hydroxyl, cyano, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, or (C1-C3)-haloalkoxy;
    • R7 and R8, independently of each other, are (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl, where the four last-mention aliphatic and cycloaliphatic radicals are each substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl and cyano;
    • R9 is hydrogen, (C1-C6)-alkyl, (C1-C6)-haloalkyl, (C3-C4)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-haloalkenyl, (C2-C6)-alkynyl, (C2-C6)-haloalkynyl, (C1-C3)-alkoxy-(C1-C3)-alkyl, (C1-C6)-alkoxy, (C1-C6)-haloalkoxy or (C1-C3)-alkoxy-(C1-C3)-alkoxy;
    • X is a bond (X0) or a divalent unit selected from the group consisting of (X1), (X2), (X3), (X4), (X5), and (X6):




embedded image




    • R10 and R11, independently of each other and independently of each occurrence, are hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, CO2Re, CONRbRd, NRbCO2Re, Ra,
      • (C1-C6)-alkyl, (C3-C5)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, where the four last-mentioned aliphatic and cycloaliphatic radicals are each substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl and cyano;
      • (C1-C6)-alkoxy, (C3-C6)-cycloalkoxy, (C2-C6)-alkenyloxy, (C2-C6)-alkynyloxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, or (C1-C3)-alkylsulfonyl, where the aliphatic or cycloaliphatic moieties of the seven last-mentioned radicals are each substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano and (C1-C2)-alkoxy;

    • R12 to R15, independently of each other and independently of each occurrence, are hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, CO2Re, CONRbRd, NRbCO2Re, Ra,
      • (C1-C6)-alkyl, (C3-C5)-cycloalkyl, (C2-C6)-alkenyl, (C2-C6)-alkynyl, phenyl, imidazolyl, where the six last-mentioned aliphatic, cycloaliphatic, aromatic and heteroaromatic radicals are each substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl and cyano;
      • (C1-C6)-alkoxy, (C3-C6)-cycloalkoxy, (C2-C6)-alkenyloxy, (C2-C6)-alkynyloxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, or (C1-C3)-alkylsulfonyl, where the aliphatic or cycloaliphatic moieties of the seven last-mentioned radicals are each substituted by m radicals from the group consisting of fluorine, chlorine, bromine, iodine, cyano and (C1-C2)-alkoxy;

    • Y is Z,
      • or is
      • (C1-C12)-alkyl, (C3-C5)-cycloalkyl, (C2-C12)-alkenyl or (C2-C12)-alkynyl, where the four last-mentioned aliphatic and cycloaliphatic radicals are each substituted by m radicals selected from the group consisting of Rb, Rc, Re and Rf; and are further substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O)nRa, SO2NRbRd, SO2NRbCORe, CORb,
      • CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRb- CONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Rb3, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe;

    • Z is a three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic ring, except phenyl, which is formed from r carbon atoms, n nitrogen atoms, n sulfur atoms and n oxygen atoms, and which is substituted by m radicals selected from the group consisting of Rb, Rc, Re and Rf and p radicals from the group consisting of CO2Re, CONRbRh, S(O),Ra, SO2NRbRd, SO2NRbCORe, CORD, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Rb3, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe, and where the sulfur and carbon ring atoms bear n oxo groups;

    • each Ra is independently (C1-C6)-alkyl, (C2-C4)-alkynyl or (C3-C6)-cycloalkyl, each of which is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, cyano, hydroxy, and (C1-C3)-alkoxy;

    • Rb, Rb1 and Rb2, independently of each other and independently of each occurrence, are hydrogen or have one of the meanings given for Ra;

    • each Rb3 has independently one of the meanings given for Rd; or

    • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 3-, 4-, 5-, 6- or 7-membered N-bound heterocyclic ring which may contain one further heteroatom or heteroatom group selected from the group consisting of N, O, S, S(O) and S(O)2 as ring member;

    • each Rc is independently fluorine, chlorine, bromine, iodine, cyano, hydroxyl, S(O)nRa, or (C1-C6)-alkoxy, (C2-C6)-alkenyloxy or (C2-C6)-alkynyloxy, where the aliphatic or cycloaliphatic moieties of the three last-mentioned radicals are each substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano and (C1-C2)-alkoxy;

    • each Rd is independently hydrogen or (C1-C6)-alkyl, (C2-C4)-alkenyl, (C2-C4)-alkynyl, (C3-C6)-cycloalkyl, (C3-C6)-cycloalkyl-(C1-C3)-alkyl, phenyl-(C1-C3)-alkyl or furanyl(C1-C3)-alkyl, where each of the seven last-mentioned radicals is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano, CO2Ra, CONRbRh, (C1-C2)-alkoxy, (C1-C3)-alkylthio, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl, phenylthio, phenylsulfinyl, and phenylsulfonyl;

    • each Re has independently one of the meanings given for Rd;

    • each Rf is independently (C1-C3)-alkyl or (C1-C3)-alkoxy;

    • each Rh is independently hydrogen or (C1-C6)-alkyl, (C1-C2)-alkoxy, (C3-C6)-cycloalkyl, (C2-C4)-alkenyl, (C1-C6)-alkoxycarbonyl-(C1-C6)-alkyl, or (C2-C4)-alkynyl, where each of the six last-mentioned radicals is substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, cyano, CO2Ra, and (C1-C2)-alkoxy; 5 each m is independently 0, 1, 2, 3, 4 or 5;

    • each n is independently 0, 1 or 2;

    • each p is independently 1, 2 or 3;

    • r is 1, 2, 3, 4, 5 or 6;





including their agriculturally acceptable salts, stereoisomers and tautomers.


The invention also relates to a composition comprising at least one compound of formula (I) and at least one auxiliary, which is customary for formulating crop protection compounds.


The present invention also provides combinations comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C(component C).


The invention relates moreover to the use of a compound of formula (I) or of said compositions for controlling unwanted vegetation, and to a method for controlling unwanted vegetation which comprises allowing a herbicidally effective amount of at least one compound of formula (I) or of said compositions to act on plants, their seed and/or their habitat.







DETAILED DESCRIPTION OF THE INVENTION
Definitions:

Depending on the kind of substituents, the compounds of formula (I) may have one or more centers of chirality, in which case they may be present as mixtures of enantiomers or diastereomers but also in the form of the pure enantiomers or pure diastereomers. The invention provides both the pure enantiomers or pure diastereomers of the compounds of formula I, and their mixtures and the use according to the invention of the pure enantiomers or pure diastereomers of the compound of formula I or its mixtures. Suitable compounds of formula I also include all possible geometrical stereoisomers (cis/trans isomers) as a specific form of diastereomers and mixtures thereof. Cis/trans isomers may be present with respect to an alkene, carbon-nitrogen doublebond, nitrogen-sulfur double bond, amide group or a cyclic, non-aromatic moiety. The term “stereoisomer(s)” encompasses both optical isomers, such as enantiomers or diastereomers existing due to more than one stereogenic center in the molecule, as well as geometrical isomers (cis/trans isomers). Just by way of example, a stereogenic center is the C atom carrying R10 and R11 in X1 to X6, provided of course that R10 and R11 are different. Another example for a stereogenic center is the C atom carrying R7 and R8, provided, of course, that R7 and R8 are different from each other.


If the above-mentioned herbicidal compounds B and/or the safeners C have one or more centres of chirality they may also be present as enantiomers or diastereomers, and it is possible to use both the pure enantiomers and diastereomers or their mixtures.


If the compounds of formula (I), the herbicidal compounds B and/or the safeners C as described herein have ionizable functional groups, they can also be employed in the form of their agriculturally acceptable salts. Suitable are, in general, the salts of those cations and the acid addition salts of those acids whose cations and anions, respectively, have no adverse effect on the activity of the active compounds.


Preferred cations are the ions of the alkali metals, preferably of lithium, sodium and potassium, of the alkaline earth metals, preferably of calcium and magnesium, and of the transition metals, preferably of manganese, copper, zinc and iron, further ammonium and substituted ammonium in which one to four hydrogen atoms are replaced by C1-C4-alkyl, hydroxy-C1-C4-alkyl, C1-C4-alkoxy-C1-C4-alkyl, hydroxy-C1-C4-alkoxy-C1-C4-alkyl, phenyl or benzyl, preferably ammonium, methylammonium, isopropylammonium, dimethylammonium, diethylammonium, diisopropylammonium, trimethylammonium, triethylammonium, tris(isopropyl) ammonium, heptylammonium, dodecylammonium, tetradecylammonium, tetramethylammonium, tetraethylammonium, tetrabutylammonium, 2-hydroxyethylammonium (olamine salt), 2-(2-hydroxyeth-1-oxy) eth-1-ylammonium (diglycolamine salt), di(2-hydroxyeth-1-yl) ammonium (diolamine salt), tris(2-hydroxyethyl) ammonium (trolamine salt), tris(2-hydroxypropyl) ammonium, benzyltrimethylammonium, benzyltriethylammonium, N,N, N-trimethylethanolammonium (choline salt), furthermore phosphonium ions, sulfonium ions, preferably tri (C1-C4-alkyl) sulfonium, such as trimethylsulfonium, and sulfoxonium ions, preferably tri (C1-C4-alkyl) sulfoxonium, and finally the salts of polybasic amines such as N, N-bis-(3-aminopropyl)methylamine and diethylenetriamine.


Anions of useful acid addition salts are primarily chloride, bromide, fluoride, iodide, hydrogensulfate, methylsulfate, sulfate, dihydrogenphosphate, hydrogenphosphate, nitrate, bicarbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate and also the anions of C1-C4-alkanoic acids, preferably formate, acetate, propionate and butyrate.


The compounds (I) may be present in form of different tautomers. For instance, if ring Z is a lactam, i.e. contains an amide group as ring member (=unsubstituted, secondary nitrogen ring atom neighboured to a carbon ring atom carrying an oxo group), this ring moiety —N(H)—C(═O)— can be in equilibrium with its tautomeric form —N═C(OH)—. The same applies to the two mandatorily present amide groups of the malonamide moiety —N(R1)—C(═O)—C(R7) (R8)—C(═O)—N(R9)— if one or both of R1 and R9 are hydrogen:

    • If only R1 is hydrogen, the malonamide moiety can be present as —N(H)—C(═O)—C(R7) (R8)—C(═O)—N(R9)— or as —N═C(OH)—C(R7) (R8)—C(═O)—N(R9)— or as a mixture of the two forms;
    • If only R9 is hydrogen, the malonamide moiety can be present as —N(R1)—C(═O)—C(R7) (R8)—C(═O)—N(H)— or as —N(R1)—C(═O)—C(R7) (R8)—C(OH)═N— or as a mixture of the two forms;
    • If both of R1 and R9 are hydrogen, the malonamide moiety can be present as —N(H)—C(═O)—C(R7) (R8)—C(═O)—N(H)— or as —N═C(OH)—C(R7) (R8)—C(═O)—N(H)— or as —N(H)—C(═O)—C(R7) (R8)—C(OH)═N— or as —N═C(OH)—C(R7) (R8)—C(OH)═N— or as mixture of two, three all four of the above forms.


The amount in which the one or other tautomeric form is present depends on the complete molecular structure and even stronger on the surrounding conditions (presence or absence of solvent, type of solvent, pH, temperature etc.).


The term “undesired vegetation” (“weeds”) is understood to include any vegetation growing in non-crop-areas or at a crop plant site or locus of seeded and otherwise desired crop, where the vegetation is any plant species, including their germinant seeds, emerging seedlings and established vegetation, other than the seeded or desired crop (if any). Weeds, in the broadest sense, are plants considered undesirable in a particular location.


The organic moieties mentioned in the above definitions of the variables are—like the term halogen-collective terms for individual listings of the individual group members. The prefix Cn-Cm indicates in each case the possible number of carbon atoms in the group.


The term “halogen” denotes in each case fluorine, bromine, chlorine or iodine, in particular fluorine, chlorine or bromine.


The term “partially or completely halogenated” will be taken to mean that 1 or more, e.g. 1, 2, 3, 4 or 5 or all of the hydrogen atoms of a given radical have been replaced by a halogen atom, in particular by fluorine or chlorine. A partially or completely halogenated radical is termed below also “halo-radical”. For example, partially or completely halogenated alkyl is also termed haloalkyl.


The term “alkyl” as used herein (and in the alkyl moieties of other groups comprising an alkyl group, e.g. alkoxy, alkylamino, dialkylamino, alkylcarbonyl, alkoxycarbonyl, alkylthio, alkylsulfonyl and alkoxyalkyl) denotes in each case a straight-chain or branched alkyl group having usually from 1 to 12 carbon atoms (═C1-C12-alkyl), frequently from 1 to 6 carbon atoms (═C1-C6-alkyl), in particular 1 to 4 carbon atoms (═C1-C4-alkyl) and especially from 1 to 3 carbon atoms (═C1-C3-alkyl) or 1 or 2 carbon atoms (═C1-C2-alkyl). C1-C2-Alkyl is methyl or ethyl. C1-C3-Alkyl is methyl, ethyl, npropyl or iso-propyl. Examples of C1-C4-alkyl are methyl, ethyl, n-propyl, iso-propyl, nbutyl, 2-butyl(=sec-butyl), isobutyl and tert-butyl. Examples for C1-C6-alkyl are, in addition to those mentioned for C1-C4-alkyl, n-pentyl, 1-methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1-ethylpropyl, n-hexyl, 1,1-dimethylpropyl, 1,2-dimethylpropyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, 1,1-dimethylbutyl, 1,2-dimethylbutyl, 1,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3-dimethylbutyl, 3,3-dimethylbutyl, 1-ethylbutyl, 2-ethylbutyl, 1,1,2-trimethylpropyl, 1,2,2-trimethylpropyl, 1-ethyl-1-methylpropyl and 1-ethyl-2-methylpropyl. Examples for C1-C8-alkyl are, in addition to those mentioned for C1-C6-alkyl, n-heptyl, 1-methylhexyl, 2-methylhexyl, 3-methylhexyl, 4-methylhexyl, 5-methylhexyl, 1-ethylpentyl, 2-ethylpentyl, 3-ethylpentyl, n-octyl, 1-methylheptyl, 2-methylheptyl, 1-ethylhexyl, 2-ethylhexyl, 1,2-dimethylhexyl, 1-propylpentyl and 2-propylpentyl. Examples for C1-C12-alkyl are, apart those mentioned for C1-C6-alkyl, nonyl, decyl, 2-propylheptyl, 3-propylheptyl, undecyl, dodecyl and positional isomers thereof.


The term “haloalkyl” as used herein (and in the haloalkyl moieties of other groups comprising a haloalkyl group, e.g. haloalkoxy, haloalkylthio, haloalkylcarbonyl, haloalkylsulfonyl and haloalkylsulfinyl), which is also expressed as “alkyl which is partially or fully halogenated”, denotes in each case a straight-chain or branched alkyl group having usually from 1 to 6 carbon atoms (═C1-C6-haloalkyl), more frequently 1 to 3 carbon atoms (═C1-C3-haloalkyl), as defined above, wherein the hydrogen atoms of this group are partially or totally replaced with halogen atoms. Preferred haloalkyl moieties are selected from C1-C3-haloalkyl, specifically from C1-C2-haloalkyl, in particular from fluorinated C1-C2-alkyl. Examples for C1-C2-haloalkyl are fluoromethyl, difluoromethyl, trifluoromethyl, chloromethyl, dichloromethyl, trichloromethyl, chlorofluoromethyl, dichlorofluoromethyl, chlorodifluoromethyl, bromomethyl, 1-fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, 1-chloroethyl, 2-chloroethyl, 2,2, dichloroethyl, 2,2,2-trichloroethyl, 2-chloro-2-fluoroethyl, 2-chloro-2,2-difluoroethyl, 2,2-dichloro-2-fluoroethyl, 1-bromoethyl, and the like. Examples for C1-C3-haloalkyl are, in addition to those mentioned for C1-C2-haloalkyl, 1-fluoropropyl, 2-fluoropropyl, 3 -fluoropropyl, 3,3-difluoropropyl, 3,3,3-trifluoropropyl, heptafluoropropyl, 1,1,1-trifluoroprop-2-yl, 3-chloropropyl, and the like.


The term “hydroxyalkyl” denotes in each case a straight-chain or branched alkyl group having usually from 1 to 6 carbon atoms (═C1-C6-hydroxyalkyl), more frequently 1 to 3 carbon atoms (═C1-C3-hydroxyalkyl), as defined above, wherein one hydrogen atom of this group is replaced with a hydroxyl group. Examples are hydroxymethyl, 1-hydroxyethyl, 2-hydroxyethyl, 1-hydroxypropyl, 2-hydroxypropyl, 3-hydroxypropyl, 1-hydroxy-2-propyl and the like.


The term “alkenyl” as used herein denotes in each case a monounsaturated straight-chain or branched hydrocarbon radical having usually 2 to 12 (═C2-C12-alkenyl), preferably 2 to 6 carbon atoms (═C2-C6-alkenyl), e.g. 3 to 6 carbon atoms (═C3-C6-alkenyl), in particular 2 or 3 carbon atoms (═C2-C3-alkenyl), and a double bond in any position, for example C2-C3-alkenyl, such as ethenyl, 1-propenyl, 2-propenyl or 1-methylethenyl; C2-C6-alkenyl, such as ethenyl, 1-propenyl, 2-propenyl, 1-methylethenyl, 1-butenyl, 2-butenyl, 3-butenyl, 1-methyl-1-propenyl, 2-methyl-1-propenyl, 1-methyl-2-propenyl, 2-methyl-2-propenyl, 1-pentenyl, 2-pentenyl, 3-pentenyl, 4-pentenyl, 1-methyl-1-butenyl, 2-methyl-1-butenyl, 3-methyl-1-butenyl, 1-methyl-2-butenyl, 2-methyl-2-butenyl, 3-methyl-2-butenyl, 1-methyl-3-butenyl, 2-methyl-3-butenyl, 3-methyl-3-butenyl, 1,1-dimethyl-2-propenyl, 1,2-dimethyl-1-propenyl, 1,2-dimethyl-2-propenyl, 1-ethyl-1-propenyl, 1-ethyl-2-propenyl, 1-hexenyl, 2-hexenyl, 3-hexenyl, 4-hexenyl, 5-hexenyl, 1-methyl-1-pentenyl, 2-methyl-1-pentenyl, 3-methyl-1-pentenyl, 4-methyl-1-pentenyl, 1-methyl-2-pentenyl, 2-methyl-2-pentenyl, 3-methyl-2-pentenyl, 4-methyl-2-pentenyl, 1-methyl-3-pentenyl, 2-methyl-3-pentenyl, 3-methyl-3-pentenyl, 4-methyl-3-pentenyl, 1-methyl-4-pentenyl, 2-methyl-4-pentenyl, 3-methyl-4-pentenyl, 4-methyl-4-pentenyl, 1,1-dimethyl-2-butenyl, 1,1-dimethyl-3-butenyl, 1,2-dimethyl-1-butenyl, 1,2-dimethyl-2-butenyl, 1,2-dimethyl-3-butenyl, 1,3-dimethyl-1-butenyl, 1,3-dimethyl-2-butenyl, 1,3-dimethyl-3-butenyl, 2,2-dimethyl-3-butenyl, 2,3-dimethyl-1-butenyl, 2,3-dimethyl-2-butenyl, 2,3-dimethyl-3-butenyl, 3,3-dimethyl-1-butenyl, 3,3-dimethyl-2-butenyl, 1-ethyl-1-butenyl, 1-ethyl-2-butenyl, 1-ethyl-3-butenyl, 2-ethyl-1-butenyl, 2-ethyl-2-butenyl, 2-ethyl-3-butenyl, 1,1,2-trimethyl-2-propenyl, 1-ethyl-1-methyl-2-propenyl, 1-ethyl-2-methyl-1-propenyl, 1-ethyl-2-methyl-2-propenyl and the like, or C2-C12-alkenyl, such as the radicals mentioned for C2-C6-alkenyl and additionally 1-heptenyl, 2-heptenyl, 3-heptenyl, 1-octenyl, 2-octenyl, 3-octenyl, 4-octenyl, the nonenyls, decenyls, undecenyls, dodecenyls and the positional isomers thereof.


Examples for C3-C6-alkenyl are those mentioned above for C2-C6-alkenyl, except for ethenyl.


The term “haloalkenyl” as used herein, which may also be expressed as “alkenyl which is substituted by halogen”, and the haloalkenyl moieties in haloalkenyloxy and the like refers to unsaturated straight-chain or branched hydrocarbon radicals having 2 to 6 (═C2-C6-haloalkenyl) or 2 to 3 (═C2-C3-haloalkenyl) carbon atoms and a double bond in any position, where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as mentioned above, in particular fluorine, chlorine and bromine, for example chlorovinyl, chloroallyl and the like.


The term “alkynyl” as used herein denotes unsaturated straight-chain or branched hydrocarbon radicals having usually 2 to 12 (═C2-C12-alkynyl), frequently 2 to 6 (═C2-C6-alkynyl), preferably 2 to 4 carbon atoms (═C2-C4-alkynyl) or 2 to 3 carbon atoms (═C2-C3-alkynyl) and a triple bond in any position, for example C2-C3-alkynyl, such as ethynyl, 1-propynyl or 2-propynyl; C2-C4-alkynyl, such as ethynyl, 1-propynyl or 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl and the like; C2-C6-alkynyl, such as ethynyl, 1-propynyl, 2-propynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1-methyl-2-propynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1-methyl-2-butynyl, 1-methyl-3-butynyl, 2-methyl-3-butynyl, 3-methyl-1-butynyl, 1,1-dimethyl-2-propynyl, 1-ethyl-2-propynyl, 1-hexynyl, 2-hexynyl, 3-hexynyl, 4-hexynyl, 5-hexynyl, 1-methyl-2-pentynyl, 1-methyl-3-pentynyl, 1-methyl-4-pentynyl, 2-methyl-3-pentynyl, 2-methyl-4-pentynyl, 3-methyl-1-pentynyl, 3-methyl-4-pentynyl, 4-methyl-1-pentynyl, 4-methyl-2-pentynyl, 1,1-dimethyl-2-butynyl, 1,1-dimethyl-3-butynyl, 1,2-dimethyl-3-butynyl, 2,2-dimethyl-3-butynyl, 3,3-dimethyl-1-butynyl, 1-ethyl-2-butynyl, 1-ethyl-3-butynyl, 2-ethyl-3-butynyl, 1-ethyl-1-methyl-2-propynyl and the like.


The term “haloalkynyl” as used herein, which is also expressed as “alkynyl which is substituted by halogen”, refers to unsaturated straight-chain or branched hydrocarbon radicals having usually 2 to 6 carbon atoms (═C2-C6-haloalkynyl), preferabyl 2 or 3 carbon atoms (═C2-C3-haloalkynyl), and a triple bond in any position (as mentioned above), where some or all of the hydrogen atoms in these groups are replaced by halogen atoms as mentioned above, in particular fluorine, chlorine and bromine.


The term “cycloalkyl” as used herein (and in the cycloalkyl moieties of other groups comprising a cycloalkyl group, e.g. cycloalkoxy and cycloalkylalkyl) denotes in each case a mono- or bicyclic, saturated cycloaliphatic radical having usually from 3 to 8 carbon atoms (═C3-C8-cycloalkyl), preferably 3 to 6 carbon atoms (═C3-C6-cycloalkyl), 3 to 5 carbon atoms (═C3-C5-cycloalkyl) or 3 to 4 carbon atoms (═C3-C4-cycloalkyl) as (only) ring members. Examples of monocyclic saturated cycloaliphatic radicals having 3 or 4 carbon atoms comprise cyclopropyl and cyclobutyl. Examples of monocyclic saturated cycloaliphatic radicals having 3 to 5 carbon atoms comprise cyclopropyl, cyclobutyl and cyclopentyl. Examples of monocyclic saturated cycloaliphatic radicals having 3 to 6 carbon atoms comprise cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. Examples of monocyclic saturated cycloaliphatic radicals having 3 to 8 carbon atoms comprise cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl and cyclooctyl. C5-C6-Cycloalkyl is cyclopentyl or cyclohexyl. Examples of bicyclic radicals having 6 to 8 carbon atoms comprise bicyclo[2.1.1]hexyl, bicyclo[2.2.1]heptyl, bicyclo [3.1.1]heptyl, bicyclo[2.2.1]heptyl, bicyclo[2.2.2]octyl and bicyclo[3.2.1]octyl.


The term “halocycloalkyl” as used herein (and in the halocycloalkyl moieties of other groups comprising an halocycloalkyl group) denotes in each case a mono- or bicyclic cycloaliphatic radical having usually from 3 to 8 carbon atoms (“C3-C8-halocycloalkyl”), preferably 3 to 5 carbon atoms (“C3-C5-halocycloalkyl”), wherein at least one, e.g. 1, 2, 3, 4 or 5 of the hydrogen atoms are replaced by halogen, in particular by fluorine or chlorine. Examples are 1- and 2-fluorocyclopropyl, 1,2-, 2,2- and 2,3-difluorocyclopropyl, 1,2,2-trifluorocyclopropyl, 2,2,3,3-tetrafluorocyclpropyl, 1- and 2-chlorocyclopropyl, 1,2-, 2,2- and 2,3-dichlorocyclopropyl, 1,2,2-trichlorocyclopropyl, 2,2,3,3-tetrachlorocyclpropyl, 1-, 2- and 3-fluorocyclopentyl, 1,2-, 2,2-, 2,3-, 3,3-, 3,4-, 2,5-difluorocyclopentyl, 1-, 2- and 3-chlorocyclopentyl, 1,2-, 2,2-, 2,3-, 3,3-, 3,4-, 2,5-dichlorocyclopentyl and the like.


The term “hydroxycycloalkyl” denotes in each case a mono- or bicyclic cycloaliphatic radical having usually from 3 to 6 carbon atoms (“hydroxy-(C3-C6)-cycloalkyl”), preferably 3 to 5 carbon atoms (“hydroxy-(C3-C5)-cycloalkyl”), wherein at least one, e.g. 1, 2, 3, 4 or 5 of the hydrogen atoms are replaced by a hydroxyl group. Examples are 1-hydroxycyclopropyl, 2-hydroxycyclopropyl, 1,2-dihydroxycyclopropyl, 2,3-dihydroxycyclopropyl, 1-hydroxycyclobutyl, 2-hydroxycyclobutyl, 3-hydroxycyclobutyl, 1,2-dihydroxycyclobutyl, 1,3-dihydroxycyclobutyl, 2,3-dihydroxycyclobutyl, 1-hydroxycyclopentyl, 2-hydroxycyclopentyl, 3-hydroxycyclopentyl, 1,2-dihydroxycyclopentyl, 1,3-dihydroxycyclopentyl, 2,3-dihydroxycyclopentyl and the like.


The term “alkoxy” as used herein denotes in each case a straight-chain or branched alkyl group usually having from 1 to 6 carbon atoms (═C1-C6-alkoxy), preferably 1 to 3 carbon atoms (═C1-C3-alkoxy), in particular 1 or 2 carbon atoms (═C1-C2-alkoxy), which is bound to the remainder of the molecule via an oxygen atom. C1-C2-Alkoxy is methoxy or ethoxy. C1-C3-Alkoxy is additionally, for example, n-propoxy or 1-methylethoxy (isopropoxy). C1-C6-Alkoxy is additionally, for example, butoxy, 1-methylpropoxy (sec-butoxy), 2-methylpropoxy (isobutoxy) or 1,1-dimethylethoxy (tertbutoxy), pentoxy, 1-methylbutoxy, 2-methylbutoxy, 3-methylbutoxy, 1,1-dimethylpropoxy, 1,2-dimethylpropoxy, 2,2-dimethylpropoxy, 1-ethylpropoxy, hexoxy, 1-methylpentoxy, 2-methylpentoxy, 3-methylpentoxy, 4-methylpentoxy, 1,1-dimethylbutoxy, 1,2-dimethylbutoxy, 1,3-dimethylbutoxy, 2,2-dimethylbutoxy, 2,3-dimethylbutoxy, 3,3-dimethylbutoxy, 1-ethylbutoxy, 2-ethylbutoxy, 1,1,2-trimethylpropoxy, 1,2,2-trimethylpropoxy, 1-ethyl-1-methylpropoxy or 1-ethyl-2-methylpropoxy.


The term “haloalkoxy” as used herein denotes in each case a straight-chain or branched alkoxy group, as defined above, having from 1 to 6 carbon atoms (═C1-C6-haloalkoxy), preferably 1 to 3 carbon atoms (═C1-C3-haloalkoxy), in particular 1 or 2 carbon atoms (═C1-C2-haloalkoxy), wherein the hydrogen atoms of this group are partially or totally replaced with halogen atoms, in particular fluorine atoms (in this case, the radical is also termed fluorinated alkoxy). C1-C2-Haloalkoxy is, for example, OCH2F, OCHF2, OCF3, OCH2Cl, OCHCl2, OCCl3, chlorofluoromethoxy, dichlorofluoromethoxy, chlorodifluoromethoxy, 2-fluoroethoxy, 2-chloroethoxy, 2-bromoethoxy, 2-iodoethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2-chloro-2-fluoroethoxy, 2-chloro-2,2-difluoroethoxy, 2,2-dichloro-2-fluoroethoxy, 2,2,2-trichloroethoxy or OC2F5. C1-C3-Haloalkoxy is additionally, for example, 2-fluoropropoxy, 3-fluoropropoxy, 2,2-difluoropropoxy, 2,3-difluoropropoxy, 2-chloropropoxy, 3-chloropropoxy, 2,3-dichloropropoxy, 2-bromopropoxy, 3-bromopropoxy, 3,3,3-trifluoropropoxy, 3,3,3-trichloropropoxy, OCH2-C2F5, OCF2-C2F5, 1-(CH2F)-2-fluoroethoxy, 1-(CH2Cl)-2-chloroethoxy or 1-(CH2Br)-2-bromoethoxy. C1-C6-Haloalkoxy is additionally, for example, 4-fluorobutoxy, 4-chlorobutoxy, 4-bromobutoxy or nonafluorobutoxy, 5-fluoropentoxy, 5-chloropentoxy, 5-brompentoxy, 5-iodopentoxy, undecafluoropentoxy, 6-fluorohexoxy, 6-chlorohexoxy, 6-bromohexoxy, 6-iodohexoxy or dodecafluorohexoxy.


The term “alkenyloxy” denotes an alkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C2-C6-Alkenyloxy is a C2-C6-alkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C3-C6-Alkenyloxy is a C3-C6-alkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule.


The term “haloalkenyloxy” denotes a haloalkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C2-C6-Haloalkenyloxy is a C2-C6-haloalkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C3-C6-Haloalkenyloxy is a C3-C6-haloalkenyl group, as defined above, attached via an oxygen atom to the remainder of the molecule.


The term “alkynyloxy” denotes an alkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C2-C6-Alkynyloxy is a C2-C6-alkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C3-C6-Alkynyloxy is a C3-C6-alkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule.


The term “haloalkynyloxy” denotes a haloalkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C2-C6-Haloalkynyloxy is a C2-C6-haloalkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C3-C6-Haloalkynyloxy is a C3-C6-haloalkynyl group, as defined above, attached via an oxygen atom to the remainder of the molecule.


The term “cycloalkoxy” denotes a cycloalkyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. C3-C6-Cycloalkoxy is a C3-C6-cycloalkyl group, as defined above, attached via an oxygen atom to the remainder of the molecule. Examples of C3-C6-cycloalkoxy comprise cyclopropoxy, cyclobutoxy, cyclopentoxy and cyclohexoxy.


The term “alkoxy-alkoxy” as used herein, refers to an alkoxy group, as defined above, where one hydrogen atom is replaced by another alkoxy group, as defined above. The term “C1-C3-alkoxy-C1-C3-alkoxy” as used herein, refers to an alkoxy group having 1 to 3 carbon atoms, as defined above, where one hydrogen atom is replaced by a C1-C3-alkoxy group, as defined above. Examples are methoxymethoxy, ethoxymethoxy, propoxymethoxy, isopropoxymethoxy, 1-methoxyethoxy, 1-ethoxyethoxy, 1-propoxyethoxy, 1-isopropoxyethoxy, 2-methoxyethoxy, 2-ethoxyethoxy, 2-propoxyethoxy, 2-isopropoxyethoxy, 1-methoxypropoxy, 1-ethoxypropoxy, 1-propoxypropoxy, 1-isopropoxypropoxy, 2-methoxypropoxy, 2-ethoxypropoxy, 2-propoxypropoxy, 2-isopropoxypropoxy, 3-methoxypropoxy, 3-ethoxypropoxy, 3-propoxypropoxy, 3-isopropoxypropoxy, and the like.


The term “alkylthio” (also alkylsulfanyl or “alkyl-S”) as used herein denotes in each case a straight-chain or branched saturated alkyl group as defined above, usually comprising 1 to 6 carbon atoms (═C1-C6-alkylthio), preferably 1 to 3 carbon atoms (═C1-C3-alkylthio), which is attached via a sulfur atom at any position in the alkyl group. C1-C2-Alkylthio is methylthio or ethylthio. C1-C3-Alkylthio is additionally, for example, npropylthio or 1-methylethylthio(isopropylthio). C1-C6-Alkylthio is additionally, for example, butylthio, 1-methylpropylthio(sec-butylthio), 2-methylpropylthio(isobutylthio), 1,1-dimethylethylthio(tert-butylthio), pentylthio, 1-methylbutylthio, 2-methylbutylthio, 3-methylbutylthio, 1,1-dimethylpropylthio, 1,2-dimethylpropylthio, 2,2-dimethylpropylthio, 1-ethylpropylthio, hexylthio, 1-methylpentylthio, 2-methylpentylthio, 3-methylpentylthio, 4-methylpentylthio, 1,1-dimethylbutylthio, 1,2-dimethylbutylthio, 1,3-dimethylbutylthio, 2,2-dimethylbutylthio, 2,3-dimethylbutylthio, 3,3-dimethylbutylthio, 1-ethylbutylthio, 2-ethylbutylthio, 1,1,2-trimethylpropylthio, 1,2,2-trimethylpropylthio, 1-ethyl-1-methylpropylthio or 1-ethyl-2-methylpropylthio.


The term “haloalkylthio” as used herein refers to an alkylthio group as defined above wherein the hydrogen atoms are partially or completely substituted by fluorine, chlorine, bromine and/or iodine. C1-C2-Haloalkylthio is, for example, SCH2F, SCHF2, SCF3, SCH2Cl, SCHCl2, SCCl3, chlorofluoromethylthio, dichlorofluoromethylthio, chlorodifluoromethylthio, 2-fluoroethylthio, 2-chloroethylthio, 2-bromoethylthio, 2-iodoethylthio, 2,2-difluoroethylthio, 2,2,2-trifluoroethylthio, 2-chloro-2-fluoroethylthio, 2-chloro-2,2-difluoroethylthio, 2,2-dichloro-2-fluoroethylthio, 2,2,2-trichloroethylthio or SC2F5. C1-C4-Haloalkylthio is additionally, for example, 2-fluoropropylthio, 3-fluoropropylthio, 2,2-difluoropropylthio, 2,3-difluoropropylthio, 2-chloropropylthio, 3-chloropropylthio, 2,3-dichloropropylthio, 2-bromopropylthio, 3-bromopropylthio, 3,3,3-trifluoropropylthio, 3,3,3-trichloropropylthio, SCH2-C2F5, SCF2-C2F5, 1-(CH2F)-2-fluoroethylthio, 1-(CH2Cl)-2-chloroethylthio, 1-(CH2Br)-2-bromoethylthio, 4-fluorobutylthio, 4-chlorobutylthio, 4-bromobutylthio or nonafluorobutylthio. C1-C6-Haloalkylthio is additionally, for example, 5-fluoropentylthio, 5-chloropentylthio, 5-brompentylthio, 5-iodopentylthio, undecafluoropentylthio, 6-fluorohexylthio, 6-chlorohexylthio, 6-bromohexylthio, 6-iodohexylthio or dodecafluorohexylthio.


The term “alkylsulfinyl” denotes an alkyl group, as defined above, attached via a sulfinyl [S(O)] group. For example, the term “C1-C2-alkylsulfinyl” refers to a C1-C2-alkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term “C1-C3-alkylsulfinyl” refers to a C1-C3-alkyl group, as defined above, attached via a sulfinyl [S(O)] group. The term “C1-C6-alkylsulfinyl” refers to a C1-C6-alkyl group, as defined above, attached via a sulfinyl [S(O)] group. C1-C2-alkylsulfinyl is methylsulfinyl or ethylsulfinyl. C1-C3-alkylsulfinyl is additionally, for example, n-propylsulfinyl or 1-methylethylsulfinyl(isopropylsulfinyl). C1-C6-alkylsulfinyl is additionally, for example, butylsulfinyl, 1-methylpropylsulfinyl(sec-butylsulfinyl), 2-methylpropylsulfinyl(isobutylsulfinyl), 1,1-dimethylethylsulfinyl(tert-butylsulfinyl), pentylsulfinyl, 1-methylbutylsulfinyl, 2-methylbutylsulfinyl, 3-methylbutylsulfinyl, 1,1-dimethylpropylsulfinyl, 1,2-dimethylpropylsulfinyl, 2,2-dimethylpropylsulfinyl, 1-ethylpropylsulfinyl, hexylsulfinyl, 1-methylpentylsulfinyl, 2-methylpentylsulfinyl, 3-methylpentylsulfinyl, 4-methylpentylsulfinyl, 1,1-dimethylbutylsulfinyl, 1,2-dimethylbutylsulfinyl, 1,3-dimethylbutylsulfinyl, 2,2-dimethylbutylsulfinyl, 2,3-dimethylbutylsulfinyl, 3,3-dimethylbutylsulfinyl, 1-ethylbutylsulfinyl, 2-ethylbutylsulfinyl, 1,1,2-trimethylpropylsulfinyl, 1,2,2-trimethylpropylsulfinyl, 1-ethyl-1-methylpropylsulfinyl or 1-ethyl-2-methylpropylsulfinyl.


The term “haloalkylsulfinyl” denotes a haloalkyl group, as defined above, attached via a sulfinyl [S(O)] group to the remainder of the molecule. C1-C2-Haloalkylsulfinyl is, for example, S(O)CH2F, S(O)CHF2, S(O)CF3, S(O)CH2Cl, S(O)CHCl2, S(O)CCl3, chlorofluoromethylsulfinyl, dichlorofluoromethylsulfinyl, chlorodifluoromethylsulfinyl, 2-fluoroethylsulfinyl, 2-chloroethylsulfinyl, 2-bromoethylsulfinyl, 2-iodoethylsulfinyl, 2,2-difluoroethylsulfinyl, 2,2,2-trifluoroethylsulfinyl, 2-chloro-2-fluoroethylsulfinyl, 2-chloro-2,2-difluoroethylsulfinyl, 2,2-dichloro-2-fluoroethylsulfinyl, 2,2,2-trichloroethylsulfinyl or S(O) C2F5. C1-C3-Haloalkylsulfinyl is additionally, for example, 2-fluoropropylsulfinyl, 3-fluoropropylsulfinyl, 2,2-difluoropropylsulfinyl, 2,3-difluoropropylsulfinyl, 2-chloropropylsulfinyl, 3-chloropropylsulfinyl, 2,3-dichloropropylsulfinyl, 2-bromopropylsulfinyl, 3-bromopropylsulfinyl, 3,3,3-trifluoropropylsulfinyl, 3,3,3-trichloropropylsulfinyl, S(O)CH2-C2F5, S(O)CF2-C2F5, 1-(CH2F)-2-fluoroethylsulfinyl, 1-(CH2Cl)-2-chloroethylsulfinylor 1-(CH2Br)-2-bromoethylsulfinyl. C1-C4-Haloalkylsulfinyl is additionally, for example, 4-fluorobutylsulfinyl, 4-chlorobutylsulfinyl, 4-bromobutylsulfinyl or nonafluorobutylsulfinyl. C1-C6-Haloalkylsulfinyl is additionally, for example, 5-fluoropentylsulfinyl, 5-chloropentylsulfinyl, 5-brompentylsulfinyl, 5-iodopentylsulfinyl, undecafluoropentylsulfinyl, 6-fluorohexylsulfinyl, 6-chlorohexylsulfinyl, 6-bromohexylsulfinyl, 6-iodohexylsulfinyl or dodecafluorohexylsulfinyl.


The term “alkylsulfonyl” denotes an alkyl group, as defined above, attached via a sulfonyl [S(O)2] group. The term “C1-C2-alkylsulfonyl” refers to a C1-C2-alkyl group, as defined above, attached via a sulfonyl [S(O)2] group. The term “C1-C3-alkylsulfonyl” refers to a C1-C3-alkyl group, as defined above, attached via a sulfonyl [S(O)2] group. The term “C1-C6-alkylsulfonyl” refers to a C1-C6-alkyl group, as defined above, attached via a sulfonyl [S(O)2] group. C1-C2-alkylsulfonyl is methylsulfonyl or ethylsulfonyl. C1-C3-alkylsulfonyl is additionally, for example, n-propylsulfonyl or 1-methylethylsulfonyl(isopropylsulfonyl). C1-C6-alkylsulfonyl is additionally, for example, butylsulfonyl, 1-methylpropylsulfonyl(sec-butylsulfonyl), 2-methylpropylsulfonyl(isobutylsulfonyl), 1,1-dimethylethylsulfonyl (tert-butylsulfonyl), pentylsulfonyl, 1-methylbutylsulfonyl, 2-methylbutylsulfonyl, 3-methylbutylsulfonyl, 1,1-dimethylpropylsulfonyl, 1,2-dimethylpropylsulfonyl, 2,2-dimethylpropylsulfonyl, 1-ethylpropylsulfonyl, hexylsulfonyl, 1-methylpentylsulfonyl, 2-methylpentylsulfonyl, 3-methylpentylsulfonyl, 4-methylpentylsulfonyl, 1,1-dimethylbutylsulfonyl, 1,2-dimethylbutylsulfonyl, 1,3-dimethylbutylsulfonyl, 2,2-dimethylbutylsulfonyl, 2,3-dimethylbutylsulfonyl, 3,3-dimethylbutylsulfonyl, 1-ethylbutylsulfonyl, 2-ethylbutylsulfonyl, 1,1,2-trimethylpropylsulfonyl, 1,2,2-trimethylpropylsulfonyl, 1-ethyl-1-methylpropylsulfonyl or 1-ethyl-2-methylpropylsulfonyl.


The term “haloalkylsulfonyl” denotes a haloalkyl group, as defined above, attached via a sulfonyl [S(O)2] group to the remainder of the molecule. C1-C2-Haloalkylsulfonyl is, for example, S(O)2CH2F, S(O)2CHF2, S(O)2CF3, S(O)2CH2Cl, S(O)2CHCl2, S(O)2CCl3, chlorofluoromethylsulfonyl, dichlorofluoromethylsulfonyl, chlorodifluoromethylsulfonyl, 2-fluoroethylsulfonyl, 2-chloroethylsulfonyl, 2-bromoethylsulfonyl, 2-iodoethylsulfonyl, 2,2-difluoroethylsulfonyl, 2,2,2-trifluoroethylsulfonyl, 2-chloro-2-fluoroethylsulfonyl, 2-chloro-2,2-difluoroethylsulfonyl, 2,2-dichloro-2-fluoroethylsulfonyl, 2,2,2-trichloroethylsulfonyl or S(O)2C2F5. C1-C3-Haloalkylsulfonyl is additionally, for example, 2-fluoropropylsulfonyl, 3-fluoropropylsulfonyl, 2,2-difluoropropylsulfonyl, 2,3-difluoropropylsulfonyl, 2-chloropropylsulfonyl, 3-chloropropylsulfonyl, 2,3-dichloropropylsulfonyl, 2-bromopropylsulfonyl, 3-bromopropylsulfonyl, 3,3,3-trifluoropropylsulfonyl, 3,3,3-trichloropropylsulfonyl, S(O)2CH2-C2F5, S(O)2CF2-C2F5, 1-(CH2F)-2-fluoroethylsulfonyl, 1-(CH2Cl)-2-chloroethylsulfonylor 1-(CH2Br)-2-bromoethylsulfonyl. C1-C4-Haloalkylsulfonyl is additionally, for example, 4-fluorobutylsulfonyl, 4-chlorobutylsulfonyl, 4-bromobutylsulfonyl or nonafluorobutylsulfonyl. C1-C6-Haloalkylsulfonyl is additionally, for example, 5-fluoropentylsulfonyl, 5-chloropentylsulfonyl, 5-brompentylsulfonyl, 5-iodopentylsulfonyl, undecafluoropentylsulfonyl, 6-fluorohexylsulfonyl, 6-chlorohexylsulfonyl, 6-bromohexylsulfonyl, 6-iodohexylsulfonyl or dodecafluorohexylsulfonyl.


The substituent “oxo” replaces a CH2 group by a C(═O) group.


The suffix “-carbonyl” in a group denotes in each case that the group is bound to the remainder of the molecule via a carbonyl C═O group. This is the case e.g. in alkylcarbonyl, haloalkylcarbonyl, aminocarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl, alkoxycarbonyl, haloalkoxycarbonyl.


The term “alkoxycarbonyl” denotes an alkoxy group, as defined above, attached via a carbonyl [C(═O)] group to the remainder of the molecule. C1-C3-Alkoxycarbonyl is a C1-C3-alkoxy group, as defined above, attached via a carbonyl [C(═O)] group to the remainder of the molecule. Examples for C1-C3-alkoxycarbonyl are methoxycarbonyl, ethoxycarbonyl, propoxycarbonyl and isopropoxycarbonyl. C1-C6-Alkoxycarbonyl is a C1-C6-alkoxy group, as defined above, attached via a carbonyl [C(═O)] group to the remainder of the molecule. Examples for C1-C6-alkoxycarbonyl are, in addition to those listed for C1-C3-alkoxycarbonyl, n-butoxycarbonyl, sec-butoxycarbonyl, isobutoxycarbonyl, tert-butoxycarbonyl, pentoxycarbonyl and hexoxycarbonyl.


The term “haloalkoxycarbonyl” denotes a haloalkoxy group, as defined above, attached via a carbonyl [C(═O)] group to the remainder of the molecule. C1-C3-Halolkoxycarbonyl is a C1-C3-haloalkoxy group, as defined above, attached via a carbonyl [C(═O)] group to the remainder of the molecule. Examples for C1-C3-haloalkoxycarbonyl are —C(O)OCH2F, —C(O)OCHF2, —C(O)OCF3, —C(O)OCH2Cl, C(O) OCHCl2, —C(O) OCCl3, chlorofluoromethoxycarbonyl, dichlorofluoromethoxycarbonyl, chlorodifluoromethoxycarbonyl, 2-fluoroethoxycarbonyl, 2-chloroethoxycarbonyl, 2-bromoethoxycarbonyl, 2-iodoethoxycarbonyl, 2,2-difluoroethoxycarbonyl, 2,2,2-trifluoroethoxycarbonyl, 2-chloro-2-fluoroethoxycarbonyl, 2-chloro-2,2-difluoroethoxycarbonyl, 2,2-dichloro-2-fluoroethoxycarbonyl, 2,2,2-trichloroethoxycarbonyl, —C(O) OC2F5, 2-fluoropropoxycarbonyl, 3-fluoropropoxycarbonyl, 2,2-difluoropropoxycarbonyl, 2,3-difluoropropoxycarbonyl, 2-chloropropoxycarbonyl, 3-chloropropoxycarbonyl, 2,3-dichloropropoxycarbonyl, 2-bromopropoxycarbonyl, 3-bromopropoxycarbonyl, 3,3,3-trifluoropropoxycarbonyl, 3,3,3-trichloropropoxycarbonyl, —C(O)OCH2-C2F5, —C(O)OCF2-C2F5, 1-(CH2F)-2-fluoroethoxycarbonyl, 1-(CH2Cl)-2-chloroethoxycarbonyl or 1-(CH2Br)-2-bromoethoxycarbonyl.


The term “alkoxycarbonyl-alkyl” denotes an alkyl group, as defined above, in which one hydrogen atom is replaced by an alkoxycarbonyl group, as defined above. C1-C6-Alkoxycarbonyl-C1-C6-alkyl is a C1-C6-alkyl group, as defined above, in which one hydrogen atom is replaced by a C1-C6-alkoxycarbonyl group, as defined above.


Phenyl-(C1-C3-alkyl) is a C1-C3-alkyl group, as defined above, in which one hydrogen atom is replaced by a phenyl ring (i.e. the attachment to the remainder of the molecule is via the alkyl group). Examples are benzyl, 1-phenylethyl, 2-phenylethyl, 1-phenylpropyl, 2-phenylpropyl, 3-phenylpropyl or 2-phenyl-2-propyl.


Furanyl-(C1-C3-alkyl) is a C1-C3-alkyl group, as defined above, in which one hydrogen atom is replaced by a 2- or 3-furanyl ring (i.e. the attachment to the remainder of the molecule is via the alkyl group). Examples are furan-2-yl-methyl, furan-3-yl-methyl, 1-(furan-2-yl)-ethyl, 1-(furan-3-yl)-ethyl, 2-(furan-2-yl)-ethyl, 2-(furan-3-yl)-ethyl and the like.


Phenylthio is a phenyl ring attached via an S atom to the remainder of the molecule.


Phenylsulfinyl is a phenyl ring attached via a S(O) group to the remainder of the molecule.


Phenylsulfonyl is a phenyl ring attached via a S(O)2 group to the remainder of the molecule.


Z is a three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic ring, except phenyl, which is formed from r carbon atoms, n nitrogen atoms, n sulfur atoms and n oxygen atoms. The ring can thus be carbocyclic (i.e. containing only carbon atoms as ring members; r being here 3 to 6 and n being 0) or heterocyclic (i.e. containing also at least one N, O and/or S atom as ring member(s); r being here thus from 1 to 5 and at least one of the n's being 1).


An unsaturated carbocycle contains at least one C═C double bond(s). An unsaturated heterocycle contains at least one C—C and/or C—N and/or N—N double bond(s). Partially unsaturated carbocyclic rings contain less than the maximum number of C═C double bond(s) allowed by the ring size. Partially unsaturated heterocyclic rings contain less than the maximum number of C—C and/or C—N and/or N—N double bond(s) allowed by the ring size. A fully (or maximally) unsaturated carbocyclic ring contains as many conjugated C═C double bonds as allowed by the size(s) of the ring(s). Not encompassed in the definition of Z is however phenyl. A fully (or maximally) unsaturated heterocycle contains as many conjugated C—C and/or C—N and/or N—N double bonds as allowed by the size(s) of the ring(s). Maximally unsaturated 5- or 6-membered heteromonocyclic rings are generally aromatic. Exceptions are maximally unsaturated 6-membered rings containing O, S, SO and/or SO2 as ring members, such as pyran and thiopyran, which are not aromatic.


Examples for three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic carbocyclic rings Z are cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloprop-1-enyl, cycloprop-2-enyl, cyclobut-1-enyl, cyclobut-2-enyl, cyclobutadienyl, cyclopent-1-enyl, cyclopent-2-enyl, cyclopent-3-enyl, cyclopenta-1,3-dienyl, cyclopenta-1,4-dienyl, cyclopenta-2,4-dienyl, cyclohex-1-enyl, cyclohex-2-enyl, cyclohex-3-enyl, cyclohexa-1,3-dienyl, cyclohexa-1,4-dienyl, cyclohexa-1,5-dienyl, cyclohexa-2,4-dienyl, cyclohexa-2,5-dienyl, and the like.


Examples for three-, four-, five- or six-membered saturated, partly unsaturated, fully unsaturated or aromatic heterocyclic rings Z are:


3-, 4-, 5- or 6-membered monocyclic saturated heterocycle: e.g. oxiran-2-yl, thiiran-2-yl, aziridin-1-yl, aziridin-2-yl, oxetan-2-yl, oxetan-3-yl, thietan-2-yl, thietan-3-yl, 1-oxothietan-2-yl, 1-oxothietan-3-yl, 1,1-dioxothietan-2-yl, 1,1-dioxothietan-3-yl, azetidin-1-yl, azetidin-2-yl, azetidin-3-yl, tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahydrothien-2-yl, tetrahydrothien-3-yl, 1-oxotetrahydrothien-2-yl, 1,1-dioxotetrahydrothien-2-yl, 1-oxotetrahydrothien-3-yl, 1,1-dioxotetrahydrothien-3-yl, 1,3-dioxolan-2-yl, 1,3-dioxolan-4-yl, 1,3-ditholan-2-yl, 1,3-ditholan-4-yl, 1,3-oxathiolan-2-yl, 1,3-oxathiolan-4-yl, 1,3-oxathiolan-5-yl, pyrrolidin-1-yl, pyrrolidin-2-yl, pyrrolidin-3-yl, pyrazolidin-1-yl, pyrazolidin-3-yl, pyrazolidin-4-yl, pyrazolidin-5-yl, imidazolidin-1-yl, imidazolidin-2-yl, imidazolidin-4-yl, oxazolidin-2-yl, oxazolidin-3-yl, oxazolidin-4-yl, oxazolidin-5-yl, isoxazolidin-2-yl, isoxazolidin-3-yl, isoxazolidin-4-yl, isoxazolidin-5-yl, thiazolidin-2-yl, thiazolidin-3-yl, thiazolidin-4-yl, thiazolidin-5-yl, isothiazolidin-2-yl, isothiazolidin-3-yl, isothiazolidin-4-yl, isothiazolidin-5-yl, 1,2,4-oxadiazolidin-3-yl, 1,2,4-oxadiazolidin-5-yl, 1,2,4-thiadiazolidin-3-yl, 1,2,4-thiadiazolidin-5-yl, 1,3,4-oxadiazolidin-2-yl, 1,3,4-thiadiazolidin-2-yl, 2-tetrahydropyranyl, 3-tetrahydropyranyl, 4-tetrahydropyranyl, 1,3-dioxan-2-yl, 1,3-dioxan-4-yl, 1,3-dioxan-5-yl, 1,4-dioxan-2-yl, piperidin-1-yl, piperidin-2-yl, piperidin-3-yl, piperidin-4-yl, hexahydropyridazin-1-yl, hexahydropyridazin-3-yl, hexahydropyridazin-4-yl, hexahydropyrimidin-1-yl, hexahydropyrimidin-2-yl, hexahydropyrimidin-4-yl, hexahydropyrimidin-5-yl, piperazin-1-yl, piperazin-2-yl, morpholin-2-yl, morpholin-3-yl, morpholin-4-yl, thiomorpholin-2-yl, thiomorpholin-3-yl, thiomorpholin-4-yl, 1-oxothiomorpholin-2-yl, 1 oxothiomorpholin-3-yl, 1-oxothiomorpholin-4-yl, 1,1 dioxothiomorpholin-2-yl, 1,1 dioxothiomorpholin-3-yl, 1,1-dioxothiomorpholin-4-yl, and the like;


5- or 6-membered monocyclic partially unsaturated heterocycles: e.g. 2,3-dihydrofur-2-yl, 2,3-dihydrofur-3-yl, 2,5-dihydrofur-2-yl, 2,5-dihydrofur-3-yl, 2,3-dihydrothien-2-yl, 2,3-dihydrothien-3-yl, 2,5-dihydrothien-2-yl, 2,5-dihydrothien-3-yl, 2-pyrrolin-2-yl, 2-pyrrolin-3-yl, 3-pyrrolin-2-yl, 3-pyrrolin-3-yl, 2-isoxazolin-3-yl, 3-isoxazolin-3-yl, 4-isoxazolin-3-yl, 2-isoxazolin-4-yl, 3-isoxazolin-4-yl, 4-isoxazolin-4-yl, 2-isoxazolin-5-yl, 3-isoxazolin-5-yl, 4-isoxazolin-5-yl, 2-isothiazolin-3-yl, 3-isothiazolin-3-yl, 4-isothiazolin-3-yl, 2-isothiazolin-4-yl, 3-isothiazolin-4-yl, 4-isothiazolin-4-yl, 2-isothiazolin-5-yl, 3-isothiazolin-5-yl, 4-isothiazolin-5-yl, 2,3-dihydropyrazol-1-yl, 2,3-dihydropyrazol-2-yl, 2,3-dihydropyrazol-3-yl, 2,3-dihydropyrazol-4-yl, 2,3-dihydropyrazol-5-yl, 3,4-dihydropyrazol-1-yl, 3,4-dihydropyrazol-3-yl, 3,4-dihydropyrazol-4-yl, 3,4-dihydropyrazol-5-yl, 4,5-dihydropyrazol-1-yl, 4,5-dihydropyrazol-3-yl, 4,5-dihydropyrazol-4-yl, 4,5-dihydropyrazol-5-yl, 2,3-dihydrooxazol-2-yl, 2,3-dihydrooxazol-3-yl, 2,3-dihydrooxazol-4-yl, 2,3-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 3,4-dihydrooxazol-5-yl, 3,4-dihydrooxazol-2-yl, 3,4-dihydrooxazol-3-yl, 3,4-dihydrooxazol-4-yl, 3,6-dihydro-2H-pyran-2-, -3-, -4-, -5- or 6-yl, 3,4-dihydro-2H-pyran-2-, -3-, -4-, -5- or 6-yl, 3,6-dihydro-2H-thiopyran-2-, -3-, -4-, -5- or 6-yl, 3,4-dihydro-2H-thiopyran-2-, -3-, -4-, -5- or 6-yl, 2-, 3-, 4-, 5- or 6-di- or tetrahydropyridinyl, 3-di- or tetrahydropyridazinyl, 4-di- or tetrahydropyridazinyl, 2-di- or tetrahydropyrimidinyl, 4-di- or tetrahydropyrimidinyl, 5-di- or tetrahydropyrimidinyl, di- or tetrahydropyrazinyl;


5- or 6-membered monocyclic fully unsaturated (including aromatic) heterocyclic ring: e.g. 2-furyl, 3-furyl, 2-thienyl, 3-thienyl, 1-pyrrolyl, 2-pyrrolyl, 3-pyrrolyl, 1-pyrazolyl, 3-pyrazolyl, 4-pyrazolyl, 5-pyrazolyl, 2-oxazolyl, 4-oxazolyl, 5-oxazolyl, 2-thiazolyl, 4-thiazolyl, 5-thiazolyl, 1-imidazolyl, 2-imidazolyl, 4-imidazolyl, 5-imidazolyl, 2-pyridinyl, 3-pyridinyl, 4-pyridinyl, 3-pyridazinyl, 4-pyridazinyl, 2-pyrimidinyl, 4-pyrimidinyl, 5-pyrimidinyl and 2-pyrazinyl.


Specifically, Z is a five- or six-membered partly unsaturated carbocyclic ring. Examples therefor are cyclopent-1-en-1-yl, cyclopent-2-en-1-yl, cyclopent-3-en-1-yl, cyclopenta-1,3-dien-1-yl, cyclopenta-1,4-dien-1-yl, cyclopenta-2,4-dien-1-yl, cyclohex-1-en-1-yl, cyclohex-2-en-1-yl, cyclohex-3-en-1-yl, cyclohexa-1,3-dien-1-yl, cyclohexa-1,4-dien-1-yl, cyclohexa-1,5-dien-1-yl, cyclohexa-2,4-dien-1-yl and cyclohexa-2,5-dien-1-yl.


If two radicals bound on the same nitrogen atom (for example Rb2 and Rb3), together with the nitrogen atom to which they are bound, form a 3-, 4-, 5-, 6- or 7-membered, saturated N-bound heterocyclic ring which may contain as a ring member a further heteroatom or heteroatom group selected from the group consisting of N, O, S, S(O) and S(O)2, this is for example aziridn-1-yl, azetidin-1-yl, pyrrolidin-1-yl, pyrazolidin-1-yl, imidazolidin-1-yl, oxazolidin-3-yl, thiazolidin-3-yl, isoxazolidin-2-yl, isothiazolin-2-yl, piperdin-1-yl, piperazin-1-yl, morpholin-1-yl, thiomorpholin-1-yl, 1-oxothiomorpholin-1-yl, 1,1-dioxothiomorpholin-1-yl, azepan-1-yl or 1,4-diazepan-1-yl.


If two radicals bound on the same nitrogen atom (for example Rb2 and Rb3), together with the nitrogen atom to which they are bound, form a 5- or 6-membered, saturated N-bound heterocyclic ring, this is pyrrolidin-1-yl or piperidin-1-yl.


The remarks made below as to preferred embodiments of the variables (substituents) of the compounds of formula I are valid on their own as well as preferably in combination with each other, as well as in combination with the stereoisomers or salts thereof. The remarks made below concerning preferred embodiments of the variables further are valid on their own as well as preferably in combination with each other concerning the compounds of formulae I, where applicable, as well as concerning the uses and methods according to the invention and the composition according to the invention.


Preferably, R1 is hydrogen or (C1-C3)-alkyl, and is more preferably hydrogen.


Preferably, R9 is hydrogen or (C1-C3)-alkyl, and is more preferably hydrogen.


Preferably, R1 and R9 are both hydrogen.


Preferably, R2 is hydrogen, halogen or (C1-C3)-alkyl. More preferably, R2 is hydrogen or halogen. In particular, R2 is hydrogen.


Preferably, R6 is hydrogen, halogen or (C1-C3)-alkyl. More preferably, R6 is hydrogen.


Preferably, R2 and R6, independently of each other, are hydrogen, halogen or (C1-C3)alkyl. More preferably, R2 is hydrogen or halogen and R6 is hydrogen. In particular, R2 is hydrogen and R6 is hydrogen.


Preferably, R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or


(C1-C3)-haloalkoxy. More preferably, R3 is hydrogen, halogen, (C1-C2)-alkyl, (C1-C2)-haloalkyl, (C1-C2)-alkoxy or (C1-C2)-haloalkoxy. Even more preferably, R3 is halogen, (C1-C2)-alkyl, (C1-C2)-haloalkyl, (C1-C2)-alkoxy or (C1-C2)-haloalkoxy. In particular, R3 is halogen, (C1-C2)-alkyl or (C1-C2)-haloalkoxy. Specifically, R3 is hydrogen or halogen.


Preferably, R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy. More preferably, R5 is hydrogen, halogen or (C1-C2)-alkyl. Specifically, R5 is hydrogen or halogen.


Preferably R3 and R5, independently of each other, are hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy. More preferably, R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy and R5 is hydrogen, halogen or (C1-C2)-alkyl. Even more preferably, R3 is halogen, (C1-C3)-alkyl or (C1-C3)-haloalkoxy and R5 is hydrogen or halogen. In particular, R3 and R5, independently of each other, are hydrogen or halogen.


Preferably, R4 is hydrogen or halogen. In particular, R4 is hydrogen.


Preferably, R7 and R8, independently of each other, are (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl, each substituted by m radicals selected from the group consisting of fluorine, chlorine, bromine, iodine, hydroxyl and cyano. Preferably, m is 0, 1 or 2, more preferably, 0 or 1 and specifically 0. Thus, more preferably, R7 and R8, independently of each other, are (in each case unsubstituted) (C1-C6)-alkyl, (C3-C6)-cycloalkyl, (C2-C6)-alkenyl or (C2-C6)-alkynyl. Even more preferably, R7 and R8, independently of each other, are (C1-C6)-alkyl, (C3-C6)-cycloalkyl or (C2-C6)-alkenyl. In particular, R7 and R8, independently of each other, are (C1-C6)-alkyl or (C2-C6)-alkenyl; more particularly (C1-C6)-alkyl; even more particularly (C1-C4)-alkyl, specifically methyl or ethyl, and are very specifically both methyl.


In the divalent radicals (X1) to (X6), the orientation within the molecule is as depicted, the left arrow representing the bond to the adjacent nitrogen atom and the right arrow representing the bond to Y.


When X is a bond (“X0”), the compound (I) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X1), the compound (I) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X2), the compound (I) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X3), the compound (I) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X4), the compound (I) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X5), the compound (I) can also be depicted as follows:




embedded image


When X is a divalent radical of the formula (X6), the compound (I) can also be depicted as follows:




embedded image


In the divalent radicals (X1) to (X6), R10-R15, independently of each other and independently of each occurrence, are preferably selected from the group consisting of hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, CO2Re, CONRbRd; (C1-C6)-alkyl, (C3-C5)-cycloalkyl, (C2-C6)-alkenyl, where the three last-mentioned aliphatic and cycloaliphatic radicals are each independently substituted by m fluorine atoms; (C1-C6)-alkoxy, (C3-C6)-cycloalkoxy, (C2-C6)-alkenyloxy, (C2-C6)-alkynyloxy, (C1-C3)-alkylsulfinyl, (C1-C3)-alkylsulfonyl and (C1-C3)-alkylthio, where the aliphatic and cycloaliphatic moieties in the 7 last-mentioned radicals are each independently substituted by m fluorine atoms.


More preferably, R10-R15, independently of each other and independently of each occurrence, are selected from the group consisting of hydrogen, fluorine, chlorine, bromine, iodine, hydroxyl, cyano, CO2Re, CONRbRd; (C1-C6)-alkyl, (C3-C5)-cycloalkyl, (C2-C6)-alkenyl, where the three last-mentioned aliphatic and cycloaliphatic radicals are each independently substituted by m fluorine atoms; (C1-C6)-alkoxy, (C3-C6)-cycloalkoxy, (C2-C6)-alkenyloxy or (C2-C6)-alkynyloxy, where the aliphatic and cycloaliphatic moieties in the four last-mentioned radicals are each independently substituted by m fluorine atoms.


In particular, R10-R15, independently of each other and independently of each occurrence, are selected from the group consisting of hydrogen, fluorine, chlorine, CO2Re, CONRbRd, (C1-C6)-alkyl substituted by m fluorine atoms, or (C1-C6)-alkoxy substituted by m fluorine atoms.


In particular, R10-R15, independently of each other and independently of each occurrence, are selected from the group consisting of hydrogen, halogen, (C1-C6)-alkyl, (C1-C3)-alkoxy, and CO2Re. More particularly, R10-R15, independently of each other and independently of each occurrence, are hydrogen or (C1-C6)-alkyl and specifically hydrogen or methyl.


Non-exhaustive examples for suitable divalent radicals (X1) to (X6) are CH2, CH2CH2, CH(CH3), CH2CH2CH2, CH(CH2CH3), CH(CH3) CH2, C(CH3) 2, C(CH3) 2CH2, C(iPr)CH3, CH(CH2iPr) CH2, CH2CH═CH, C(CH3) 2C═C, CH(CF3) CH2, CH(CH3) CH2O, CH2CH2O, CH(cPr) CH2O, CH(CH2OCH3), CH(CH2CH2SCH3), CH(COOH), CH(COOCH3), CH(COOH) CH2, CH(COOCH3) CH2, CH2C(OH) (CF3), CH(CONHCH3), CH(CONHCH3) CH2 and CH2CH2CONHCH2, cPr is cyclopropyl; iPr is isopropyl.


In a preferred embodiment, X is a bond or the divalent unit (X1). In the latter, preferably, R10 and R11, independently of each other, are hydrogen or (C1-C6)-alkyl, and more preferably hydrogen or methyl. In particular, one of R10 and R11 is hydrogen and the other is methyl, X1 thus being in particular CH(CH3).


In a preferred embodiment, Y is Z.


Z is preferably a three-, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated carbocyclic ring, except phenyl, which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O), Ra, SO2NRbRd, SO2NRbCORe, CORD, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe, and more preferably by p radicals selected from the group consisting of CO2Re, CONRbRh and CONReS(O)Ra; and where the carbon ring atoms bear n oxo groups. p is in this context preferably 1 or 2, more preferably 1. n is in this context preferably 0 or 1, in particular 0. More preferably, Z is a five- or sixmembered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh and CONReS(O)Ra. In particular, Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re. Re is in this context preferably hydrogen, (C1 -C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and p is in this context preferably 1 or 2, more preferably 1. Thus, more particularly, Z is a five- or sixmembered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, more specifically hydrogen or (C1-C4)-alkyl, very specifically hydrogen or methyl, and p is 1 or 2, preferably 1. Even more particularly, Z is a five- or six-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, more specifically hydrogen or (C1-C4)-alkyl, very specifically hydrogen or methyl, and p is 1 or 2, preferably 1. Specifically, Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, more specifically hydrogen or (C1-C4)-alkyl, very specifically hydrogen or methyl, and p is 1 or 2, preferably 1.


Examples for five- or six-membered saturated or partly unsaturated carbocyclic rings are listed above. Among these, preference is given to cyclopentyl, cyclopent-1-en-1-yl, cyclopent-2-en-1-yl, cyclopent-3-en-1-yl and cyclohexyl. A specific example is cyclopent-2-en-1-yl. In the latter ring, if p is 1, the mandatory substituent (CO2Re etc.) is preferably bound in the 4-position.


In an alternatively preferred embodiment, Z is a three-, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated heterocyclic ring containing one or two oxygen atoms as ring members, where the ring is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O), Ra, SO2NRbRd, SO2NRbCORe, CORD, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRb- CONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORIRf and C(Rb)═NORe, and where the carbon ring atoms bear n oxo groups. p is in this context preferably 1 or 2, more preferably 1. n is in this context preferably 0 or 1, in particular 0. More preferably, Z is a saturated or partly unsaturated five- or six-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re. Re is in this context preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and p is in this context preferably 1 or 2, more preferably 1. Thus, more particularly, Z is a saturated or partly unsaturated five- or six-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and p is 1 or 2, preferably 1. Even more particularly, Z is a saturated or partly unsaturated five-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl. and p is in this context preferably 1 or 2, more preferably 1. Specifically, Z is a saturated or partly unsaturated five-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by one radical CO2Re, where Re is hydrogen or (C1-C6)-alkyl.


Examples for three-, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated heterocyclic rings containing one or two oxygen atoms as ring members are oxiran-2-yl, oxetan-2-yl, oxetan-3-yl, tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, 1,3-dioxolan-2-yl, 1,3-dioxolan-4-yl, tetrahydropyran-2-yl, tetrahydropyran-3-yl, tetrahydropyran-4-yl, 1,3-dioxan-2-yl, 1,3-dioxan-4-yl, 1,3-dioxan-5-yl, 1,4-dioxan-2-yl, 2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,5-dihydrofuran-2-yl, 2,5-dihydrofuran-3-yl, 3,6-dihydro-2H-pyran-2-yl, 3,6-dihydro-2H-pyran-3-yl, 3,6-dihydro-2H-pyran-4-yl, 3,6-dihydro-2H-pyran-5-yl, 3,6-dihydro-2H-pyran-6-yl, 3,4-dihydro-2H-pyran-2-yl, 3,4-dihydro-2H-pyran-3-yl, 3,4-dihydro-2H-pyran-4-yl, 3,4-dihydro-2H-pyran-5-yl or 3,4-dihydro-2H-pyran-6-yl.


Examples for saturated or partly unsaturated five- or six-membered heterocyclic rings containing one oxygen atom as ring member are tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, tetrahydropyran-2-yl, tetrahydropyran-3-yl, tetrahydropyran-4-yl, 2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,5-dihydrofuran-2-yl, 2,5-dihydrofuran-3-yl, 3,6-dihydro-2Hpyran-2-yl, 3,6-dihydro-2H-pyran-3-yl, 3,6-dihydro-2H-pyran-4-yl, 3,6-dihydro-2Hpyran-5-yl, 3,6-dihydro-2H-pyran-6-yl, 3,4-dihydro-2H-pyran-2-yl, 3,4-dihydro-2Hpyran-3-yl, 3,4-dihydro-2H-pyran-4-yl, 3,4-dihydro-2H-pyran-5-yl or 3,4-dihydro-2Hpyran-6-yl.


Examples for saturated or partly unsaturated five-membered heterocyclic rings containing one oxygen atom as ring member are tetrahydrofuran-2-yl, tetrahydrofuran-3-yl, 2,3-dihydrofuran-2-yl, 2,3-dihydrofuran-3-yl, 2,5-dihydrofuran-2-yl, or 2,5-dihydrofuran-3-yl.


Preferably, however, ring Z is carbocyclic.


In another preferred embodiment, Y is (C1-C8)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O), Ra, SO2NRbRd, SO2NRbCORe, CORD, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe. p is in this context preferably 1 or 2, more preferably 1.


More preferably, Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and


CONRb1SO2NRb2Rb3, where Ra, Rb, Rb1, Rb2, Rb3, Re and Rh are as defined above, where however in particular:

    • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl; or phenyl-(C1-C3)-alkyl; preferably (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, more specifically hydrogen or (C1-C4)-alkyl, very specifically hydrogen or methyl;
    • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
    • Rh in CONRbRh is (C1-C3)-alkoxy;
    • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
    • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
    • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
    • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
    • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
    • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
    • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
    • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


In a preferred embodiment, X is a bond and Y is Z, where Z has one of the above general or preferred meanings.


Preferably, Z is a three-, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated carbocyclic ring, except phenyl, which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O), Ra, SO2NRbRd, SO2NRbCORe, CORD, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe, and where the carbon ring atoms bear n oxo groups. p is in this context preferably 1 or 2, more preferably 1. n is in this context preferably 0 or 1, in particular 0.


More preferably, Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh and CONReS(O)Ra. In particular, Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re. Re is in this context preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, more specifically hydrogen or (C1-C4)-alkyl, very specifically hydrogen or methyl, and p is in this context preferably 1 or 2, more preferably 1. Thus, particularly, Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, more specifically hydrogen or (C1-C4)-alkyl, very specifically hydrogen or methyl, and p is 1 or 2, preferably 1. More particularly, Z is a five- or six-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, more specifically hydrogen or (C1-C4)-alkyl, very specifically hydrogen or methyl, and p is 1 or 2, preferably 1. Specifically, Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl, specifically hydrogen or (C1-C4)-alkyl, very specifically hydrogen or methyl, and p is 1 or 2, preferably 1.


In an alternatively preferred embodiment, Z is a three-, four-, five- or six-membered saturated, partly unsaturated or fully unsaturated heterocyclic ring containing one or two oxygen atoms as ring members, where the ring is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O),Ra, SO2NRbRd, SO2NRbCORe, CORD, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRb- CONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe, and where the carbon ring atoms bear n oxo groups. p is in this context preferably 1 or 2, more preferably 1. n is in this context preferably 0 or 1, in particular 0.


More preferably, Z is a saturated or partly unsaturated five- or six-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re. Re is in this context preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and p is in this context preferably 1 or 2, more preferably 1. Thus, particularly, Z is a saturated or partly unsaturated five- or six-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; specifically hydrogen or (C1-C6)-alkyl, and p is 1 or 2, preferably 1. More particularly, Z is a saturated or partly unsaturated five-membered heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl and p is 1 or 2, preferably 1.


Preferably, however, ring Z is carbocyclic.


In another preferred embodiment,

    • X is a divalent unit (X1), where R10 and R11 are as defined above and are in particular independently hydrogen or (C1-C6)-alkyl; and
    • Y is (C1-C8)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O),Ra, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O) Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe.


In an alternative preferred embodiment,

    • X is a bond; and
    • Y is (C1-C8)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O), Ra, SO2NRbRd, SO2NRbCORe, CORb, CONReS(O) Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORfRf and C(Rb)═NORe.


More preferably,

    • X is a divalent unit (X1), where R10 and R11 are independently hydrogen or methyl; and
    • Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where Ra, Rb, Rb1, Rb2, Rb3, Re and Rh have one of the above general or preferred meanings.


In this context, Y is preferably (C1-C4)-alkyl which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C4)-alkyl, e.g. hydrogen or methyl; specifically (C1-C4)-alkyl, e.g. methyl.


In an alternative more preferred embodiment,

    • X is a bond; and
    • Y is (C1-C6)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where Ra, Rb, Rb1, Rb2, Rb3, Re and Rh have one of the above general or preferred meanings.


In this latter alternative more preferred embodiment, (C1-C6)-alkyl in Y is preferably a group-C(R101) (R111)—C1-C4-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where Ra, Rb, Rb1, Rb2, Rb3, Re and Rh have one of the above general or preferred meanings and R101 and R111 are independently hydrogen or methyl, where however preferably one of R101 and R111 is hydrogen and the other is methyl.


In this context, Y is preferably a group-C(R101) (R111)—C1-C4-alkyl which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C4)-alkyl, e.g. hydrogen or methyl, specifically (C1-C4)-alkyl, e.g. methyl, and R101 and R111 are independently hydrogen or methyl, where however preferably one of R101 and R111 is hydrogen and the other is methyl.


Even more preferably,

    • X is a divalent unit (X1), where R10 and R11 are independently hydrogen or methyl; anc
    • Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; more preferably hydrogen or (C1-C6)-alkyl (e.g. hydrogen or (C1-C4)-alkyl; specifically hydrogen or methyl), specifically (C1-C6)-alkyl (e.g. (C1-C4)-alkyl; specifically methyl);
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
      • p is 1 or 2, preferably 1.


In this context, Y is preferably (C1-C4)-alkyl which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C4)-alkyl (e.g. hydrogen or methyl), in particular (C1-C4)-alkyl (e.g. methyl).


In an alternative even more preferred embodiment,

    • X is a bond; and
    • Y is (C1-C6)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3 where
      • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; more preferably hydrogen or (C1-C6)-alkyl (e.g. hydrogen or (C1-C4)-alkyl; specifically hydrogen or methyl), specifically (C1-C6)-alkyl (e.g. (C1-C4)-alkyl; specifically methyl);
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
      • p is 1 or 2, preferably 1.


In this latter alternative even more preferred embodiment, (C1-C6)-alkyl in Y is preferably a group-C(R101) (R111)—C1-C4-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where Ra, Rb, Rb1, Rb2, Rb3, Re and Rh have one of the above general or preferred meanings and R101 and R111 are independently hydrogen or methyl, where however preferably one of R101 and R111 is hydrogen and the other is methyl.


In this context, Y is preferably a group-C(R101) (R111)—C1-C4-alkyl which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C4)-alkyl, specifically hydrogen or methyl, and R101 and R111 are independently hydrogen or methyl, where however preferably one of R101 and R111 is hydrogen and the other is methyl.


Specifically,

    • X is CH(CH3); and
    • Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen or (C1-C6)-alkyl (preferably hydrogen or (C1-C4)-alkyl; specifically hydrogen or methyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl; Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
      • p is 1 or 2, preferably 1.


In this context, Y is preferably (C1-C4)-alkyl which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C4)-alkyl; specifically hydrogen or methyl.


In an alternative specific embodiment,

    • X is a bond; and
    • Y is CH(CH3)—(C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
      • Re in CO2Re is hydrogen or (C1-C6)-alkyl;
      • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
      • Rh in CONRbRh is (C1-C3)-alkoxy;
      • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
      • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
      • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
      • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
      • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1


In this context, Y is preferably CH(CH3)—(C1-C4)-alkyl which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C4)-alkyl.


In an alternatively preferred embodiment, -X-Y form together a group of the formula (XY1) or (XY2)




embedded image


where

    • # designates the attachment point to NR9;
    • RA, RB, RC, RD, RE and RF, independently of each other, have one of the meanings given for R10 and R11; or
    • RA and Rc, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated carbocyclic ring; or
    • Rc and RE, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated carbocyclic ring; or
    • RA and RE, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated carbocyclic ring.


Re in groups (XY1) and (XY2) is preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; more preferably hydrogen or (C1-C6)-alkyl, and is specifically (C1-C6)-alkyl.


More preferably,

    • in group of the formula (XY1)
    • RA is hydrogen or methyl; and
    • RB, Rc and RD are hydrogen; and


in group of the formula (XY2)

    • RA is hydrogen or methyl; and
    • RB, RC, RD, RE and RF are hydrogen; or
    • RA and RE, together with the carbon atoms they are bound to, form a 5- or 6-membered saturated or partly unsaturated carbocyclic ring; and form preferably a 5-membered partly unsaturated carbocyclic ring; and
    • RB, RC, RD and RF are hydrogen;
    • and
    • Re is hydrogen or (C1-C4)-alkyl.


In an alternatively preferred embodiment, -X-Y form together a group of the formula (XY1) or (XY2)




embedded image


where

    • # designates the attachment point to NR9;
    • RA and RC, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated heterocyclic ring containing 1 or 2 oxygen atoms as ring members; or
    • Rc and RE, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated heterocyclic ring containing 1 or 2 oxygen atoms as ring members; or
    • RA and RE, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated heterocyclic ring containing 1 or 2 oxygen atoms as ring members.


Re in this context is preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; more preferably hydrogen or (C1-C6)-alkyl, and is specifically (C1-C6)-alkyl.


More preferably,

    • RA and RE, together with the carbon atoms they are bound to, form a 5- or 6-membered saturated or partly unsaturated heterocyclic ring containing one oxygen atom as ring member; and form even more preferably a 5-membered saturated or partly unsaturated heterocyclic ring containing one oxygen atom as ring member; and
    • RB, RC, RD and RF are hydrogen;
      • and
    • Re is (C1-C4)-alkyl.


In a particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R6 is hydrogen;
    • R7 and R8, independently of each other, are (C1-C6)-alkyl or (C2-C6)-alkenyl; preferably (C1-C6)-alkyl;
    • R9 hydrogen; and
    • X is a bond; and Y is Z; where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl, preferably hydrogen or (C1-C6)-alkyl; or
    • X is a bond; and Y is Z; where Z is a five- or six-membered saturated or partly unsaturated heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl, preferably hydrogen or (C1-C6)-alkyl; or
    • X is a divalent unit (X1), where R10 and R11 are independently of each other hydrogen or (C1-C6)-alkyl; and Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONRe- SO2Ra and CONRb1SO2NRb2Rb3, where
    • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; in particular hydrogen or (C1-C6)-alkyl; specifically (C1-C6)-alkyl;
    • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
    • Rh in CONRbRh is (C1-C3)-alkoxy;
    • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
    • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
    • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
    • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
    • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
    • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
    • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
    • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


In a more particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R6 is hydrogen;
    • R7 and R8, independently of each other, are (C1-C6)-alkyl or (C2-C6)-alkenyl; preferably (C1-C6)-alkyl;
    • R9 hydrogen; and
    • X is a bond; and Y is Z; where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl, preferably hydrogen or (C1-C6)-alkyl; or
    • X is a divalent unit (X1), where R10 and R11 are independently of each other hydrogen or (C1-C6)-alkyl; and Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONRe- SO2Ra and CONRb1SO2NRb2Rb3, where
    • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; in particular hydrogen or (C1-C6)-alkyl; specifically (C1-C6)-alkyl;
    • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
    • Rh in CONRbRh is (C1-C3)-alkoxy;
    • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
    • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
    • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
    • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
    • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
    • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
    • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or


Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and

    • p is 1 or 2, preferably 1.


In an even more particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 and R8, independently of each other, are (C1-C6)-alkyl; preferably methyl or ethyl;
    • R9 hydrogen; and
    • X is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl (preferably hydrogen or (C1-C4)-alkyl; in particular hydrogen or methyl); or
    • X is a bond; and Y is Z; where Z is a five-membered saturated or partly unsaturated heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl; or
    • X is a divalent unit (X1), where R10 and R11 are independently of each other hydrogen or methyl; and Y is (C1-C4)-alkyl which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl (preferably hydrogen or (C1-C4)-alkyl; in particular hydrogen or methyl); and
    • p is 1 or 2, preferably 1.


In a specific embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 and R8, independently of each other, are (C1-C4)-alkyl, preferably methyl or ethyl, in particular methyl;
    • R9 hydrogen; and
    • X is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl (preferably hydrogen or (C1-C4)-alkyl; in particular hydrogen or methyl); or
    • X is a divalent unit (X1), where R10 and R11 are independently of each other hydrogen or methyl; and Y is (C1-C4)-alkyl which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl (preferably hydrogen or (C1-C4)-alkyl; in particular hydrogen or methyl); and
    • p is 1 or 2, preferably 1.


In a more specific embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 hydrogen;
    • R2 is hydrogen;
    • R3 is halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 and R8, independently of each other, are (C1-C4)-alkyl, preferably methyl or ethyl, in particular methyl;
    • R9 hydrogen; and
    • X is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl (preferably hydrogen or (C1-C4)-alkyl; in particular hydrogen or methyl); or
    • X is a divalent unit (X1), where one of R10 and R11 is hydrogen and the other is methyl; and Y is (C1-C4)-alkyl which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl (preferably hydrogen or (C1-C4)-alkyl; in particular hydrogen or methyl); and
    • p is 1.


In a very specific embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 hydrogen;
    • R2 is hydrogen;
    • R3 is halogen, (C1-C3)-alkyl or (C1-C3)-haloalkoxy;
    • R4 is hydrogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 and R8 are methyl;
    • R9 hydrogen; and
    • X is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C4)-alkyl (in particular hydrogen or methyl); or
    • X is a divalent unit (X1), where one of R10 and R11 is hydrogen and the other is methyl; and Y is (C1-C4)-alkyl which is substituted by p radicals CO2Re, where Re is (C1-C4)-alkyl (in particular hydrogen or methyl); and
    • p is 1.


In an alternative particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R6 is hydrogen;
    • R7 and R8, independently of each other, are (C1-C6)-alkyl or (C2-C6)-alkenyl; preferably (C1-C6)-alkyl;
    • R9 hydrogen; and
    • X is a bond; and Y is Z; where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl, preferably hydrogen or (C1-C6)-alkyl (more preferably hydrogen or (C1-C4)-alkyl; in particular hydrogen or methyl); or Z is a five- or six-membered saturated or partly unsaturated heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl, preferably hydrogen or (C1-C6)-alkyl; or
      • Y is (C1-C6)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
    • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; in particular hydrogen or (C1-C6)-alkyl (more particularly hydrogen or (C1-C4)-alkyl; e.g. hydrogen or methyl); specifically (C1-C6)-alkyl; Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
    • Rh in CONRbRh is (C1-C3)-alkoxy;
    • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
    • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
    • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
    • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
    • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
    • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
    • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
    • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


In an alternative more particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R6 is hydrogen;
    • R7 and R8, independently of each other, are (C1-C6)-alkyl or (C2-C6)-alkenyl; preferably (C1-C6)-alkyl;
    • R9 hydrogen; and
    • X is a bond; and Y is Z; where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl, preferably hydrogen or (C1-C6)-alkyl (preferably hydrogen or (C1-C4)-alkyl; in particular hydrogen or methyl); or Y is (C1-C6)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra and CONRb1SO2NRb2Rb3, where
    • Re in CO2Re is hydrogen, (C1-C6)-alkyl which may carry a cyano substituent; (C3-C6)-cycloalkyl; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl; preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; in particular hydrogen or (C1-C6)-alkyl (more particularly hydrogen or (C1-C4)-alkyl; e.g. hydrogen or methyl); specifically (C1-C6)-alkyl;
    • Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;
    • Rh in CONRbRh is (C1-C3)-alkoxy;
    • Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;
    • Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
    • Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;
    • Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;
    • Rb1 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
    • Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;
    • Rb3 in CONRb1SO2NRb2Rb3 is (C1-C6)-alkyl; or
    • Rb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; and
    • p is 1 or 2, preferably 1.


In an even more particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 and R8, independently of each other, are (C1-C6)-alkyl; preferably methyl or ethyl;
    • R9 hydrogen; and
    • X is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl (preferably hydrogen or (C1-C4)-alkyl; in particular hydrogen or methyl); or Z is a five-membered saturated or partly unsaturated heterocyclic ring containing one oxygen atom as ring member, where the ring is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl; or
      • Y is (C1-C6)-alkyl which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl (preferably hydrogen or (C1-C4)-alkyl; in particular hydrogen or methyl); and
    • p is 1 or 2, preferably 1.


In a specific embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 and R8, independently of each other, are methyl or ethyl;
    • R9 hydrogen; and
    • X is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl (preferably hydrogen or (C1-C4)-alkyl; in particular hydrogen or methyl); or Y is (C1-C6)-alkyl which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl (preferably hydrogen or (C1-C4)-alkyl; in particular hydrogen or methyl); and
    • p is 1 or 2, preferably 1.


In an alternative more specific embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 hydrogen;
    • R2 is hydrogen;
    • R3 is halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 and R8, independently of each other, are (C1-C4)-alkyl, preferably methyl or ethyl, in particular methyl;
    • R9 hydrogen; and
    • X is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl (preferably hydrogen or (C1-C4)-alkyl; in particular hydrogen or methyl); or Y is (C1-C6)-alkyl which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl (preferably hydrogen or (C1-C4)-alkyl; in particular hydrogen or methyl); and
    • p is 1.


In a very specific embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 hydrogen;
    • R2 is hydrogen;
    • R3 is halogen, (C1-C3)-alkyl or (C1-C3)-haloalkoxy;
    • R4 is hydrogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 and R8 are methyl;
    • R9 hydrogen; and
    • X is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C4)-alkyl (in particular hydrogen or methyl); or
      • Y is (C1-C6)-alkyl which is substituted by p radicals CO2Re, where Re is (C1-C4)-alkyl (in particular hydrogen or methyl); and
      • p is 1.


In the above particular and specific embodiments, the five-membered partly unsaturated carbocyclic ring Z is preferably a ring Z9 (depicted below), wherein # denotes the attachment point to the remainder of the molecule and Rx is CO2Re.


In another particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R6 is hydrogen;
    • R7 and R8, independently of each other, are (C1-C6)-alkyl or (C2-C6)-alkenyl; preferably (C1-C6)-alkyl;
    • R9 hydrogen; and
    • -X-Y form together a group of the formula (XY1) or (XY2)




embedded image


where

    • # designates the attachment point to NR9;
    • RA, RB, RC, RD, RE and RF, independently of each other, have one of the meanings given for R10 and R11; or
    • RA and Rc, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated carbocyclic ring; or
    • Rc and RE, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated carbocyclic ring; or
    • RA and RE, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated carbocyclic ring.
    • Re in groups (XY1) and (XY2) is preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; more preferably hydrogen or (C1-C6)-alkyl, and is specifically (C1-C6)-alkyl.


In another more particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 and R8, independently of each other, are (C1-C6)-alkyl; preferably methyl or ethyl, in particular methyl;
    • R9 hydrogen; and
    • X-Y form together a group of the formula (XY1) or (XY2), where in group of the formula (XY1)
    • RA is hydrogen or methyl; and
    • RB, Rc and RD are hydrogen; and


in group of the formula (XY2)

    • RA is hydrogen or methyl; and
    • RB, RC, RD, RE and RF are hydrogen; or
    • RA and RE, together with the carbon atoms they are bound to, form a 5- or 6-membered saturated or partly unsaturated carbocyclic ring; and form preferably a 5-membered partly unsaturated carbocyclic ring; and
    • RB, RC, RD and RF are hydrogen;
    • and
    • Re is hydrogen or (C1-C4)-alkyl (in particular hydrogen or methyl).


In another specific embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen;
    • R3 is halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 and R8, independently of each other, are (C1-C4)-alkyl; preferably methyl or ethyl, in particular methyl;
    • R9 hydrogen; and
    • X-Y form together a group of the formula (XY1) or (XY2), where


in group of the formula (XY1)

    • RA is hydrogen or methyl; and
    • RB, RC and RD are hydrogen; and


in group of the formula (XY2)

    • RA is hydrogen or methyl; and
    • RB, RC, RD, RE and RF are hydrogen; or
    • RA and RE, together with the carbon atoms they are bound to, form a 5-membered partly unsaturated carbocyclic ring; and
    • RB, RC, RD and RF are hydrogen;
    • and
    • Re is hydrogen or (C1-C4)-alkyl (in particular hydrogen or methyl).


In another more specific embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen;
    • R3 is halogen, (C1-C3)-alkyl or (C1-C3)-haloalkoxy;
    • R4 is hydrogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 and R8 are methyl;
    • R9 hydrogen; and
    • X-Y form together a group of the formula (XY1) or (XY2), where


in group of the formula (XY1)

    • RA is hydrogen or methyl; and
    • RB, RC and RD are hydrogen; and


in group of the formula (XY2)

    • RA is hydrogen or methyl; and
    • RB, RC, RD, RE and RF are hydrogen; or
    • RA and RE, together with the carbon atoms they are bound to, form a 5-membered partly unsaturated carbocyclic ring; and
    • RB, RC, RD and RF are hydrogen;
    • and
    • Re is hydrogen or (C1-C4)-alkyl (in particular hydrogen or methyl).


In yet another particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 hydrogen;
    • R2 is hydrogen or halogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen or halogen;
    • R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R6 is hydrogen;
    • R7 and R8, independently of each other, are (C1-C6)-alkyl or (C2-C6)-alkenyl; preferably (C1-C6)-alkyl;
    • R9 hydrogen; and
    • -X-Y form together a group of the formula (XY1) or (XY2)




embedded image


where

    • # designates the attachment point to NR9;
    • RA and Rc, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated heterocyclic ring containing 1 or 2 oxygen atoms as ring members; or
    • Rc and RE, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated heterocyclic ring containing 1 or 2 oxygen atoms as ring members; or
    • RA and RE, together with the carbon atoms they are bound to, form a 3-, 4-, 5- or 6-membered saturated or partially unsaturated heterocyclic ring containing 1 or 2 oxygen atoms as ring members.
    • Re in this context is preferably hydrogen, (C1-C6)-alkyl or (C3-C6)-cycloalkyl; more preferably hydrogen or (C1-C6)-alkyl, and is specifically (C1-C6)-alkyl.


In yet another more particular embodiment, in the compounds of formula (I), the substituents have the following meanings:

    • R1 is hydrogen;
    • R2 is hydrogen;
    • R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;
    • R4 is hydrogen;
    • R5 is hydrogen or halogen;
    • R6 is hydrogen;
    • R7 and R8, independently of each other, are (C1-C6)-alkyl; preferably methyl or ethyl;
    • R9 hydrogen; and
    • X-Y form together a group of the formula (XY1) or (XY2), where
    • RA and RE, together with the carbon atoms they are bound to, form a 5- or 6-membered saturated or partly unsaturated heterocyclic ring containing one oxygen atom as ring member; and form preferably a 5-membered saturated or partly unsaturated heterocyclic ring containing one oxygen atom as ring member;
    • RB, RC, RD and RF are hydrogen;
    • and
    • Re is (C1-C4)-alkyl.


Compounds (I), wherein R1, R6 and R9 are hydrogen and R2, R3, R4, R5, R7 and R8 have the meanings as defined in each line of table A below are particularly preferred.















TABLE A





No.
R2
R3
R4
R5
R7
R8





















1.
H
H
H
H
CH3
CH3


2.
H
F
H
H
CH3
CH3


3.
H
Cl
H
H
CH3
CH3


4.
H
Br
H
H
CH3
CH3


5.
H
I
H
H
CH3
CH3


6.
H
CH3
H
H
CH3
CH3


7.
H
Et
H
H
CH3
CH3


8.
H
CF3
H
H
CH3
CH3


9.
H
OCH3
H
H
CH3
CH3


10.
H
OCF3
H
H
CH3
CH3


11.
H
CN
H
H
CH3
CH3


12.
H
H
H
H
CH3
Et


13.
H
F
H
H
CH3
Et


14.
H
Cl
H
H
CH3
Et


15.
H
Br
H
H
CH3
Et


16.
H
I
H
H
CH3
Et


17.
H
CH3
H
H
CH3
Et


18.
H
Et
H
H
CH3
Et


19.
H
CF3
H
H
CH3
Et


20.
H
OCH3
H
H
CH3
Et


21.
H
OCF3
H
H
CH3
Et


22.
H
CN
H
H
CH3
Et


23.
H
H
H
H
Et
Et


24.
H
F
H
H
Et
Et


25.
H
Cl
H
H
Et
Et


26.
H
Br
H
H
Et
Et


27.
H
I
H
H
Et
Et


28.
H
CH3
H
H
Et
Et


29.
H
Et
H
H
Et
Et


30.
H
CF3
H
H
Et
Et


31.
H
OCH3
H
H
Et
Et


32.
H
OCF3
H
H
Et
Et


33.
H
CN
H
H
Et
Et


34.
H
H
H
H
CH3
Vin


35.
H
F
H
H
CH3
Vin


36.
H
Cl
H
H
CH3
Vin


37.
H
Br
H
H
CH3
Vin


38.
H
I
H
H
CH3
Vin


39.
H
CH3
H
H
CH3
Vin


40.
H
Et
H
H
CH3
Vin


41.
H
CF3
H
H
CH3
Vin


42.
H
OCH3
H
H
CH3
Vin


43.
H
OCF3
H
H
CH3
Vin


44.
H
CN
H
H
CH3
Vin


45.
H
H
H
H
Et
Vin


46.
H
F
H
H
Et
Vin


47.
H
Cl
H
H
Et
Vin


48.
H
Br
H
H
Et
Vin


49.
H
I
H
H
Et
Vin


50.
H
CH3
H
H
Et
Vin


51.
H
Et
H
H
Et
Vin


52.
H
CF3
H
H
Et
Vin


53.
H
OCH3
H
H
Et
Vin


54.
H
OCF3
H
H
Et
Vin


55.
H
CN
H
H
Et
Vin


56.
H
F
H
F
CH3
CH3


57.
H
Cl
H
F
CH3
CH3


58.
H
Br
H
F
CH3
CH3


59.
H
I
H
F
CH3
CH3


60.
H
CH3
H
F
CH3
CH3


61.
H
Et
H
F
CH3
CH3


62.
H
CF3
H
F
CH3
CH3


63.
H
OCH3
H
F
CH3
CH3


64.
H
OCF3
H
F
CH3
CH3


65.
H
CN
H
F
CH3
CH3


66.
H
F
H
F
CH3
Et


67.
H
Cl
H
F
CH3
Et


68.
H
Br
H
F
CH3
Et


69.
H
I
H
F
CH3
Et


70.
H
CH
H
F
CH3
Et


71.
H
Et
H
F
CH3
Et


72.
H
CF3
H
F
CH3
Et


73.
H
OCH3
H
F
CH3
Et


74.
H
OCF3
H
F
CH3
Et


75.
H
CN
H
F
CH3
Et


76.
H
F
H
F
Et
Et


77.
H
Cl
H
F
Et
Et


78.
H
Br
H
F
Et
Et


79.
H
I
H
F
Et
Et


80.
H
CH3
H
F
Et
Et


81.
H
Et
H
F
Et
Et


82.
H
CF3
H
F
Et
Et


83.
H
OCH3
H
F
Et
Et


84.
H
OCF3
H
F
Et
Et


85.
H
CN
H
F
Et
Et


86.
H
F
H
F
CH3
Vin


87.
H
Cl
H
F
CH3
Vin


88.
H
Br
H
F
CH3
Vin


89.
H
I
H
F
CH3
Vin


90.
H
CH3
H
F
CH3
Vin


91.
H
Et
H
F
CH3
Vin


92.
H
CF3
H
F
CH3
Vin


93.
H
OCH3
H
F
CH3
Vin


94.
H
OCF3
H
F
CH3
Vin


95.
H
CN
H
F
CH3
Vin


96.
H
F
H
F
Et
Vin


97.
H
Cl
H
F
Et
Vin


98.
H
Br
H
F
Et
Vin


99.
H
I
H
F
Et
Vin


100.
H
CH3
H
F
Et
Vin


101.
H
Et
H
F
Et
Vin


102.
H
CF3
H
F
Et
Vin


103.
H
OCH3
H
F
Et
Vin


104.
H
OCF3
H
F
Et
Vin


105.
H
CN
H
F
Et
Vin


106.
H
Cl
H
Cl
CH3
CH3


107.
H
Br
H
Cl
CH3
CH3


108.
H
I
H
Cl
CH3
CH3


109.
H
CH3
H
Cl
CH3
CH3


110.
H
Et
H
Cl
CH3
CH3


111.
H
CF3
H
Cl
CH3
CH3


112.
H
OCH3
H
Cl
CH3
CH3


113.
H
OCF3
H
Cl
CH3
CH3


114.
H
CN
H
Cl
CH3
CH3


115.
H
Cl
H
Cl
CH3
Et


116.
H
Br
H
Cl
CH3
Et


117.
H
I
H
Cl
CH3
Et


118.
H
CH3
H
Cl
CH3
Et


119.
H
Et
H
Cl
CH3
Et


120.
H
CF3
H
Cl
CH3
Et


121.
H
OCH3
H
Cl
CH3
Et


122.
H
OCF3
H
Cl
CH3
Et


123.
H
CN
H
Cl
CH3
Et


124.
H
Cl
H
Cl
Et
Et


125.
H
Br
H
Cl
Et
Et


126.
H
I
H
Cl
Et
Et


127.
H
CH3
H
Cl
Et
Et


128.
H
Et
H
Cl
Et
Et


129.
H
CF3
H
Cl
Et
Et


130.
H
OCH3
H
Cl
Et
Et


131.
H
OCF3
H
Cl
Et
Et


132.
H
CN
H
Cl
Et
Et


133.
H
Cl
H
Cl
CH3
Vin


134.
H
Br
H
Cl
CH3
Vin


135.
H
I
H
Cl
CH3
Vin


136.
H
CH3
H
Cl
CH3
Vin


137.
H
Et
H
Cl
CH3
Vin


138.
H
CF3
H
Cl
CH3
Vin


139.
H
OCH3
H
Cl
CH3
Vin


140.
H
OCF3
H
Cl
CH3
Vin


141.
H
CN
H
Cl
CH3
Vin


142.
H
Cl
H
Cl
Et
Vin


143.
H
Br
H
Cl
Et
Vin


144.
H
I
H
Cl
Et
Vin


145.
H
CH3
H
Cl
Et
Vin


146.
H
Et
H
Cl
Et
Vin


147.
H
CF3
H
Cl
Et
Vin


148.
H
OCH3
H
Cl
Et
Vin


149.
H
OCF3
H
Cl
Et
Vin


150.
H
CN
H
Cl
Et
Vin


151.
H
Br
H
Br
CH3
CH3


152.
H
Br
H
Br
CH3
Et


153.
H
Br
H
Br
Et
Et


154.
H
Br
H
Br
CH3
Vin


155.
H
Br
H
Br
Et
Vin


156.
H
I
H
I
CH3
CH3


157.
H
I
H
I
CH3
Et


158.
H
I
H
I
Et
Et


159.
H
I
H
I
CH3
Vin


160.
H
I
H
I
Et
Vin


161.
H
Br
H
CN
CH3
CH3


162.
H
I
H
CN
CH3
CH3


163.
H
CH3
H
CN
CH3
CH3


164.
H
Et
H
CN
CH3
CH3


165.
H
CF3
H
CN
CH3
CH3


166.
H
OCH3
H
CN
CH3
CH3


167.
H
OCF3
H
CN
CH3
CH3


168.
H
CN
H
CN
CH3
CH3


169.
H
Br
H
CN
CH3
Et


170.
H
I
H
CN
CH3
Et


171.
H
CH3
H
CN
CH3
Et


172.
H
Et
H
CN
CH3
Et


173.
H
CF3
H
CN
CH3
Et


174.
H
OCH3
H
CN
CH3
Et


175.
H
OCF3
H
CN
CH3
Et


176.
H
CN
H
CN
CH3
Et


177.
H
Br
H
CN
Et
Et


178.
H
I
H
CN
Et
Et


179.
H
CH3
H
CN
Et
Et


180.
H
Et
H
CN
Et
Et


181.
H
CF3
H
CN
Et
Et


182.
H
OCH3
H
CN
Et
Et


183.
H
OCF3
H
CN
Et
Et


184.
H
CN
H
CN
Et
Et


185.
H
Br
H
CN
CH3
Vin


186.
H
I
H
CN
CH3
Vin


187.
H
CH3
H
CN
CH3
Vin


188.
H
Et
H
CN
CH3
Vin


189.
H
CF
H
CN
CH3
Vin


190.
H
OCH3
H
CN
CH3
Vin


191.
H
OCF3
H
CN
CH3
Vin


192.
H
CN
H
CN
CH3
Vin


193.
H
Br
H
CN
Et
Vin


194.
H
I
H
CN
Et
Vin


195.
H
CH3
H
CN
Et
Vin


196.
H
Et
H
CN
Et
Vin


197.
H
CF
H
CN
Et
Vin


198.
H
OCH3
H
CN
Et
Vin


199.
H
OCF3
H
CN
Et
Vin


200.
H
CN
H
CN
Et
Vin


201.
H
H
F
H
CH3
CH3


202.
H
F
F
H
CH3
CH3


203.
H
Cl
F
H
CH3
CH3


204.
H
Br
F
H
CH3
CH3


205.
H
I
F
H
CH3
CH3


206.
H
CH3
F
H
CH3
CH3


207.
H
Et
F
H
CH3
CH3


208.
H
CF3
F
H
CH3
CH3


209.
H
OCH3
F
H
CH3
CH3


210.
H
OCF3
F
H
CH3
CH3


211.
H
CN
F
H
CH3
CH3


212.
H
H
F
H
CH3
Et


213.
H
F
F
H
CH3
Et


214.
H
Cl
F
H
CH3
Et


215.
H
Br
F
H
CH3
Et


216.
H
I
F
H
CH3
Et


217.
H
CH3
F
H
CH3
Et


218.
H
Et
F
H
CH3
Et


219.
H
CF3
F
H
CH3
Et


220.
H
OCH3
F
H
CH3
Et


221.
H
OCF3
F
H
CH3
Et


222.
H
CN
F
H
CH3
Et


223.
H
H
F
H
Et
Et


224.
H
F
F
H
Et
Et


225.
H
Cl
F
H
Et
Et


226.
H
Br
F
H
Et
Et


227.
H
I
F
H
Et
Et


228.
H
CH3
F
H
Et
Et


229.
H
Et
F
H
Et
Et


230.
H
CF
F
H
Et
Et


231.
H
OCH3
F
H
Et
Et


232.
H
OCF3
F
H
Et
Et


233.
H
CN
F
H
Et
Et


234.
H
H
F
H
CH3
Vin


235.
H
F
F
H
CH3
Vin


236.
H
Cl
F
H
CH3
Vin


237.
H
Br
F
H
CH3
Vin


238.
H
I
F
H
CH3
Vin


239.
H
CH3
F
H
CH3
Vin


240.
H
Et
F
H
CH3
Vin


241.
H
CF3
F
H
CH3
Vin


242.
H
OCH3
F
H
CH3
Vin


243.
H
OCF3
F
H
CH3
Vin


244.
H
CN
F
H
CH3
Vin


245.
H
H
F
H
Et
Vin


246.
H
F
F
H
Et
Vin


247.
H
Cl
F
H
Et
Vin


248.
H
Br
F
H
Et
Vin


249.
H
I
F
H
Et
Vin


250.
H
CH3
F
H
Et
Vin


251.
H
Et
F
H
Et
Vin


252.
H
CF3
F
H
Et
Vin


253.
H
OCH3
F
H
Et
Vin


254.
H
OCF3
F
H
Et
Vin


255.
H
CN
F
H
Et
Vin


256.
H
F
F
F
CH3
CH3


257.
H
Cl
F
F
CH3
CH3


258.
H
Br
F
F
CH3
CH3


259.
H
I
F
F
CH3
CH3


260.
H
CH3
F
F
CH3
CH3


261.
H
Et
F
F
CH3
CH3


262.
H
CF3
F
F
CH3
CH3


263.
H
OCH3
F
F
CH3
CH3


264.
H
OCF3
F
F
CH3
CH3


265.
H
CN
F
F
CH3
CH3


266.
H
F
F
F
CH3
Et


267.
H
Cl
F
F
CH3
Et


268.
H
Br
F
F
CH3
Et


269.
H
I
F
F
CH3
Et


270.
H
CH3
F
F
CH3
Et


271.
H
Et
F
F
CH3
Et


272.
H
CF3
F
F
CH3
Et


273.
H
OCH3
F
F
CH3
Et


274.
H
OCF3
F
F
CH3
Et


275.
H
CN
F
F
CH3
Et


276.
H
F
F
F
Et
Et


277.
H
Cl
F
F
Et
Et


278.
H
Br
F
F
Et
Et


279.
H
I
F
F
Et
Et


280.
H
CH3
F
F
Et
Et


281.
H
Et
F
F
Et
Et


282.
H
CF3
F
F
Et
Et


283.
H
OCH3
F
F
Et
Et


284.
H
OCF3
F
F
Et
Et


285.
H
CN
F
F
Et
Et


286.
H
F
F
F
CH
Vin


287.
H
Cl
F
F
CH3
Vin


288.
H
Br
F
F
CH3
Vin


289.
H
I
F
F
CH3
Vin


290.
H
CH3
F
F
CH3
Vin


291.
H
Et
F
F
CH
Vin


292.
H
CF
F
F
CH3
Vin


293.
H
OCH3
F
F
CH
Vin


294.
H
OCF3
F
F
CH3
Vin


295.
H
CN
F
F
CH3
Vin


296.
H
F
F
F
Et
Vin


297.
H
Cl
F
F
Et
Vin


298.
H
Br
F
F
Et
Vin


299.
H
I
F
F
Et
Vin


300.
H
CH3
F
F
Et
Vin


301.
H
Et
F
F
Et
Vin


302.
H
CF3
F
F
Et
Vin


303.
H
OCH3
F
F
Et
Vin


304.
H
OCF3
F
F
Et
Vin


305.
H
CN
F
F
Et
Vin


306.
H
Cl
F
Cl
CH3
CH3


307.
H
Br
F
Cl
CH3
CH3


308.
H
I
F
Cl
CH3
CH3


309.
H
CH3
F
Cl
CH3
CH3


310.
H
Et
F
Cl
CH3
CH3


311.
H
CF3
F
Cl
CH3
CH3


312.
H
OCH3
F
Cl
CH3
CH3


313.
H
OCF3
F
Cl
CH3
CH3


314.
H
CN
F
Cl
CH3
CH3


315.
H
Cl
F
Cl
CH3
Et


316.
H
Br
F
Cl
CH3
Et


317.
H
I
F
Cl
CH3
Et


318.
H
CH3
F
Cl
CH3
Et


319.
H
Et
F
Cl
CH3
Et


320.
H
CF3
F
Cl
CH3
Et


321.
H
OCH3
F
Cl
CH3
Et


322.
H
OCF3
F
Cl
CH3
Et


323.
H
CN
F
Cl
CH3
Et


324.
H
Cl
F
Cl
Et
Et


325.
H
Br
F
Cl
Et
Et


326.
H
I
F
Cl
Et
Et


327.
H
CH3
F
Cl
Et
Et


328.
H
Et
F
Cl
Et
Et


329.
H
CF3
F
Cl
Et
Et


330.
H
OCH3
F
Cl
Et
Et


331.
H
OCF3
F
Cl
Et
Et


332.
H
CN
F
Cl
Et
Et


333.
H
Cl
F
Cl
CH3
Vin


334.
H
Br
F
Cl
CH3
Vin


335.
H
I
F
Cl
CH3
Vin


336.
H
CH3
F
Cl
CH3
Vin


337.
H
Et
F
Cl
CH3
Vin


338.
H
CF3
F
Cl
CH3
Vin


339.
H
OCH3
F
Cl
CH3
Vin


340.
H
OCF3
F
Cl
CH3
Vin


341.
H
CN
F
Cl
CH3
Vin


342.
H
Cl
F
Cl
Et
Vin


343.
H
Br
F
Cl
Et
Vin


344.
H
I
F
Cl
Et
Vin


345.
H
CH3
F
Cl
Et
Vin


346.
H
Et
F
Cl
Et
Vin


347.
H
CF3
F
Cl
Et
Vin


348.
H
OCH3
F
Cl
Et
Vin


349.
H
OCF3
F
Cl
Et
Vin


350.
H
CN
F
Cl
Et
Vin


351.
H
Br
F
Br
CH3
CH3


352.
H
Br
F
Br
CH3
Et


353.
H
Br
F
Br
Et
Et


354.
H
Br
F
Br
CH3
Vin


355.
H
Br
F
Br
Et
Vin


356.
H
I
F
I
CH3
CH3


357.
H
I
F
I
CH3
Et


358.
H
I
F
I
Et
Et


359.
H
I
F
I
CH3
Vin


360.
H
I
F
I
Et
Vin


361.
H
Br
F
CN
CH3
CH3


362.
H
I
F
CN
CH3
CH3


363.
H
CH3
F
CN
CH3
CH3


364.
H
Et
F
CN
CH3
CH3


365.
H
CF3
F
CN
CH3
CH3


366.
H
OCH3
F
CN
CH3
CH3


367.
H
OCF3
F
CN
CH3
CH3


368.
H
CN
F
CN
CH3
CH3


369.
H
Br
F
CN
CH3
Et


370.
H
I
F
CN
CH3
Et


371.
H
CH3
F
CN
CH3
Et


372.
H
Et
F
CN
CH3
Et


373.
H
CF3
F
CN
CH3
Et


374.
H
OCH3
F
CN
CH3
Et


375.
H
OCF3
F
CN
CH3
Et


376.
H
CN
F
CN
CH3
Et


377.
H
Br
F
CN
Et
Et


378.
H
I
F
CN
Et
Et


379.
H
CH3
F
CN
Et
Et


380.
H
Et
F
CN
Et
Et


381.
H
CF3
F
CN
Et
Et


382.
H
OCH3
F
CN
Et
Et


383.
H
OCF3
F
CN
Et
Et


384.
H
CN
F
CN
Et
Et


385.
H
Br
F
CN
CH3
Vin


386.
H
I
F
CN
CH3
Vin


387.
H
CH3
F
CN
CH3
Vin


388.
H
Et
F
CN
CH3
Vin


389.
H
CF3
F
CN
CH3
Vin


390.
H
OCH3
F
CN
CH3
Vin


391.
H
OCF3
F
CN
CH3
Vin


392.
H
CN
F
CN
CH3
Vin


393.
H
Br
F
CN
Et
Vin


394.
H
I
F
CN
Et
Vin


395.
H
CH3
F
CN
Et
Vin


396.
H
Et
F
CN
Et
Vin


397.
H
CF3
F
CN
Et
Vin


398.
H
OCH3
F
CN
Et
Vin


399.
H
OCF3
F
CN
Et
Vin


400.
H
CN
F
CN
Et
Vin


401.
H
H
Cl
H
CH3
CH3


402.
H
F
Cl
H
CH3
CH3


403.
H
Cl
Cl
H
CH3
CH3


404.
H
Br
Cl
H
CH3
CH3


405.
H
I
Cl
H
CH3
CH3


406.
H
CH3
Cl
H
CH3
CH3


407.
H
Et
Cl
H
CH3
CH3


408.
H
CF3
Cl
H
CH3
CH3


409.
H
OCH3
Cl
H
CH3
CH3


410.
H
OCF3
Cl
H
CH3
CH3


411.
H
CN
Cl
H
CH3
CH3


412.
H
H
Cl
H
CH3
Et


413.
H
F
Cl
H
CH3
Et


414.
H
Cl
Cl
H
CH3
Et


415.
H
Br
Cl
H
CH3
Et


416.
H
I
Cl
H
CH3
Et


417.
H
CH3
Cl
H
CH3
Et


418.
H
Et
Cl
H
CH3
Et


419.
H
CF3
Cl
H
CH3
Et


420.
H
OCH3
Cl
H
CH3
Et


421.
H
OCF3
Cl
H
CH3
Et


422.
H
CN
Cl
H
CH3
Et


423.
H
H
Cl
H
Et
Et


424.
H
F
Cl
H
Et
Et


425.
H
Cl
Cl
H
Et
Et


426.
H
Br
Cl
H
Et
Et


427.
H
I
Cl
H
Et
Et


428.
H
CH3
Cl
H
Et
Et


429.
H
Et
Cl
H
Et
Et


430.
H
CF3
Cl
H
Et
Et


431.
H
OCH3
Cl
H
Et
Et


432.
H
OCF3
Cl
H
Et
Et


433.
H
CN
Cl
H
Et
Et


434.
H
H
Cl
H
CH3
Vin


435.
H
F
Cl
H
CH3
Vin


436.
H
Cl
Cl
H
CH3
Vin


437.
H
Br
Cl
H
CH3
Vin


438.
H
I
Cl
H
CH3
Vin


439.
H
CH3
Cl
H
CH3
Vin


440.
H
Et
Cl
H
CH3
Vin


441.
H
CF3
Cl
H
CH3
Vin


442.
H
OCH3
Cl
H
CH3
Vin


443.
H
OCF3
Cl
H
CH3
Vin


444.
H
CN
Cl
H
CH3
Vin


445.
H
H
Cl
H
Et
Vin


446.
H
F
Cl
H
Et
Vin


447.
H
Cl
Cl
H
Et
Vin


448.
H
Br
Cl
H
Et
Vin


449.
H
I
Cl
H
Et
Vin


450.
H
CH3
Cl
H
Et
Vin


451.
H
Et
Cl
H
Et
Vin


452.
H
CF3
Cl
H
Et
Vin


453.
H
OCH3
Cl
H
Et
Vin


454.
H
OCF3
Cl
H
Et
Vin


455.
H
CN
Cl
H
Et
Vin


456.
H
F
Cl
F
CH3
CH3


457.
H
Cl
Cl
F
CH3
CH3


458.
H
Br
Cl
F
CH3
CH3


459.
H
I
Cl
F
CH3
CH3


460.
H
CH3
Cl
F
CH3
CH3


461.
H
Et
Cl
F
CH3
CH3


462.
H
CF3
Cl
F
CH3
CH3


463.
H
OCH3
Cl
F
CH3
CH3


464.
H
OCF3
Cl
F
CH3
CH3


465.
H
CN
Cl
F
CH3
CH3


466.
H
F
Cl
F
CH3
Et


467.
H
Cl
Cl
F
CH3
Et


468.
H
Br
Cl
F
CH3
Et


469.
H
I
Cl
F
CH3
Et


470.
H
CH3
Cl
F
CH3
Et


471.
H
Et
Cl
F
CH3
Et


472.
H
CF3
Cl
F
CH3
Et


473.
H
OCH3
Cl
F
CH3
Et


474.
H
OCF3
Cl
F
CH3
Et


475.
H
CN
Cl
F
CH3
Et


476.
H
F
Cl
F
Et
Et


477.
H
Cl
Cl
F
Et
Et


478.
H
Br
Cl
F
Et
Et


479.
H
I
Cl
F
Et
Et


480.
H
CH3
Cl
F
Et
Et


481.
H
Et
Cl
F
Et
Et


482.
H
CF3
Cl
F
Et
Et


483.
H
OCH3
Cl
F
Et
Et


484.
H
OCF3
Cl
F
Et
Et


485.
H
CN
Cl
F
Et
Et


486.
H
F
Cl
F
CH3
Vin


487.
H
Cl
Cl
F
CH3
Vin


488.
H
Br
Cl
F
CH3
Vin


489.
H
I
Cl
F
CH3
Vin


490.
H
CH3
Cl
F
CH3
Vin


491.
H
Et
Cl
F
CH3
Vin


492.
H
CF3
Cl
F
CH3
Vin


493.
H
OCH3
Cl
F
CH3
Vin


494.
H
OCF3
Cl
F
CH3
Vin


495.
H
CN
Cl
F
CH3
Vin


496.
H
F
Cl
F
Et
Vin


497.
H
Cl
Cl
F
Et
Vin


498.
H
Br
Cl
F
Et
Vin


499.
H
I
Cl
F
Et
Vin


500.
H
CH3
Cl
F
Et
Vin


501.
H
Et
Cl
F
Et
Vin


502.
H
CF3
Cl
F
Et
Vin


503.
H
OCH3
Cl
F
Et
Vin


504.
H
OCF3
Cl
F
Et
Vin


505.
H
CN
Cl
F
Et
Vin


506.
H
Cl
Cl
Cl
CH3
CH3


507.
H
Br
Cl
Cl
CH3
CH3


508.
H
I
Cl
Cl
CH3
CH3


509.
H
CH3
Cl
Cl
CH3
CH3


510.
H
Et
Cl
Cl
CH3
CH3


511.
H
CF3
Cl
Cl
CH3
CH3


512.
H
OCH3
Cl
Cl
CH3
CH3


513.
H
OCF3
Cl
Cl
CH3
CH3


514.
H
CN
Cl
Cl
CH3
CH3


515.
H
Cl
Cl
Cl
CH3
Et


516.
H
Br
Cl
Cl
CH3
Et


517.
H
I
Cl
Cl
CH3
Et


518.
H
CH3
Cl
Cl
CH3
Et


519.
H
Et
Cl
Cl
CH3
Et


520.
H
CF3
Cl
Cl
CH3
Et


521.
H
OCH3
Cl
Cl
CH3
Et


522.
H
OCF3
Cl
Cl
CH3
Et


523.
H
CN
Cl
Cl
CH3
Et


524.
H
Cl
Cl
Cl
Et
Et


525.
H
Br
Cl
Cl
Et
Et


526.
H
I
Cl
Cl
Et
Et


527.
H
CH3
Cl
Cl
Et
Et


528.
H
Et
Cl
Cl
Et
Et


529.
H
CF3
Cl
Cl
Et
Et


530.
H
OCH3
Cl
Cl
Et
Et


531.
H
OCF3
Cl
Cl
Et
Et


532.
H
CN
Cl
Cl
Et
Et


533.
H
Cl
Cl
Cl
CH3
Vin


534.
H
Br
Cl
Cl
CH3
Vin


535.
H
I
Cl
Cl
CH3
Vin


536.
H
CH3
Cl
Cl
CH3
Vin


537.
H
Et
Cl
Cl
CH3
Vin


538.
H
CF3
Cl
Cl
CH3
Vin


539.
H
OCH3
Cl
Cl
CH3
Vin


540.
H
OCF3
Cl
Cl
CH3
Vin


541.
H
CN
Cl
Cl
CH3
Vin


542.
H
Cl
Cl
Cl
Et
Vin


543.
H
Br
Cl
Cl
Et
Vin


544.
H
I
Cl
Cl
Et
Vin


545.
H
CH3
Cl
Cl
Et
Vin


546.
H
Et
Cl
Cl
Et
Vin


547.
H
CF3
Cl
Cl
Et
Vin


548.
H
OCH3
Cl
Cl
Et
Vin


549.
H
OCF3
Cl
Cl
Et
Vin


550.
H
CN
Cl
Cl
Et
Vin


551.
H
Br
Cl
Br
CH3
CH3


552.
H
Br
Cl
Br
CH3
Et


553.
H
Br
Cl
Br
Et
Et


554.
H
Br
Cl
Br
CH3
Vin


555.
H
Br
Cl
Br
Et
Vin


556.
H
I
Cl
I
CH3
CH3


557.
H
I
Cl
I
CH3
Et


558.
H
I
Cl
I
Et
Et


559.
H
I
Cl
I
CH3
Vin


560.
H
I
Cl
I
Et
Vin


561.
H
Br
Cl
CN
CH3
CH3


562.
H
I
Cl
CN
CH3
CH3


563.
H
CH3
Cl
CN
CH3
CH3


564.
H
Et
Cl
CN
CH3
CH3


565.
H
CF3
Cl
CN
CH3
CH3


566.
H
OCH3
Cl
CN
CH3
CH3


567.
H
OCF3
Cl
CN
CH3
CH3


568.
H
CN
Cl
CN
CH3
CH3


569.
H
Br
Cl
CN
CH3
Et


570.
H
I
Cl
CN
CH3
Et


571.
H
CH3
Cl
CN
CH3
Et


572.
H
Et
Cl
CN
CH3
Et


573.
H
CF3
Cl
CN
CH3
Et


574.
H
OCH3
Cl
CN
CH3
Et


575.
H
OCF3
Cl
CN
CH3
Et


576.
H
CN
Cl
CN
CH3
Et


577.
H
Br
Cl
CN
Et
Et


578.
H
I
Cl
CN
Et
Et


579.
H
CH3
Cl
CN
Et
Et


580.
H
Et
Cl
CN
Et
Et


581.
H
CF3
Cl
CN
Et
Et


582.
H
OCH3
Cl
CN
Et
Et


583.
H
OCF3
Cl
CN
Et
Et


584.
H
CN
Cl
CN
Et
Et


585.
H
Br
Cl
CN
CH3
Vin


586.
H
I
Cl
CN
CH3
Vin


587.
H
CH3
Cl
CN
CH3
Vin


588.
H
Et
Cl
CN
CH3
Vin


589.
H
CF3
Cl
CN
CH3
Vin


590.
H
OCH3
Cl
CN
CH3
Vin


591.
H
OCF3
Cl
CN
CH3
Vin


592.
H
CN
Cl
CN
CH3
Vin


593.
H
Br
Cl
CN
Et
Vin


594.
H
I
Cl
CN
Et
Vin


595.
H
CH3
Cl
CN
Et
Vin


596.
H
Et
Cl
CN
Et
Vin


597.
H
CF3
Cl
CN
Et
Vin


598.
H
OCH3
Cl
CN
Et
Vin


599.
H
OCF3
Cl
CN
Et
Vin


600.
H
CN
Cl
CN
Et
Vin


601.
F
H
H
H
CH3
CH3


602.
F
F
H
H
CH3
CH3


603.
F
Cl
H
H
CH3
CH3


604.
F
Br
H
H
CH3
CH3


605.
F
I
H
H
CH3
CH3


606.
F
CH3
H
H
CH3
CH3


607.
F
Et
H
H
CH3
CH


608.
F
CF3
H
H
CH3
CH3


609.
F
OCH3
H
H
CH3
CH3


610.
F
OCF3
H
H
CH3
CH3


611.
F
CN
H
H
CH3
CH3


612.
F
H
H
H
CH3
Et


613.
F
F
H
H
CH3
Et


614.
F
Cl
H
H
CH3
Et


615.
F
Br
H
H
CH3
Et


616.
F
I
H
H
CH3
Et


617.
F
CH3
H
H
CH3
Et


618.
F
Et
H
H
CH3
Et


619.
F
CF3
H
H
CH3
Et


620.
F
OCH3
H
H
CH3
Et


621.
F
OCF3
H
H
CH3
Et


622.
F
CN
H
H
CH3
Et


623.
F
H
H
H
Et
Et


624.
F
F
H
H
Et
Et


625.
F
Cl
H
H
Et
Et


626.
F
Br
H
H
Et
Et


627.
F
I
H
H
Et
Et


628.
F
CH3
H
H
Et
Et


629.
F
Et
H
H
Et
Et


630.
F
CF3
H
H
Et
Et


631.
F
OCH3
H
H
Et
Et


632.
F
OCF3
H
H
Et
Et


633.
F
CN
H
H
Et
Et


634.
F
H
H
H
CH3
Vin


635.
F
F
H
H
CH3
Vin


636.
F
Cl
H
H
CH3
Vin


637.
F
Br
H
H
CH3
Vin


638.
F
I
H
H
CH3
Vin


639.
F
CH3
H
H
CH3
Vin


640.
F
Et
H
H
CH3
Vin


641.
F
CF3
H
H
CH3
Vin


642.
F
OCH3
H
H
CH3
Vin


643.
F
OCF3
H
H
CH3
Vin


644.
F
CN
H
H
CH3
Vin


645.
F
H
H
H
Et
Vin


646.
F
F
H
H
Et
Vin


647.
F
Cl
H
H
Et
Vin


648.
F
Br
H
H
Et
Vin


649.
F
I
H
H
Et
Vin


650.
F
CH3
H
H
Et
Vin


651.
F
Et
H
H
Et
Vin


652.
F
CF3
H
H
Et
Vin


653.
F
OCH3
H
H
Et
Vin


654.
F
OCF3
H
H
Et
Vin


655.
F
CN
H
H
Et
Vin


656.
F
H
H
F
CH3
CH3


657.
F
F
H
F
CH3
CH3


658.
F
Cl
H
F
CH3
CH3


659.
F
Br
H
F
CH3
CH3


660.
F
I
H
F
CH3
CH3


661.
F
CH3
H
F
CH3
CH3


662.
F
Et
H
F
CH3
CH3


663.
F
CF3
H
F
CH3
CH3


664.
F
OCH3
H
F
CH3
CH3


665.
F
OCF3
H
F
CH3
CH3


666.
F
CN
H
F
CH3
CH3


667.
F
H
H
F
CH3
Et


668.
F
F
H
F
CH3
Et


669.
F
Cl
H
F
CH3
Et


670.
F
Br
H
F
CH3
Et


671.
F
I
H
F
CH3
Et


672.
F
CH3
H
F
CH3
Et


673.
F
Et
H
F
CH3
Et


674.
F
CF3
H
F
CH3
Et


675.
F
OCH3
H
F
CH3
Et


676.
F
OCF3
H
F
CH3
Et


677.
F
CN
H
F
CH3
Et


678.
F
H
H
F
Et
Et


679.
F
F
H
F
Et
Et


680.
F
Cl
H
F
Et
Et


681.
F
Br
H
F
Et
Et


682.
F
I
H
F
Et
Et


683.
F
CH3
H
F
Et
Et


684.
F
Et
H
F
Et
Et


685.
F
CF3
H
F
Et
Et


686.
F
OCH3
H
F
Et
Et


687.
F
OCF3
H
F
Et
Et


688.
F
CN
H
F
Et
Et


689.
F
H
H
F
CH3
Vin


690.
F
F
H
F
CH3
Vin


691.
F
Cl
H
F
CH3
Vin


692.
F
Br
H
F
CH3
Vin


693.
F
I
H
F
CH3
Vin


694.
F
CH3
H
F
CH3
Vin


695.
F
Et
H
F
CH3
Vin


696.
F
CF3
H
F
CH3
Vin


697.
F
OCH3
H
F
CH3
Vin


698.
F
OCF3
H
F
CH3
Vin


699.
F
CN
H
F
CH3
Vin


700.
F
H
H
F
Et
Vin


701.
F
F
H
F
Et
Vin


702.
F
Cl
H
F
Et
Vin


703.
F
Br
H
F
Et
Vin


704.
F
I
H
F
Et
Vin


705.
F
CH3
H
F
Et
Vin


706.
F
Et
H
F
Et
Vin


707.
F
CF3
H
F
Et
Vin


708.
F
OCH3
H
F
Et
Vin


709.
F
OCF3
H
F
Et
Vin


710.
F
CN
H
F
Et
Vin


711.
F
H
H
Cl
CH3
CH3


712.
F
F
H
Cl
CH3
CH3


713.
F
Cl
H
Cl
CH3
CH3


714.
F
Br
H
Cl
CH3
CH3


715.
F
I
H
Cl
CH3
CH3


716.
F
CH3
H
Cl
CH3
CH3


717.
F
Et
H
Cl
CH3
CH3


718.
F
CF3
H
Cl
CH3
CH3


719.
F
OCH3
H
Cl
CH3
CH3


720.
F
OCF3
H
Cl
CH3
CH3


721.
F
CN
H
Cl
CH3
CH3


722.
F
H
H
Cl
CH3
Et


723.
F
F
H
Cl
CH3
Et


724.
F
Cl
H
Cl
CH3
Et


725.
F
Br
H
Cl
CH3
Et


726.
F
I
H
Cl
CH3
Et


727.
F
CH3
H
Cl
CH3
Et


728.
F
Et
H
Cl
CH3
Et


729.
F
CF3
H
Cl
CH3
Et


730.
F
OCH3
H
Cl
CH3
Et


731.
F
OCF3
H
Cl
CH3
Et


732.
F
CN
H
Cl
CH3
Et


733.
F
H
H
Cl
Et
Et


734.
F
F
H
Cl
Et
Et


735.
F
Cl
H
Cl
Et
Et


736.
F
Br
H
Cl
Et
Et


737.
F
I
H
Cl
Et
Et


738.
F
CH3
H
Cl
Et
Et


739.
F
Et
H
Cl
Et
Et


740.
F
CF3
H
Cl
Et
Et


741.
F
OCH3
H
Cl
Et
Et


742.
F
OCF3
H
Cl
Et
Et


743.
F
CN
H
Cl
Et
Et


744.
F
H
H
Cl
CH3
Vin


745.
F
F
H
Cl
CH3
Vin


746.
F
Cl
H
Cl
CH3
Vin


747.
F
Br
H
Cl
CH3
Vin


748.
F
I
H
Cl
CH3
Vin


749.
F
CH3
H
Cl
CH3
Vin


750.
F
Et
H
Cl
CH3
Vin


751.
F
CF3
H
Cl
CH3
Vin


752.
F
OCH3
H
Cl
CH3
Vin


753.
F
OCF3
H
Cl
CH3
Vin


754.
F
CN
H
Cl
CH3
Vin


755.
F
H
H
Cl
Et
Vin


756.
F
F
H
Cl
Et
Vin


757.
F
Cl
H
Cl
Et
Vin


758.
F
Br
H
Cl
Et
Vin


759.
F
I
H
Cl
Et
Vin


760.
F
CH3
H
Cl
Et
Vin


761.
F
Et
H
Cl
Et
Vin


762.
F
CF3
H
Cl
Et
Vin


763.
F
OCH3
H
Cl
Et
Vin


764.
F
OCF3
H
Cl
Et
Vin


765.
F
CN
H
Cl
Et
Vin


766.
F
Br
H
Br
CH3
CH3


767.
F
Br
H
Br
CH3
Et


768.
F
Br
H
Br
Et
Et


769.
F
Br
H
Br
CH3
Vin


770.
F
Br
H
Br
Et
Vin


771.
F
I
H
I
CH3
CH3


772.
F
I
H
I
CH3
Et


773.
F
I
H
I
Et
Et


774.
F
I
H
I
CH3
Vin


775.
F
I
H
I
Et
Vin


776.
F
H
H
CN
CH3
CH3


777.
F
F
H
CN
CH3
CH3


778.
F
Cl
H
CN
CH3
CH3


779.
F
Br
H
CN
CH3
CH3


780.
F
I
H
CN
CH3
CH3


781.
F
CH3
H
CN
CH3
CH3


782.
F
Et
H
CN
CH3
CH3


783.
F
CF3
H
CN
CH3
CH3


784.
F
OCH3
H
CN
CH3
CH3


785.
F
OCF3
H
CN
CH3
CH3


786.
F
CN
H
CN
CH3
CH3


787.
F
H
H
CN
CH3
Et


788.
F
F
H
CN
CH3
Et


789.
F
Cl
H
CN
CH3
Et


790.
F
Br
H
CN
CH3
Et


791.
F
I
H
CN
CH3
Et


792.
F
CH3
H
CN
CH3
Et


793.
F
Et
H
CN
CH3
Et


794.
F
CF3
H
CN
CH3
Et


795.
F
OCH3
H
CN
CH3
Et


796.
F
OCF3
H
CN
CH3
Et


797.
F
CN
H
CN
CH3
Et


798.
F
H
H
CN
Et
Et


799.
F
F
H
CN
Et
Et


800.
F
Cl
H
CN
Et
Et


801.
F
Br
H
CN
Et
Et


802.
F
I
H
CN
Et
Et


803.
F
CH3
H
CN
Et
Et


804.
F
Et
H
CN
Et
Et


805.
F
CF3
H
CN
Et
Et


806.
F
OCH3
H
CN
Et
Et


807.
F
OCF3
H
CN
Et
Et


808.
F
CN
H
CN
Et
Et


809.
F
H
H
CN
CH3
Vin


810.
F
F
H
CN
CH3
Vin


811.
F
Cl
H
CN
CH3
Vin


812.
F
Br
H
CN
CH3
Vin


813.
F
I
H
CN
CH3
Vin


814.
F
CH3
H
CN
CH3
Vin


815.
F
Et
H
CN
CH3
Vin


816.
F
CF3
H
CN
CH3
Vin


817.
F
OCH3
H
CN
CH3
Vin


818.
F
OCF3
H
CN
CH3
Vin


819.
F
CN
H
CN
CH3
Vin


820.
F
H
H
CN
Et
Vin


821.
F
F
H
CN
Et
Vin


822.
F
Cl
H
CN
Et
Vin


823.
F
Br
H
CN
Et
Vin


824.
F
I
H
CN
Et
Vin


825.
F
CH3
H
CN
Et
Vin


826.
F
Et
H
CN
Et
Vin


827.
F
CF3
H
CN
Et
Vin


828.
F
OCH3
H
CN
Et
Vin


829.
F
OCF3
H
CN
Et
Vin


830.
F
CN
H
CN
Et
Vin


831.
F
H
F
H
CH3
CH3


832.
F
F
F
H
CH3
CH3


833.
F
Cl
F
H
CH3
CH3


834.
F
Br
F
H
CH3
CH3


835.
F
I
F
H
CH3
CH3


836.
F
CH3
F
H
CH3
CH3


837.
F
Et
F
H
CH3
CH3


838.
F
CF3
F
H
CH3
CH3


839.
F
OCH3
F
H
CH3
CH3


840.
F
OCF3
F
H
CH3
CH3


841.
F
CN
F
H
CH3
CH3


842.
F
H
F
H
CH3
Et


843.
F
F
F
H
CH3
Et


844.
F
Cl
F
H
CH3
Et


845.
F
Br
F
H
CH3
Et


846.
F
I
F
H
CH3
Et


847.
F
CH3
F
H
CH3
Et


848.
F
Et
F
H
CH3
Et


849.
F
CF3
F
H
CH3
Et


850.
F
OCH3
F
H
CH3
Et


851.
F
OCF3
F
H
CH3
Et


852.
F
CN
F
H
CH3
Et


853.
F
H
F
H
Et
Et


854.
F
F
F
H
Et
Et


855.
F
Cl
F
H
Et
Et


856.
F
Br
F
H
Et
Et


857.
F
I
F
H
Et
Et


858.
F
CH3
F
H
Et
Et


859.
F
Et
F
H
Et
Et


860.
F
CF3
F
H
Et
Et


861.
F
OCH3
F
H
Et
Et


862.
F
OCF3
F
H
Et
Et


863.
F
CN
F
H
Et
Et


864.
F
H
F
H
CH3
Vin


865.
F
F
F
H
CH3
Vin


866.
F
Cl
F
H
CH3
Vin


867.
F
Br
F
H
CH3
Vin


868.
F
I
F
H
CH3
Vin


869.
F
CH3
F
H
CH3
Vin


870.
F
Et
F
H
CH3
Vin


871.
F
CF3
F
H
CH3
Vin


872.
F
OCH3
F
H
CH3
Vin


873.
F
OCF3
F
H
CH3
Vin


874.
F
CN
F
H
CH3
Vin


875.
F
H
F
H
Et
Vin


876.
F
F
F
H
Et
Vin


877.
F
Cl
F
H
Et
Vin


878.
F
Br
F
H
Et
Vin


879.
F
I
F
H
Et
Vin


880.
F
CH3
F
H
Et
Vin


881.
F
Et
F
H
Et
Vin


882.
F
CF3
F
H
Et
Vin


883.
F
OCH3
F
H
Et
Vin


884.
F
OCF3
F
H
Et
Vin


885.
F
CN
F
H
Et
Vin


886.
F
H
F
F
CH3
CH3


887.
F
F
F
F
CH3
CH3


888.
F
Cl
F
F
CH3
CH3


889.
F
Br
F
F
CH3
CH3


890.
F
I
F
F
CH3
CH3


891.
F
CH3
F
F
CH3
CH3


892.
F
Et
F
F
CH3
CH3


893.
F
CF3
F
F
CH3
CH3


894.
F
OCH3
F
F
CH3
CH3


895.
F
OCF3
F
F
CH3
CH3


896.
F
CN
F
F
CH3
CH3


897.
F
H
F
F
CH3
Et


898.
F
F
F
F
CH3
Et


899.
F
Cl
F
F
CH3
Et


900.
F
Br
F
F
CH3
Et


901.
F
I
F
F
CH3
Et


902.
F
CH3
F
F
CH3
Et


903.
F
Et
F
F
CH3
Et


904.
F
CF3
F
F
CH3
Et


905.
F
OCH3
F
F
CH3
Et


906.
F
OCF3
F
F
CH3
Et


907.
F
CN
F
F
CH3
Et


908.
F
H
F
F
Et
Et


909.
F
F
F
F
Et
Et


910.
F
Cl
F
F
Et
Et


911.
F
Br
F
F
Et
Et


912.
F
I
F
F
Et
Et


913.
F
CH3
F
F
Et
Et


914.
F
Et
F
F
Et
Et


915.
F
CF3
F
F
Et
Et


916.
F
OCH3
F
F
Et
Et


917.
F
OCF3
F
F
Et
Et


918.
F
CN
F
F
Et
Et


919.
F
H
F
F
CH3
Vin


920.
F
F
F
F
CH3
Vin


921.
F
Cl
F
F
CH3
Vin


922.
F
Br
F
F
CH3
Vin


923.
F
I
F
F
CH3
Vin


924.
F
CH3
F
F
CH3
Vin


925.
F
Et
F
F
CH3
Vin


926.
F
CF3
F
F
CH3
Vin


927.
F
OCH3
F
F
CH3
Vin


928.
F
OCF3
F
F
CH3
Vin


929.
F
CN
F
F
CH3
Vin


930.
F
H
F
F
Et
Vin


931.
F
F
F
F
Et
Vin


932.
F
Cl
F
F
Et
Vin


933.
F
Br
F
F
Et
Vin


934.
F
I
F
F
Et
Vin


935.
F
CH3
F
F
Et
Vin


936.
F
Et
F
F
Et
Vin


937.
F
CF3
F
F
Et
Vin


938.
F
OCH3
F
F
Et
Vin


939.
F
OCF3
F
F
Et
Vin


940.
F
CN
F
F
Et
Vin


941.
F
H
F
Cl
CH3
CH3


942.
F
F
F
Cl
CH3
CH3


943.
F
Cl
F
Cl
CH3
CH3


944.
F
Br
F
Cl
CH3
CH3


945.
F
I
F
Cl
CH3
CH3


946.
F
CH3
F
Cl
CH3
CH3


947.
F
Et
F
Cl
CH3
CH3


948.
F
CF3
F
Cl
CH3
CH3


949.
F
OCH3
F
Cl
CH3
CH3


950.
F
OCF3
F
Cl
CH3
CH3


951.
F
CN
F
Cl
CH3
CH3


952.
F
H
F
Cl
CH3
Et


953.
F
F
F
Cl
CH3
Et


954.
F
Cl
F
Cl
CH3
Et


955.
F
Br
F
Cl
CH3
Et


956.
F
I
F
Cl
CH3
Et


957.
F
CH3
F
Cl
CH3
Et


958.
F
Et
F
Cl
CH3
Et


959.
F
CF3
F
Cl
CH3
Et


960.
F
OCH3
F
Cl
CH3
Et


961.
F
OCF3
F
Cl
CH3
Et


962.
F
CN
F
Cl
CH3
Et


963.
F
H
F
Cl
Et
Et


964.
F
F
F
Cl
Et
Et


965.
F
Cl
F
Cl
Et
Et


966.
F
Br
F
Cl
Et
Et


967.
F
I
F
Cl
Et
Et


968.
F
CH3
F
Cl
Et
Et


969.
F
Et
F
Cl
Et
Et


970.
F
CF3
F
Cl
Et
Et


971.
F
OCH3
F
Cl
Et
Et


972.
F
OCF3
F
Cl
Et
Et


973.
F
CN
F
Cl
Et
Et


974.
F
H
F
Cl
CH3
Vin


975.
F
F
F
Cl
CH3
Vin


976.
F
Cl
F
Cl
CH3
Vin


977.
F
Br
F
Cl
CH3
Vin


978.
F
I
F
Cl
CH3
Vin


979.
F
CH3
F
Cl
CH3
Vin


980.
F
Et
F
Cl
CH3
Vin


981.
F
CF3
F
Cl
CH3
Vin


982.
F
OCH3
F
Cl
CH3
Vin


983.
F
OCF3
F
Cl
CH3
Vin


984.
F
CN
F
Cl
CH3
Vin


985.
F
H
F
Cl
Et
Vin


986.
F
F
F
Cl
Et
Vin


987.
F
Cl
F
Cl
Et
Vin


988.
F
Br
F
Cl
Et
Vin


989.
F
I
F
Cl
Et
Vin


990.
F
CH3
F
Cl
Et
Vin


991.
F
Et
F
Cl
Et
Vin


992.
F
CF3
F
Cl
Et
Vin


993.
F
OCH3
F
Cl
Et
Vin


994.
F
OCF3
F
Cl
Et
Vin


995.
F
CN
F
Cl
Et
Vin


996.
F
Br
F
Br
CH3
CH3


997.
F
Br
F
Br
CH3
Et


998.
F
Br
F
Br
Et
Et


999.
F
Br
F
Br
CH3
Vin


1000.
F
Br
F
Br
Et
Vin


1001.
F
I
F
I
CH3
CH3


1002.
F
I
F
I
CH3
Et


1003.
F
I
F
I
Et
Et


1004.
F
I
F
I
CH3
Vin


1005.
F
I
F
I
Et
Vin


1006.
F
H
F
CN
CH3
CH3


1007.
F
F
F
CN
CH3
CH3


1008.
F
Cl
F
CN
CH3
CH3


1009.
F
Br
F
CN
CH3
CH3


1010.
F
I
F
CN
CH3
CH3


1011.
F
CH3
F
CN
CH3
CH3


1012.
F
Et
F
CN
CH3
CH3


1013.
F
CF3
F
CN
CH3
CH3


1014.
F
OCH3
F
CN
CH3
CH3


1015.
F
OCF3
F
CN
CH3
CH3


1016.
F
CN
F
CN
CH3
CH3


1017.
F
H
F
CN
CH3
Et


1018.
F
F
F
CN
CH3
Et


1019.
F
Cl
F
CN
CH3
Et


1020.
F
Br
F
CN
CH3
Et


1021.
F
I
F
CN
CH3
Et


1022.
F
CH3
F
CN
CH3
Et


1023.
F
Et
F
CN
CH3
Et


1024.
F
CF3
F
CN
CH3
Et


1025.
F
OCH3
F
CN
CH3
Et


1026.
F
OCF3
F
CN
CH3
Et


1027.
F
CN
F
CN
CH3
Et


1028.
F
H
F
CN
Et
Et


1029.
F
F
F
CN
Et
Et


1030.
F
Cl
F
CN
Et
Et


1031.
F
Br
F
CN
Et
Et


1032.
F
I
F
CN
Et
Et


1033.
F
CH3
F
CN
Et
Et


1034.
F
Et
F
CN
Et
Et


1035.
F
CF3
F
CN
Et
Et


1036.
F
OCH3
F
CN
Et
Et


1037.
F
OCF3
F
CN
Et
Et


1038.
F
CN
F
CN
Et
Et


1039.
F
H
F
CN
CH3
Vin


1040.
F
F
F
CN
CH3
Vin


1041.
F
Cl
F
CN
CH3
Vin


1042.
F
Br
F
CN
CH3
Vin


1043.
F
I
F
CN
CH3
Vin


1044.
F
CH3
F
CN
CH3
Vin


1045.
F
Et
F
CN
CH3
Vin


1046.
F
CF3
F
CN
CH3
Vin


1047.
F
OCH3
F
CN
CH3
Vin


1048.
F
OCF3
F
CN
CH3
Vin


1049.
F
CN
F
CN
CH3
Vin


1050.
F
H
F
CN
Et
Vin


1051.
F
F
F
CN
Et
Vin


1052.
F
Cl
F
CN
Et
Vin


1053.
F
Br
F
CN
Et
Vin


1054.
F
I
F
CN
Et
Vin


1055.
F
CH3
F
CN
Et
Vin


1056.
F
Et
F
CN
Et
Vin


1057.
F
CF3
F
CN
Et
Vin


1058.
F
OCH3
F
CN
Et
Vin


1059.
F
OCF3
F
CN
Et
Vin


1060.
F
CN
F
CN
Et
Vin


1061.
F
H
Cl
H
CH3
CH3


1062.
F
F
Cl
H
CH3
CH3


1063.
F
Cl
Cl
H
CH3
CH3


1064.
F
Br
Cl
H
CH3
CH3


1065.
F
I
Cl
H
CH3
CH3


1066.
F
CH3
Cl
H
CH3
CH3


1067.
F
Et
Cl
H
CH3
CH3


1068.
F
CF3
Cl
H
CH3
CH3


1069.
F
OCH3
Cl
H
CH3
CH3


1070.
F
OCF3
Cl
H
CH3
CH3


1071.
F
CN
Cl
H
CH3
CH3


1072.
F
H
Cl
H
CH3
Et


1073.
F
F
Cl
H
CH3
Et


1074.
F
Cl
Cl
H
CH3
Et


1075.
F
Br
Cl
H
CH3
Et


1076.
F
I
Cl
H
CH3
Et


1077.
F
CH3
Cl
H
CH3
Et


1078.
F
Et
Cl
H
CH3
Et


1079.
F
CF3
Cl
H
CH3
Et


1080.
F
OCH3
Cl
H
CH3
Et


1081.
F
OCF3
Cl
H
CH3
Et


1082.
F
CN
Cl
H
CH3
Et


1083.
F
H
Cl
H
Et
Et


1084.
F
F
Cl
H
Et
Et


1085.
F
Cl
Cl
H
Et
Et


1086.
F
Br
Cl
H
Et
Et


1087.
F
I
Cl
H
Et
Et


1088.
F
CH3
Cl
H
Et
Et


1089.
F
Et
Cl
H
Et
Et


1090.
F
CF3
Cl
H
Et
Et


1091.
F
OCH3
Cl
H
Et
Et


1092.
F
OCF3
Cl
H
Et
Et


1093.
F
CN
Cl
H
Et
Et


1094.
F
H
Cl
H
CH3
Vin


1095.
F
F
Cl
H
CH3
Vin


1096.
F
Cl
Cl
H
CH3
Vin


1097.
F
Br
Cl
H
CH3
Vin


1098.
F
I
Cl
H
CH3
Vin


1099.
F
CH3
Cl
H
CH3
Vin


1100.
F
Et
Cl
H
CH3
Vin


1101.
F
CF3
Cl
H
CH3
Vin


1102.
F
OCH3
Cl
H
CH3
Vin


1103.
F
OCF3
Cl
H
CH3
Vin


1104.
F
CN
Cl
H
CH3
Vin


1105.
F
H
Cl
H
Et
Vin


1106.
F
F
Cl
H
Et
Vin


1107.
F
Cl
Cl
H
Et
Vin


1108.
F
Br
Cl
H
Et
Vin


1109.
F
I
Cl
H
Et
Vin


1110.
F
CH3
Cl
H
Et
Vin


1111.
F
Et
Cl
H
Et
Vin


1112.
F
CF3
Cl
H
Et
Vin


1113.
F
OCH3
Cl
H
Et
Vin


1114.
F
OCF3
Cl
H
Et
Vin


1115.
F
CN
Cl
H
Et
Vin


1116.
F
H
Cl
F
CH3
CH3


1117.
F
F
Cl
F
CH3
CH3


1118.
F
Cl
Cl
F
CH3
CH3


1119.
F
Br
Cl
F
CH3
CH3


1120.
F
I
Cl
F
CH3
CH3


1121.
F
CH3
Cl
F
CH3
CH3


1122.
F
Et
Cl
F
CH3
CH3


1123.
F
CF3
Cl
F
CH3
CH3


1124.
F
OCH3
Cl
F
CH3
CH3


1125.
F
OCF3
Cl
F
CH3
CH3


1126.
F
CN
Cl
F
CH3
CH3


1127.
F
H
Cl
F
CH3
Et


1128.
F
F
Cl
F
CH3
Et


1129.
F
Cl
Cl
F
CH3
Et


1130.
F
Br
Cl
F
CH3
Et


1131.
F
I
Cl
F
CH3
Et


1132.
F
CH3
Cl
F
CH3
Et


1133.
F
Et
Cl
F
CH3
Et


1134.
F
CF3
Cl
F
CH3
Et


1135.
F
OCH3
Cl
F
CH3
Et


1136.
F
OCF3
Cl
F
CH3
Et


1137.
F
CN
Cl
F
CH3
Et


1138.
F
H
Cl
F
Et
Et


1139.
F
F
Cl
F
Et
Et


1140.
F
Cl
Cl
F
Et
Et


1141.
F
Br
Cl
F
Et
Et


1142.
F
I
Cl
F
Et
Et


1143.
F
CH3
Cl
F
Et
Et


1144.
F
Et
Cl
F
Et
Et


1145.
F
CF3
Cl
F
Et
Et


1146.
F
OCH3
Cl
F
Et
Et


1147.
F
OCF3
Cl
F
Et
Et


1148.
F
CN
Cl
F
Et
Et


1149.
F
H
Cl
F
CH3
Vin


1150.
F
F
Cl
F
CH3
Vin


1151.
F
Cl
Cl
F
CH3
Vin


1152.
F
Br
Cl
F
CH3
Vin


1153.
F
I
Cl
F
CH3
Vin


1154.
F
CH3
Cl
F
CH3
Vin


1155.
F
Et
Cl
F
CH3
Vin


1156.
F
CF3
Cl
F
CH3
Vin


1157.
F
OCH3
Cl
F
CH3
Vin


1158.
F
OCF3
Cl
F
CH3
Vin


1159.
F
CN
Cl
F
CH3
Vin


1160.
F
H
Cl
F
Et
Vin


1161.
F
F
Cl
F
Et
Vin


1162.
F
Cl
Cl
F
Et
Vin


1163.
F
Br
Cl
F
Et
Vin


1164.
F
I
Cl
F
Et
Vin


1165.
F
CH3
Cl
F
Et
Vin


1166.
F
Et
Cl
F
Et
Vin


1167.
F
CF3
Cl
F
Et
Vin


1168.
F
OCH3
Cl
F
Et
Vin


1169.
F
OCF3
Cl
F
Et
Vin


1170.
F
CN
Cl
F
Et
Vin


1171.
F
H
Cl
Cl
CH3
CH3


1172.
F
F
Cl
Cl
CH3
CH3


1173.
F
Cl
Cl
Cl
CH3
CH3


1174.
F
Br
Cl
Cl
CH3
CH3


1175.
F
I
Cl
Cl
CH3
CH3


1176.
F
CH3
Cl
Cl
CH3
CH3


1177.
F
Et
Cl
Cl
CH3
CH3


1178.
F
CF3
Cl
Cl
CH3
CH3


1179.
F
OCH3
Cl
Cl
CH3
CH3


1180.
F
OCF3
Cl
Cl
CH3
CH3


1181.
F
CN
Cl
Cl
CH3
CH3


1182.
F
H
Cl
Cl
CH3
Et


1183.
F
F
Cl
Cl
CH3
Et


1184.
F
Cl
Cl
Cl
CH3
Et


1185.
F
Br
Cl
Cl
CH3
Et


1186.
F
I
Cl
Cl
CH3
Et


1187.
F
CH3
Cl
Cl
CH3
Et


1188.
F
Et
Cl
Cl
CH3
Et


1189.
F
CF3
Cl
Cl
CH3
Et


1190.
F
OCH3
Cl
Cl
CH3
Et


1191.
F
OCF3
Cl
Cl
CH3
Et


1192.
F
CN
Cl
Cl
CH3
Et


1193.
F
H
Cl
Cl
Et
Et


1194.
F
F
Cl
Cl
Et
Et


1195.
F
Cl
Cl
Cl
Et
Et


1196.
F
Br
Cl
Cl
Et
Et


1197.
F
I
Cl
Cl
Et
Et


1198.
F
CH3
Cl
Cl
Et
Et


1199.
F
Et
Cl
Cl
Et
Et


1200.
F
CF3
Cl
Cl
Et
Et


1201.
F
OCH3
Cl
Cl
Et
Et


1202.
F
OCF3
Cl
Cl
Et
Et


1203.
F
CN
Cl
Cl
Et
Et


1204.
F
H
Cl
Cl
CH3
Vin


1205.
F
F
Cl
Cl
CH3
Vin


1206.
F
Cl
Cl
Cl
CH3
Vin


1207.
F
Br
Cl
Cl
CH3
Vin


1208.
F
I
Cl
Cl
CH3
Vin


1209.
F
CH3
Cl
Cl
CH3
Vin


1210.
F
Et
Cl
Cl
CH3
Vin


1211.
F
CF3
Cl
Cl
CH3
Vin


1212.
F
OCH3
Cl
Cl
CH3
Vin


1213.
F
OCF3
Cl
Cl
CH3
Vin


1214.
F
CN
Cl
Cl
CH3
Vin


1215.
F
H
Cl
Cl
Et
Vin


1216.
F
F
Cl
Cl
Et
Vin


1217.
F
Cl
Cl
Cl
Et
Vin


1218.
F
Br
Cl
Cl
Et
Vin


1219.
F
I
Cl
Cl
Et
Vin


1220.
F
CH3
Cl
Cl
Et
Vin


1221.
F
Et
Cl
Cl
Et
Vin


1222.
F
CF3
Cl
Cl
Et
Vin


1223.
F
OCH3
Cl
Cl
Et
Vin


1224.
F
OCF3
Cl
Cl
Et
Vin


1225.
F
CN
Cl
Cl
Et
Vin


1226.
F
Br
Cl
Br
CH3
CH3


1227.
F
Br
Cl
Br
CH3
Et


1228.
F
Br
Cl
Br
Et
Et


1229.
F
Br
Cl
Br
CH3
Vin


1230.
F
Br
Cl
Br
Et
Vin


1231.
F
I
Cl
I
CH3
CH3


1232.
F
I
Cl
I
CH3
Et


1233.
F
I
Cl
I
Et
Et


1234.
F
I
Cl
I
CH3
Vin


1235.
F
I
Cl
I
Et
Vin


1236.
F
H
Cl
CN
CH3
CH3


1237.
F
F
Cl
CN
CH3
CH3


1238.
F
Cl
Cl
CN
CH3
CH3


1239.
F
Br
Cl
CN
CH3
CH3


1240.
F
I
Cl
CN
CH3
CH3


1241.
F
CH3
Cl
CN
CH3
CH3


1242.
F
Et
Cl
CN
CH3
CH3


1243.
F
CF3
Cl
CN
CH3
CH3


1244.
F
OCH3
Cl
CN
CH3
CH3


1245.
F
OCF3
Cl
CN
CH3
CH3


1246.
F
CN
Cl
CN
CH3
CH3


1247.
F
H
Cl
CN
CH3
Et


1248.
F
F
Cl
CN
CH3
Et


1249.
F
Cl
Cl
CN
CH3
Et


1250.
F
Br
Cl
CN
CH3
Et


1251.
F
I
Cl
CN
CH3
Et


1252.
F
CH3
Cl
CN
CH3
Et


1253.
F
Et
Cl
CN
CH3
Et


1254.
F
CF3
Cl
CN
CH3
Et


1255.
F
OCH3
Cl
CN
CH3
Et


1256.
F
OCF3
Cl
CN
CH3
Et


1257.
F
CN
Cl
CN
CH3
Et


1258.
F
H
Cl
CN
Et
Et


1259.
F
F
Cl
CN
Et
Et


1260.
F
Cl
Cl
CN
Et
Et


1261.
F
Br
Cl
CN
Et
Et


1262.
F
I
Cl
CN
Et
Et


1263.
F
CH3
Cl
CN
Et
Et


1264.
F
Et
Cl
CN
Et
Et


1265.
F
CF3
Cl
CN
Et
Et


1266.
F
OCH3
Cl
CN
Et
Et


1267.
F
OCF3
Cl
CN
Et
Et


1268.
F
CN
Cl
CN
Et
Et


1269.
F
H
Cl
CN
CH3
Vin


1270.
F
F
Cl
CN
CH3
Vin


1271.
F
Cl
Cl
CN
CH3
Vin


1272.
F
Br
Cl
CN
CH3
Vin


1273.
F
I
Cl
CN
CH3
Vin


1274.
F
CH3
Cl
CN
CH3
Vin


1275.
F
Et
Cl
CN
CH3
Vin


1276.
F
CF3
Cl
CN
CH3
Vin


1277.
F
OCH3
Cl
CN
CH3
Vin


1278.
F
OCF3
Cl
CN
CH3
Vin


1279.
F
CN
Cl
CN
CH3
Vin


1280.
F
H
Cl
CN
Et
Vin


1281.
F
F
Cl
CN
Et
Vin


1282.
F
Cl
Cl
CN
Et
Vin


1283.
F
Br
Cl
CN
Et
Vin


1284.
F
I
Cl
CN
Et
Vin


1285.
F
CH3
Cl
CN
Et
Vin


1286.
F
Et
Cl
CN
Et
Vin


1287.
F
CF3
Cl
CN
Et
Vin


1288.
F
OCH3
Cl
CN
Et
Vin


1289.
F
OCF3
Cl
CN
Et
Vin


1290.
F
CN
Cl
CN
Et
Vin


1291.
Cl
H
H
H
CH3
CH3


1292.
Cl
F
H
H
CH3
CH3


1293.
Cl
Cl
H
H
CH3
CH3


1294.
Cl
Br
H
H
CH3
CH3


1295.
Cl
I
H
H
CH3
CH3


1296.
Cl
CH3
H
H
CH3
CH3


1297.
Cl
Et
H
H
CH3
CH3


1298.
Cl
CF3
H
H
CH3
CH3


1299.
Cl
OCH3
H
H
CH3
CH3


1300.
Cl
OCF3
H
H
CH3
CH3


1301.
Cl
CN
H
H
CH3
CH3


1302.
Cl
H
H
H
CH3
Et


1303.
Cl
F
H
H
CH3
Et


1304.
Cl
Cl
H
H
CH3
Et


1305.
Cl
Br
H
H
CH3
Et


1306.
Cl
I
H
H
CH3
Et


1307.
Cl
CH3
H
H
CH3
Et


1308.
Cl
Et
H
H
CH3
Et


1309.
Cl
CF3
H
H
CH3
Et


1310.
Cl
OCH3
H
H
CH3
Et


1311.
Cl
OCF3
H
H
CH3
Et


1312.
Cl
CN
H
H
CH3
Et


1313.
Cl
H
H
H
Et
Et


1314.
Cl
F
H
H
Et
Et


1315.
Cl
Cl
H
H
Et
Et


1316.
Cl
Br
H
H
Et
Et


1317.
Cl
I
H
H
Et
Et


1318.
Cl
CH3
H
H
Et
Et


1319.
Cl
Et
H
H
Et
Et


1320.
Cl
CF3
H
H
Et
Et


1321.
Cl
OCH3
H
H
Et
Et


1322.
Cl
OCF3
H
H
Et
Et


1323.
Cl
CN
H
H
Et
Et


1324.
Cl
H
H
H
CH3
Vin


1325.
Cl
F
H
H
CH3
Vin


1326.
Cl
Cl
H
H
CH3
Vin


1327.
Cl
Br
H
H
CH3
Vin


1328.
Cl
I
H
H
CH3
Vin


1329.
Cl
CH3
H
H
CH3
Vin


1330.
Cl
Et
H
H
CH3
Vin


1331.
Cl
CF3
H
H
CH3
Vin


1332.
Cl
OCH3
H
H
CH3
Vin


1333.
Cl
OCF3
H
H
CH3
Vin


1334.
Cl
CN
H
H
CH3
Vin


1335.
Cl
H
H
H
Et
Vin


1336.
Cl
F
H
H
Et
Vin


1337.
Cl
Cl
H
H
Et
Vin


1338.
Cl
Br
H
H
Et
Vin


1339.
Cl
I
H
H
Et
Vin


1340.
Cl
CH3
H
H
Et
Vin


1341.
Cl
Et
H
H
Et
Vin


1342.
Cl
CF3
H
H
Et
Vin


1343.
Cl
OCH3
H
H
Et
Vin


1344.
Cl
OCF3
H
H
Et
Vin


1345.
Cl
CN
H
H
Et
Vin


1346.
Cl
H
H
F
CH3
CH3


1347.
Cl
F
H
F
CH3
CH3


1348.
Cl
Cl
H
F
CH3
CH3


1349.
Cl
Br
H
F
CH3
CH3


1350.
Cl
I
H
F
CH3
CH3


1351.
Cl
CH3
H
F
CH3
CH3


1352.
Cl
Et
H
F
CH3
CH3


1353.
Cl
CF3
H
F
CH3
CH3


1354.
Cl
OCH3
H
F
CH3
CH3


1355.
Cl
OCF3
H
F
CH3
CH3


1356.
Cl
CN
H
F
CH3
CH3


1357.
Cl
H
H
F
CH3
Et


1358.
Cl
F
H
F
CH3
Et


1359.
Cl
Cl
H
F
CH3
Et


1360.
Cl
Br
H
F
CH3
Et


1361.
Cl
I
H
F
CH3
Et


1362.
Cl
CH3
H
F
CH3
Et


1363.
Cl
Et
H
F
CH
Et


1364.
Cl
CF3
H
F
CH3
Et


1365.
Cl
OCH3
H
F
CH3
Et


1366.
Cl
OCF3
H
F
CH3
Et


1367.
Cl
CN
H
F
CH3
Et


1368.
Cl
H
H
F
Et
Et


1369.
Cl
F
H
F
Et
Et


1370.
Cl
Cl
H
F
Et
Et


1371.
Cl
Br
H
F
Et
Et


1372.
Cl
I
H
F
Et
Et


1373.
Cl
CH3
H
F
Et
Et


1374.
Cl
Et
H
F
Et
Et


1375.
Cl
CF3
H
F
Et
Et


1376.
Cl
OCH3
H
F
Et
Et


1377.
Cl
OCF3
H
F
Et
Et


1378.
Cl
CN
H
F
Et
Et


1379.
Cl
H
H
F
CH3
Vin


1380.
Cl
F
H
F
CH3
Vin


1381.
Cl
Cl
H
F
CH3
Vin


1382.
Cl
Br
H
F
CH3
Vin


1383.
Cl
I
H
F
CH3
Vin


1384.
Cl
CH3
H
F
CH3
Vin


1385.
Cl
Et
H
F
CH3
Vin


1386.
Cl
CF3
H
F
CH3
Vin


1387.
Cl
OCH3
H
F
CH3
Vin


1388.
Cl
OCF3
H
F
CH3
Vin


1389.
Cl
CN
H
F
CH3
Vin


1390.
Cl
H
H
F
Et
Vin


1391.
Cl
F
H
F
Et
Vin


1392.
Cl
Cl
H
F
Et
Vin


1393.
Cl
Br
H
F
Et
Vin


1394.
Cl
I
H
F
Et
Vin


1395.
Cl
CH3
H
F
Et
Vin


1396.
Cl
Et
H
F
Et
Vin


1397.
Cl
CF3
H
F
Et
Vin


1398.
Cl
OCH3
H
F
Et
Vin


1399.
Cl
OCF3
H
F
Et
Vin


1400.
Cl
CN
H
F
Et
Vin


1401.
Cl
H
H
Cl
CH3
CH3


1402.
Cl
F
H
Cl
CH3
CH3


1403.
Cl
Cl
H
Cl
CH3
CH3


1404.
Cl
Br
H
Cl
CH3
CH3


1405.
Cl
I
H
Cl
CH3
CH3


1406.
Cl
CH3
H
Cl
CH3
CH3


1407.
Cl
Et
H
Cl
CH3
CH3


1408.
Cl
CF3
H
Cl
CH3
CH3


1409.
Cl
OCH3
H
Cl
CH3
CH3


1410.
Cl
OCF3
H
Cl
CH3
CH3


1411.
Cl
CN
H
Cl
CH3
CH3


1412.
Cl
H
H
Cl
CH3
Et


1413.
Cl
F
H
Cl
CH3
Et


1414.
Cl
Cl
H
Cl
CH3
Et


1415.
Cl
Br
H
Cl
CH3
Et


1416.
Cl
I
H
Cl
CH3
Et


1417.
Cl
CH3
H
Cl
CH3
Et


1418.
Cl
Et
H
Cl
CH3
Et


1419.
Cl
CF3
H
Cl
CH3
Et


1420.
Cl
OCH3
H
Cl
CH3
Et


1421.
Cl
OCF3
H
Cl
CH3
Et


1422.
Cl
CN
H
Cl
CH3
Et


1423.
Cl
H
H
Cl
Et
Et


1424.
Cl
F
H
Cl
Et
Et


1425.
Cl
Cl
H
Cl
Et
Et


1426.
Cl
Br
H
Cl
Et
Et


1427.
Cl
I
H
Cl
Et
Et


1428.
Cl
CH3
H
Cl
Et
Et


1429.
Cl
Et
H
Cl
Et
Et


1430.
Cl
CF3
H
Cl
Et
Et


1431.
Cl
OCH3
H
Cl
Et
Et


1432.
Cl
OCF3
H
Cl
Et
Et


1433.
Cl
CN
H
Cl
Et
Et


1434.
Cl
H
H
Cl
CH3
Vin


1435.
Cl
F
H
Cl
CH3
Vin


1436.
Cl
Cl
H
Cl
CH3
Vin


1437.
Cl
Br
H
Cl
CH3
Vin


1438.
Cl
I
H
Cl
CH3
Vin


1439.
Cl
CH3
H
Cl
CH3
Vin


1440.
Cl
Et
H
Cl
CH3
Vin


1441.
Cl
CF3
H
Cl
CH3
Vin


1442.
Cl
OCH3
H
Cl
CH3
Vin


1443.
Cl
OCF3
H
Cl
CH3
Vin


1444.
Cl
CN
H
Cl
CH3
Vin


1445.
Cl
H
H
Cl
Et
Vin


1446.
Cl
F
H
Cl
Et
Vin


1447.
Cl
Cl
H
Cl
Et
Vin


1448.
Cl
Br
H
Cl
Et
Vin


1449.
Cl
I
H
Cl
Et
Vin


1450.
Cl
CH3
H
Cl
Et
Vin


1451.
Cl
Et
H
Cl
Et
Vin


1452.
Cl
CF3
H
Cl
Et
Vin


1453.
Cl
OCH3
H
Cl
Et
Vin


1454.
Cl
OCF3
H
Cl
Et
Vin


1455.
Cl
CN
H
Cl
Et
Vin


1456.
Cl
Br
H
Br
CH3
CH3


1457.
Cl
Br
H
Br
CH3
Et


1458.
Cl
Br
H
Br
Et
Et


1459.
Cl
Br
H
Br
CH3
Vin


1460.
Cl
Br
H
Br
Et
Vin


1461.
Cl
I
H
I
CH3
CH3


1462.
Cl
I
H
I
CH3
Et


1463.
Cl
I
H
I
Et
Et


1464.
Cl
I
H
I
CH3
Vin


1465.
Cl
I
H
I
Et
Vin


1466.
Cl
H
H
CN
CH3
CH3


1467.
Cl
F
H
CN
CH3
CH3


1468.
Cl
Cl
H
CN
CH3
CH3


1469.
Cl
Br
H
CN
CH3
CH3


1470.
Cl
I
H
CN
CH3
CH3


1471.
Cl
CH3
H
CN
CH3
CH3


1472.
Cl
Et
H
CN
CH3
CH3


1473.
Cl
CF3
H
CN
CH3
CH3


1474.
Cl
OCH3
H
CN
CH3
CH3


1475.
Cl
OCF3
H
CN
CH3
CH3


1476.
Cl
CN
H
CN
CH3
CH3


1477.
Cl
H
H
CN
CH3
Et


1478.
Cl
F
H
CN
CH3
Et


1479.
Cl
Cl
H
CN
CH3
Et


1480.
Cl
Br
H
CN
CH3
Et


1481.
Cl
I
H
CN
CH3
Et


1482.
Cl
CH3
H
CN
CH3
Et


1483.
Cl
Et
H
CN
CH3
Et


1484.
Cl
CF3
H
CN
CH3
Et


1485.
Cl
OCH3
H
CN
CH3
Et


1486.
Cl
OCF3
H
CN
CH3
Et


1487.
Cl
CN
H
CN
CH3
Et


1488.
Cl
H
H
CN
Et
Et


1489.
Cl
F
H
CN
Et
Et


1490.
Cl
Cl
H
CN
Et
Et


1491.
Cl
Br
H
CN
Et
Et


1492.
Cl
I
H
CN
Et
Et


1493.
Cl
CH3
H
CN
Et
Et


1494.
Cl
Et
H
CN
Et
Et


1495.
Cl
CF3
H
CN
Et
Et


1496.
Cl
OCH3
H
CN
Et
Et


1497.
Cl
OCF3
H
CN
Et
Et


1498.
Cl
CN
H
CN
Et
Et


1499.
Cl
H
H
CN
CH3
Vin


1500.
Cl
F
H
CN
CH3
Vin


1501.
Cl
Cl
H
CN
CH3
Vin


1502.
Cl
Br
H
CN
CH3
Vin


1503.
Cl
I
H
CN
CH3
Vin


1504.
Cl
CH3
H
CN
CH3
Vin


1505.
Cl
Et
H
CN
CH3
Vin


1506.
Cl
CF3
H
CN
CH3
Vin


1507.
Cl
OCH3
H
CN
CH3
Vin


1508.
Cl
OCF3
H
CN
CH3
Vin


1509.
Cl
CN
H
CN
CH3
Vin


1510.
Cl
H
H
CN
Et
Vin


1511.
Cl
F
H
CN
Et
Vin


1512.
Cl
Cl
H
CN
Et
Vin


1513.
Cl
Br
H
CN
Et
Vin


1514.
Cl
I
H
CN
Et
Vin


1515.
Cl
CH3
H
CN
Et
Vin


1516.
Cl
Et
H
CN
Et
Vin


1517.
Cl
CF3
H
CN
Et
Vin


1518.
Cl
OCH3
H
CN
Et
Vin


1519.
Cl
OCF3
H
CN
Et
Vin


1520.
Cl
CN
H
CN
Et
Vin


1521.
Cl
H
F
H
CH3
CH3


1522.
Cl
F
F
H
CH3
CH3


1523.
Cl
Cl
F
H
CH3
CH3


1524.
Cl
Br
F
H
CH3
CH3


1525.
Cl
I
F
H
CH3
CH3


1526.
Cl
CH3
F
H
CH3
CH3


1527.
Cl
Et
F
H
CH3
CH3


1528.
Cl
CF3
F
H
CH3
CH3


1529.
Cl
OCH3
F
H
CH3
CH3


1530.
Cl
OCF3
F
H
CH3
CH3


1531.
Cl
CN
F
H
CH3
CH3


1532.
Cl
H
F
H
CH3
Et


1533.
Cl
F
F
H
CH3
Et


1534.
Cl
Cl
F
H
CH3
Et


1535.
Cl
Br
F
H
CH3
Et


1536.
Cl
I
F
H
CH3
Et


1537.
Cl
CH3
F
H
CH3
Et


1538.
Cl
Et
F
H
CH3
Et


1539.
Cl
CF3
F
H
CH3
Et


1540.
Cl
OCH3
F
H
CH3
Et


1541.
Cl
OCF3
F
H
CH3
Et


1542.
Cl
CN
F
H
CH3
Et


1543.
Cl
H
F
H
Et
Et


1544.
Cl
F
F
H
Et
Et


1545.
Cl
Cl
F
H
Et
Et


1546.
Cl
Br
F
H
Et
Et


1547.
Cl
I
F
H
Et
Et


1548.
Cl
CH3
F
H
Et
Et


1549.
Cl
Et
F
H
Et
Et


1550.
Cl
CF
F
H
Et
Et


1551.
Cl
OCH3
F
H
Et
Et


1552.
Cl
OCF3
F
H
Et
Et


1553.
Cl
CN
F
H
Et
Et


1554.
Cl
H
F
H
CH3
Vin


1555.
Cl
F
F
H
CH3
Vin


1556.
Cl
Cl
F
H
CH3
Vin


1557.
Cl
Br
F
H
CH3
Vin


1558.
Cl
I
F
H
CH3
Vin


1559.
Cl
CH3
F
H
CH3
Vin


1560.
Cl
Et
F
H
CH3
Vin


1561.
Cl
CF
F
H
CH3
Vin


1562.
Cl
OCH3
F
H
CH3
Vin


1563.
Cl
OCF3
F
H
CH3
Vin


1564.
Cl
CN
F
H
CH3
Vin


1565.
Cl
H
F
H
Et
Vin


1566.
Cl
F
F
H
Et
Vin


1567.
Cl
Cl
F
H
Et
Vin


1568.
Cl
Br
F
H
Et
Vin


1569.
Cl
I
F
H
Et
Vin


1570.
Cl
CH3
F
H
Et
Vin


1571.
Cl
Et
F
H
Et
Vin


1572.
Cl
CF3
F
H
Et
Vin


1573.
Cl
OCH3
F
H
Et
Vin


1574.
Cl
OCF3
F
H
Et
Vin


1575.
Cl
CN
F
H
Et
Vin


1576.
Cl
H
F
F
CH3
CH3


1577.
Cl
F
F
F
CH3
CH3


1578.
Cl
Cl
F
F
CH3
CH3


1579.
Cl
Br
F
F
CH3
CH3


1580.
Cl
I
F
F
CH3
CH3


1581.
Cl
CH3
F
F
CH3
CH3


1582.
Cl
Et
F
F
CH3
CH3


1583.
Cl
CF3
F
F
CH3
CH3


1584.
Cl
OCH3
F
F
CH3
CH3


1585.
Cl
OCF3
F
F
CH3
CH3


1586.
Cl
CN
F
F
CH3
CH3


1587.
Cl
H
F
F
CH3
Et


1588.
Cl
F
F
F
CH3
Et


1589.
Cl
Cl
F
F
CH3
Et


1590.
Cl
Br
F
F
CH3
Et


1591.
Cl
I
F
F
CH3
Et


1592.
Cl
CH3
F
F
CH3
Et


1593.
Cl
Et
F
F
CH3
Et


1594.
Cl
CF3
F
F
CH3
Et


1595.
Cl
OCH3
F
F
CH3
Et


1596.
Cl
OCF3
F
F
CH3
Et


1597.
Cl
CN
F
F
CH3
Et


1598.
Cl
H
F
F
Et
Et


1599.
Cl
F
F
F
Et
Et


1600.
Cl
Cl
F
F
Et
Et


1601.
Cl
Br
F
F
Et
Et


1602.
Cl
I
F
F
Et
Et


1603.
Cl
CH3
F
F
Et
Et


1604.
Cl
Et
F
F
Et
Et


1605.
Cl
CF3
F
F
Et
Et


1606.
Cl
OCH3
F
F
Et
Et


1607.
Cl
OCF3
F
F
Et
Et


1608.
Cl
CN
F
F
Et
Et


1609.
Cl
H
F
F
CH3
Vin


1610.
Cl
F
F
F
CH3
Vin


1611.
Cl
Cl
F
F
CH3
Vin


1612.
Cl
Br
F
F
CH3
Vin


1613.
Cl
I
F
F
CH3
Vin


1614.
Cl
CH3
F
F
CH3
Vin


1615.
Cl
Et
F
F
CH3
Vin


1616.
Cl
CF3
F
F
CH3
Vin


1617.
Cl
OCH3
F
F
CH3
Vin


1618.
Cl
OCF3
F
F
CH3
Vin


1619.
Cl
CN
F
F
CH3
Vin


1620.
Cl
H
F
F
Et
Vin


1621.
Cl
F
F
F
Et
Vin


1622.
Cl
Cl
F
F
Et
Vin


1623.
Cl
Br
F
F
Et
Vin


1624.
Cl
I
F
F
Et
Vin


1625.
Cl
CH3
F
F
Et
Vin


1626.
Cl
Et
F
F
Et
Vin


1627.
Cl
CF3
F
F
Et
Vin


1628.
Cl
OCH3
F
F
Et
Vin


1629.
Cl
OCF3
F
F
Et
Vin


1630.
Cl
CN
F
F
Et
Vin


1631.
Cl
H
F
Cl
CH3
CH3


1632.
Cl
F
F
Cl
CH3
CH3


1633.
Cl
Cl
F
Cl
CH3
CH3


1634.
Cl
Br
F
Cl
CH3
CH3


1635.
Cl
I
F
Cl
CH3
CH3


1636.
Cl
CH3
F
Cl
CH3
CH3


1637.
Cl
Et
F
Cl
CH3
CH3


1638.
Cl
CF3
F
Cl
CH3
CH3


1639.
Cl
OCH3
F
Cl
CH3
CH3


1640.
Cl
OCF3
F
Cl
CH3
CH3


1641.
Cl
CN
F
Cl
CH3
CH3


1642.
Cl
H
F
Cl
CH3
Et


1643.
Cl
F
F
Cl
CH3
Et


1644.
Cl
Cl
F
Cl
CH3
Et


1645.
Cl
Br
F
Cl
CH3
Et


1646.
Cl
I
F
Cl
CH3
Et


1647.
Cl
CH3
F
Cl
CH3
Et


1648.
Cl
Et
F
Cl
CH3
Et


1649.
Cl
CF3
F
Cl
CH3
Et


1650.
Cl
OCH3
F
Cl
CH3
Et


1651.
Cl
OCF3
F
Cl
CH3
Et


1652.
Cl
CN
F
Cl
CH3
Et


1653.
Cl
H
F
Cl
Et
Et


1654.
Cl
F
F
Cl
Et
Et


1655.
Cl
Cl
F
Cl
Et
Et


1656.
Cl
Br
F
Cl
Et
Et


1657.
Cl
I
F
Cl
Et
Et


1658.
Cl
CH
F
Cl
Et
Et


1659.
Cl
Et
F
Cl
Et
Et


1660.
Cl
CF3
F
Cl
Et
Et


1661.
Cl
OCH3
F
Cl
Et
Et


1662.
Cl
OCF3
F
Cl
Et
Et


1663.
Cl
CN
F
Cl
Et
Et


1664.
Cl
H
F
Cl
CH3
Vin


1665.
Cl
F
F
Cl
CH3
Vin


1666.
Cl
Cl
F
Cl
CH3
Vin


1667.
Cl
Br
F
Cl
CH3
Vin


1668.
Cl
I
F
Cl
CH3
Vin


1669.
Cl
CH3
F
Cl
CH3
Vin


1670.
Cl
Et
F
Cl
CH3
Vin


1671.
Cl
CF3
F
Cl
CH3
Vin


1672.
Cl
OCH3
F
Cl
CH3
Vin


1673.
Cl
OCF3
F
Cl
CH3
Vin


1674.
Cl
CN
F
Cl
CH3
Vin


1675.
Cl
H
F
Cl
Et
Vin


1676.
Cl
F
F
Cl
Et
Vin


1677.
Cl
Cl
F
Cl
Et
Vin


1678.
Cl
Br
F
Cl
Et
Vin


1679.
Cl
I
F
Cl
Et
Vin


1680.
Cl
CH3
F
Cl
Et
Vin


1681.
Cl
Et
F
Cl
Et
Vin


1682.
Cl
CF3
F
Cl
Et
Vin


1683.
Cl
OCH3
F
Cl
Et
Vin


1684.
Cl
OCF3
F
Cl
Et
Vin


1685.
Cl
CN
F
Cl
Et
Vin


1686.
Cl
Br
F
Br
CH3
CH3


1687.
Cl
Br
F
Br
CH3
Et


1688.
Cl
Br
F
Br
Et
Et


1689.
Cl
Br
F
Br
CH3
Vin


1690.
Cl
Br
F
Br
Et
Vin


1691.
Cl
I
F
I
CH3
CH3


1692.
Cl
I
F
I
CH3
Et


1693.
Cl
I
F
I
Et
Et


1694.
Cl
I
F
I
CH3
Vin


1695.
Cl
I
F
I
Et
Vin


1696.
Cl
H
F
CN
CH3
CH3


1697.
Cl
F
F
CN
CH3
CH3


1698.
Cl
Cl
F
CN
CH3
CH3


1699.
Cl
Br
F
CN
CH3
CH3


1700.
Cl
I
F
CN
CH3
CH3


1701.
Cl
CH3
F
CN
CH3
CH3


1702.
Cl
Et
F
CN
CH3
CH3


1703.
Cl
CF3
F
CN
CH3
CH3


1704.
Cl
OCH3
F
CN
CH3
CH3


1705.
Cl
OCF3
F
CN
CH3
CH3


1706.
Cl
CN
F
CN
CH3
CH3


1707.
Cl
H
F
CN
CH3
Et


1708.
Cl
F
F
CN
CH3
Et


1709.
Cl
Cl
F
CN
CH3
Et


1710.
Cl
Br
F
CN
CH3
Et


1711.
Cl
I
F
CN
CH3
Et


1712.
Cl
CH3
F
CN
CH3
Et


1713.
Cl
Et
F
CN
CH3
Et


1714.
Cl
CF3
F
CN
CH3
Et


1715.
Cl
OCH3
F
CN
CH3
Et


1716.
Cl
OCF3
F
CN
CH3
Et


1717.
Cl
CN
F
CN
CH3
Et


1718.
Cl
H
F
CN
Et
Et


1719.
Cl
F
F
CN
Et
Et


1720.
Cl
Cl
F
CN
Et
Et


1721.
Cl
Br
F
CN
Et
Et


1722.
Cl
I
F
CN
Et
Et


1723.
Cl
CH3
F
CN
Et
Et


1724.
Cl
Et
F
CN
Et
Et


1725.
Cl
CF3
F
CN
Et
Et


1726.
Cl
OCH3
F
CN
Et
Et


1727.
Cl
OCF3
F
CN
Et
Et


1728.
Cl
CN
F
CN
Et
Et


1729.
Cl
H
F
CN
CH3
Vin


1730.
Cl
F
F
CN
CH3
Vin


1731.
Cl
Cl
F
CN
CH3
Vin


1732.
Cl
Br
F
CN
CH3
Vin


1733.
Cl
I
F
CN
CH3
Vin


1734.
Cl
CH3
F
CN
CH3
Vin


1735.
Cl
Et
F
CN
CH3
Vin


1736.
Cl
CF3
F
CN
CH3
Vin


1737.
Cl
OCH3
F
CN
CH3
Vin


1738.
Cl
OCF3
F
CN
CH3
Vin


1739.
Cl
CN
F
CN
CH3
Vin


1740.
Cl
H
F
CN
Et
Vin


1741.
Cl
F
F
CN
Et
Vin


1742.
Cl
Cl
F
CN
Et
Vin


1743.
Cl
Br
F
CN
Et
Vin


1744.
Cl
I
F
CN
Et
Vin


1745.
Cl
CH3
F
CN
Et
Vin


1746.
Cl
Et
F
CN
Et
Vin


1747.
Cl
CF3
F
CN
Et
Vin


1748.
Cl
OCH3
F
CN
Et
Vin


1749.
Cl
OCF3
F
CN
Et
Vin


1750.
Cl
CN
F
CN
Et
Vin


1751.
Cl
H
Cl
H
CH3
CH3


1752.
Cl
F
Cl
H
CH3
CH3


1753.
Cl
Cl
Cl
H
CH3
CH3


1754.
Cl
Br
Cl
H
CH3
CH3


1755.
Cl
I
Cl
H
CH3
CH3


1756.
Cl
CH3
Cl
H
CH3
CH3


1757.
Cl
Et
Cl
H
CH3
CH3


1758.
Cl
CF3
Cl
H
CH3
CH3


1759.
Cl
OCH3
Cl
H
CH3
CH3


1760.
Cl
OCF3
Cl
H
CH3
CH3


1761.
Cl
CN
Cl
H
CH3
CH3


1762.
Cl
H
Cl
H
CH3
Et


1763.
Cl
F
Cl
H
CH3
Et


1764.
Cl
Cl
Cl
H
CH3
Et


1765.
Cl
Br
Cl
H
CH3
Et


1766.
Cl
I
Cl
H
CH3
Et


1767.
Cl
CH3
Cl
H
CH3
Et


1768.
Cl
Et
Cl
H
CH3
Et


1769.
Cl
CF3
Cl
H
CH3
Et


1770.
Cl
OCH3
Cl
H
CH3
Et


1771.
Cl
OCF3
Cl
H
CH3
Et


1772.
Cl
CN
Cl
H
CH3
Et


1773.
Cl
H
Cl
H
Et
Et


1774.
Cl
F
Cl
H
Et
Et


1775.
Cl
Cl
Cl
H
Et
Et


1776.
Cl
Br
Cl
H
Et
Et


1777.
Cl
I
Cl
H
Et
Et


1778.
Cl
CH3
Cl
H
Et
Et


1779.
Cl
Et
Cl
H
Et
Et


1780.
Cl
CF3
Cl
H
Et
Et


1781.
Cl
OCH3
Cl
H
Et
Et


1782.
Cl
OCF3
Cl
H
Et
Et


1783.
Cl
CN
Cl
H
Et
Et


1784.
Cl
H
Cl
H
CH3
Vin


1785.
Cl
F
Cl
H
CH3
Vin


1786.
Cl
Cl
Cl
H
CH3
Vin


1787.
Cl
Br
Cl
H
CH3
Vin


1788.
Cl
I
Cl
H
CH3
Vin


1789.
Cl
CH3
Cl
H
CH3
Vin


1790.
Cl
Et
Cl
H
CH3
Vin


1791.
Cl
CF3
Cl
H
CH3
Vin


1792.
Cl
OCH3
Cl
H
CH3
Vin


1793.
Cl
OCF3
Cl
H
CH3
Vin


1794.
Cl
CN
Cl
H
CH3
Vin


1795.
Cl
H
Cl
H
Et
Vin


1796.
Cl
F
Cl
H
Et
Vin


1797.
Cl
Cl
Cl
H
Et
Vin


1798.
Cl
Br
Cl
H
Et
Vin


1799.
Cl
I
Cl
H
Et
Vin


1800.
Cl
CH3
Cl
H
Et
Vin


1801.
Cl
Et
Cl
H
Et
Vin


1802.
Cl
CF3
Cl
H
Et
Vin


1803.
Cl
OCH3
Cl
H
Et
Vin


1804.
Cl
OCF3
Cl
H
Et
Vin


1805.
Cl
CN
Cl
H
Et
Vin


1806.
Cl
H
Cl
F
CH3
CH3


1807.
Cl
F
Cl
F
CH3
CH3


1808.
Cl
Cl
Cl
F
CH3
CH3


1809.
Cl
Br
Cl
F
CH3
CH3


1810.
Cl
I
Cl
F
CH3
CH3


1811.
Cl
CH3
Cl
F
CH3
CH3


1812.
Cl
Et
Cl
F
CH3
CH3


1813.
Cl
CF3
Cl
F
CH3
CH3


1814.
Cl
OCH3
Cl
F
CH3
CH3


1815.
Cl
OCF3
Cl
F
CH3
CH3


1816.
Cl
CN
Cl
F
CH3
CH3


1817.
Cl
H
Cl
F
CH3
Et


1818.
Cl
F
Cl
F
CH3
Et


1819.
Cl
Cl
Cl
F
CH3
Et


1820.
Cl
Br
Cl
F
CH3
Et


1821.
Cl
I
Cl
F
CH3
Et


1822.
Cl
CH3
Cl
F
CH3
Et


1823.
Cl
Et
Cl
F
CH3
Et


1824.
Cl
CF3
Cl
F
CH3
Et


1825.
Cl
OCH3
Cl
F
CH3
Et


1826.
Cl
OCF3
Cl
F
CH3
Et


1827.
Cl
CN
Cl
F
CH3
Et


1828.
Cl
H
Cl
F
Et
Et


1829.
Cl
F
Cl
F
Et
Et


1830.
Cl
Cl
Cl
F
Et
Et


1831.
Cl
Br
Cl
F
Et
Et


1832.
Cl
I
Cl
F
Et
Et


1833.
Cl
CH3
Cl
F
Et
Et


1834.
Cl
Et
Cl
F
Et
Et


1835.
Cl
CF3
Cl
F
Et
Et


1836.
Cl
OCH3
Cl
F
Et
Et


1837.
Cl
OCF3
Cl
F
Et
Et


1838.
Cl
CN
Cl
F
Et
Et


1839.
Cl
H
Cl
F
CH3
Vin


1840.
Cl
F
Cl
F
CH3
Vin


1841.
Cl
Cl
Cl
F
CH3
Vin


1842.
Cl
Br
Cl
F
CH3
Vin


1843.
Cl
I
Cl
F
CH3
Vin


1844.
Cl
CH3
Cl
F
CH3
Vin


1845.
Cl
Et
Cl
F
CH3
Vin


1846.
Cl
CF3
Cl
F
CH3
Vin


1847.
Cl
OCH3
Cl
F
CH3
Vin


1848.
Cl
OCF3
Cl
F
CH3
Vin


1849.
Cl
CN
Cl
F
CH3
Vin


1850.
Cl
H
Cl
F
Et
Vin


1851.
Cl
F
Cl
F
Et
Vin


1852.
Cl
Cl
Cl
F
Et
Vin


1853.
Cl
Br
Cl
F
Et
Vin


1854.
Cl
I
Cl
F
Et
Vin


1855.
Cl
CH3
Cl
F
Et
Vin


1856.
Cl
Et
Cl
F
Et
Vin


1857.
Cl
CF3
Cl
F
Et
Vin


1858.
Cl
OCH3
Cl
F
Et
Vin


1859.
Cl
OCF3
Cl
F
Et
Vin


1860.
Cl
CN
Cl
F
Et
Vin


1861.
Cl
H
Cl
Cl
CH3
CH3


1862.
Cl
F
Cl
Cl
CH3
CH3


1863.
Cl
Cl
Cl
Cl
CH3
CH3


1864.
Cl
Br
Cl
Cl
CH3
CH3


1865.
Cl
I
Cl
Cl
CH3
CH3


1866.
Cl
CH3
Cl
Cl
CH3
CH3


1867.
Cl
Et
Cl
Cl
CH3
CH3


1868.
Cl
CF3
Cl
Cl
CH3
CH3


1869.
Cl
OCH3
Cl
Cl
CH3
CH3


1870.
Cl
OCF3
Cl
Cl
CH3
CH3


1871.
Cl
CN
Cl
Cl
CH3
CH3


1872.
Cl
H
Cl
Cl
CH3
Et


1873.
Cl
F
Cl
Cl
CH3
Et


1874.
Cl
Cl
Cl
Cl
CH3
Et


1875.
Cl
Br
Cl
Cl
CH3
Et


1876.
Cl
I
Cl
Cl
CH3
Et


1877.
Cl
CH3
Cl
Cl
CH3
Et


1878.
Cl
Et
Cl
Cl
CH3
Et


1879.
Cl
CF3
Cl
Cl
CH3
Et


1880.
Cl
OCH3
Cl
Cl
CH3
Et


1881.
Cl
OCF3
Cl
Cl
CH3
Et


1882.
Cl
CN
Cl
Cl
CH3
Et


1883.
Cl
H
Cl
Cl
Et
Et


1884.
Cl
F
Cl
Cl
Et
Et


1885.
Cl
Cl
Cl
Cl
Et
Et


1886.
Cl
Br
Cl
Cl
Et
Et


1887.
Cl
I
Cl
Cl
Et
Et


1888.
Cl
CH3
Cl
Cl
Et
Et


1889.
Cl
Et
Cl
Cl
Et
Et


1890.
Cl
CF3
Cl
Cl
Et
Et


1891.
Cl
OCH3
Cl
Cl
Et
Et


1892.
Cl
OCF3
Cl
Cl
Et
Et


1893.
Cl
CN
Cl
Cl
Et
Et


1894.
Cl
H
Cl
Cl
CH3
Vin


1895.
Cl
F
Cl
Cl
CH3
Vin


1896.
Cl
Cl
Cl
Cl
CH3
Vin


1897.
Cl
Br
Cl
Cl
CH3
Vin


1898.
Cl
I
Cl
Cl
CH3
Vin


1899.
Cl
CH3
Cl
Cl
CH3
Vin


1900.
Cl
Et
Cl
Cl
CH3
Vin


1901.
Cl
CF3
Cl
Cl
CH3
Vin


1902.
Cl
OCH3
Cl
Cl
CH3
Vin


1903.
Cl
OCF3
Cl
Cl
CH3
Vin


1904.
Cl
CN
Cl
Cl
CH3
Vin


1905.
Cl
H
Cl
Cl
Et
Vin


1906.
Cl
F
Cl
Cl
Et
Vin


1907.
Cl
Cl
Cl
Cl
Et
Vin


1908.
Cl
Br
Cl
Cl
Et
Vin


1909.
Cl
I
Cl
Cl
Et
Vin


1910.
Cl
CH3
Cl
Cl
Et
Vin


1911.
Cl
Et
Cl
Cl
Et
Vin


1912.
Cl
CF3
Cl
Cl
Et
Vin


1913.
Cl
OCH3
Cl
Cl
Et
Vin


1914.
Cl
OCF3
Cl
Cl
Et
Vin


1915.
Cl
CN
Cl
Cl
Et
Vin


1916.
Cl
Br
Cl
Br
CH3
CH3


1917.
Cl
Br
Cl
Br
CH3
Et


1918.
Cl
Br
Cl
Br
Et
Et


1919.
Cl
Br
Cl
Br
CH3
Vin


1920.
Cl
Br
Cl
Br
Et
Vin


1921.
Cl
I
Cl
I
CH3
CH3


1922.
Cl
I
Cl
I
CH3
Et


1923.
Cl
I
Cl
I
Et
Et


1924.
Cl
I
Cl
I
CH3
Vin


1925.
Cl
I
Cl
I
Et
Vin


1926.
Cl
H
Cl
CN
CH3
CH3


1927.
Cl
F
Cl
CN
CH3
CH3


1928.
Cl
Cl
Cl
CN
CH3
CH3


1929.
Cl
Br
Cl
CN
CH3
CH3


1930.
Cl
I
Cl
CN
CH3
CH3


1931.
Cl
CH3
Cl
CN
CH3
CH3


1932.
Cl
Et
Cl
CN
CH3
CH3


1933.
Cl
CF3
Cl
CN
CH3
CH3


1934.
Cl
OCH3
Cl
CN
CH3
CH3


1935.
Cl
OCF3
Cl
CN
CH3
CH3


1936.
Cl
CN
Cl
CN
CH3
CH3


1937.
Cl
H
Cl
CN
CH3
Et


1938.
Cl
F
Cl
CN
CH3
Et


1939.
Cl
Cl
Cl
CN
CH3
Et


1940.
Cl
Br
Cl
CN
CH3
Et


1941.
Cl
I
Cl
CN
CH3
Et


1942.
Cl
CH3
Cl
CN
CH3
Et


1943.
Cl
Et
Cl
CN
CH3
Et


1944.
Cl
CF3
Cl
CN
CH3
Et


1945.
Cl
OCH3
Cl
CN
CH3
Et


1946.
Cl
OCF3
Cl
CN
CH3
Et


1947.
Cl
CN
Cl
CN
CH3
Et


1948.
Cl
H
Cl
CN
Et
Et


1949.
Cl
F
Cl
CN
Et
Et


1950.
Cl
Cl
Cl
CN
Et
Et


1951.
Cl
Br
Cl
CN
Et
Et


1952.
Cl
I
Cl
CN
Et
Et


1953.
Cl
CH3
Cl
CN
Et
Et


1954.
Cl
Et
Cl
CN
Et
Et


1955.
Cl
CF3
Cl
CN
Et
Et


1956.
Cl
OCH3
Cl
CN
Et
Et


1957.
Cl
OCF3
Cl
CN
Et
Et


1958.
Cl
CN
Cl
CN
Et
Et


1959.
Cl
H
Cl
CN
CH3
Vin


1960.
Cl
F
Cl
CN
CH3
Vin


1961.
Cl
Cl
Cl
CN
CH3
Vin


1962.
Cl
Br
Cl
CN
CH3
Vin


1963.
Cl
I
Cl
CN
CH3
Vin


1964.
Cl
CH3
Cl
CN
CH3
Vin


1965.
Cl
Et
Cl
CN
CH3
Vin


1966.
Cl
CF3
Cl
CN
CH3
Vin


1967.
Cl
OCH3
Cl
CN
CH3
Vin


1968.
Cl
OCF3
Cl
CN
CH3
Vin


1969.
Cl
CN
Cl
CN
CH3
Vin


1970.
Cl
H
Cl
CN
Et
Vin


1971.
Cl
F
Cl
CN
Et
Vin


1972.
Cl
Cl
Cl
CN
Et
Vin


1973.
Cl
Br
Cl
CN
Et
Vin


1974.
Cl
I
Cl
CN
Et
Vin


1975.
Cl
CH3
Cl
CN
Et
Vin


1976.
Cl
Et
Cl
CN
Et
Vin


1977.
Cl
CF3
Cl
CN
Et
Vin


1978.
Cl
OCH3
Cl
CN
Et
Vin


1979.
Cl
OCF3
Cl
CN
Et
Vin


1980.
Cl
CN
Cl
CN
Et
Vin


1981.
H
H
H
H
CH3
nPr


1982.
H
F
H
H
CH3
nPr


1983.
H
Cl
H
H
CH3
nPr


1984.
H
Br
H
H
CH3
nPr


1985.
H
I
H
H
CH3
nPr


1986.
H
CH3
H
H
CH3
nPr


1987.
H
Et
H
H
CH3
nPr


1988.
H
CF3
H
H
CH3
nPr


1989.
H
OCH3
H
H
CH3
nPr


1990.
H
OCF3
H
H
CH3
nPr


1991.
H
CN
H
H
CH3
nPr


1992.
H
H
H
F
CH3
nPr


1993.
H
F
H
F
CH3
nPr


1994.
H
Cl
H
F
CH3
nPr


1995.
H
Br
H
F
CH3
nPr


1996.
H
I
H
F
CH3
nPr


1997.
H
CH3
H
F
CH3
nPr


1998.
H
Et
H
F
CH3
nPr


1999.
H
CF3
H
F
CH3
nPr


2000.
H
OCH3
H
F
CH3
nPr


2001.
H
OCF3
H
F
CH3
nPr


2002.
H
CN
H
F
CH3
nPr


2003.
H
H
H
Cl
CH3
nPr


2004.
H
F
H
Cl
CH3
nPr


2005.
H
Cl
H
Cl
CH3
nPr


2006.
H
Br
H
Cl
CH3
nPr


2007.
H
I
H
Cl
CH3
nPr


2008.
H
CH3
H
Cl
CH3
nPr


2009.
H
Et
H
Cl
CH3
nPr


2010.
H
CF3
H
Cl
CH3
nPr


2011.
H
OCH3
H
Cl
CH3
nPr


2012.
H
OCF3
H
Cl
CH3
nPr


2013.
H
CN
H
Cl
CH3
nPr


2014.
H
H
H
H
CH3
iPr


2015.
H
F
H
H
CH3
iPr


2016.
H
Cl
H
H
CH3
iPr


2017.
H
Br
H
H
CH3
iPr


2018.
H
I
H
H
CH3
iPr


2019.
H
CH3
H
H
CH3
iPr


2020.
H
Et
H
H
CH3
iPr


2021.
H
CF3
H
H
CH3
iPr


2022.
H
OCH3
H
H
CH3
iPr


2023.
H
OCF3
H
H
CH3
iPr


2024.
H
CN
H
H
CH3
iPr


2025.
H
H
H
F
CH3
iPr


2026.
H
F
H
F
CH3
iPr


2027.
H
Cl
H
F
CH3
iPr


2028.
H
Br
H
F
CH3
iPr


2029.
H
I
H
F
CH3
iPr


2030.
H
CH3
H
F
CH3
iPr


2031.
H
Et
H
F
CH3
iPr


2032.
H
CF3
H
F
CH3
iPr


2033.
H
OCH3
H
F
CH3
iPr


2034.
H
OCF3
H
F
CH3
iPr


2035.
H
CN
H
F
CH3
iPr


2036.
H
H
H
Cl
CH3
iPr


2037.
H
F
H
Cl
CH3
iPr


2038.
H
Cl
H
Cl
CH3
iPr


2039.
H
Br
H
Cl
CH3
iPr


2040.
H
I
H
Cl
CH3
iPr


2041.
H
CH3
H
Cl
CH3
iPr


2042.
H
Et
H
Cl
CH3
iPr


2043.
H
CF3
H
Cl
CH3
iPr


2044.
H
OCH3
H
Cl
CH3
iPr


2045.
H
OCF3
H
Cl
CH3
iPr


2046.
H
CN
H
Cl
CH3
iPr





Et ethyl


Vin vinyl (—CH═CH2)


nPr n-propyl


iPr isopropyl






Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O—H.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH(CH3) 2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CH2CH2CH3.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH(CH3) CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CH(CH3) 2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O—C(CH3) 3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CHF2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CH2F.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CF3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2CH═CH2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2C═CH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O-cyclopropyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O-cyclopentyl.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O)O-cyclohexyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—H.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH(CH3) 2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH(CH3) CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CH(CH3) 2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—C(CH3) 3.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CN.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CHF2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CH2F.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CF3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2CH═CH2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2C═CH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O—CH2C6H5 (CH2C6H5=benzyl).


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O-cyclopropyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O-cyclobutyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O-cyclopentyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2CH2—C(═O)O-cyclohexyl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—OCH3.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—OCH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)—CF3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)—CH2CH2F.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)—CH2CHF2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)—CH2CF3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—CH(CH3) 2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—CH2CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—CH(CH3) CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—CH2CH(CH3) 2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—C(CH3) 3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—CF3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—CH2CHF2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—CH2CH2F.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—CH2CF3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—N(H) CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—N(H) CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—N(H) CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—N(H) CH(CH3) 2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—N(H) CH2CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—N(H) CH(CH3) CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—N(H) CH2CH(CH3) 2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—N(H) C(CH3) 2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—N(CH3) 2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—N(CH3) CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—N(CH3) CH2CH2CH3.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—N(CH3) CH(CH3) 2.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—N(CH3) CH2CH2CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—N(CH3) CH(CH3) CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—N(CH3) CH2CH(CH3) 2.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2—N(CH3) C(CH3) 2.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2-piperdin-1-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2-piperazin-1-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2-morpholin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for —CH(CH3)—CH2—C(═O) NH—S(O)2-thiomorpholin-4-yl.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z1), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z1), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z1), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z2), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z2), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z2), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z3), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z3), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z3), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z4), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z4), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z4), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z5), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z5), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z5), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z6), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z6), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z6), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z7), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z7), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z7), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z8), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z8), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z8), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z9), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z9), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z9), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z10), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z10), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z10), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z11), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z11), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z11), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z12), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z12), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z12), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z13), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z13), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z13), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z14), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z14), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z14), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z15), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z15), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z15), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z16), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z16), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z16), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z17), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z17), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z17), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z18), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z18), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z18), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z19), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z19), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z19), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z20), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z20), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z20), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z21), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z21), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z21), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z22), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z22), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z22), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z23), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z23), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z23), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z24), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z24), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z24), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z25), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z25), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z25), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z26), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z26), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z26), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z27), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z27), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z27), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z28), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z28), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z28), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z29), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z29), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z29), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z30), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z30), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z30), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z31), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z31), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z31), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z32), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z32), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z32), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z33), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z33), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z33), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z34), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z34), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (1) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z34), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z35), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z35), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z35), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH2CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z36), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O) OH.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R5, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z36), wherein # denotes the attachment point to the remainder of the molecule and Rx is-C(═O)O—CH3.


Particularly preferred are moreover compounds (I) in which for a single compound R1, R6 and R9 are hydrogen, R2, R3, R4, R6, R7 and R8 have one of the meanings as defined in a single line of table A and X-Y in combination stand for a ring of the formula (Z3%), wherein # denotes the attachment point to the remainder of the molecule and Rx is —C(═O)O—CH2CH3.




embedded image


embedded image


embedded image


embedded image


embedded image


Among rings Z1 to Z36, particular preference is given to rings Z9.


The compounds of formula (I) according to the invention can be prepared by standard processes of organic chemistry, for example by the following processes:




embedded image


The compounds of formula (I) can be prepared according to methods or in analogy to methods that are described in the prior art. The synthesis takes advantage of starting materials that are commercially available or may be prepared according to conventional procedures starting from readily available compounds.


Compounds of the formula (I) can be prepared from the carboxylic acids (III) and commercially available amines (II) using an organic base and a coupling reagent. Thus, compounds of formula (I) can be synthesized from the corresponding carboxylic acids (1 eq.) using a coupling reagent (1-2 eq.), for example T3P (propane phosphonic acid anhydride) or HATU (O-(7-azabenzotriazole-1-yl)-N,N,N′,N′-tetramethyluronium-hexafluorophosphate), an organic base (1-3 eq.) and the amines (II) (1-3 eq.). The reaction is typically carried out in an organic solvent. Preferably an aprotic organic solvent is used. Most preferably tetrahydrofuran (THF), N,N-dimethylformamide (DMF) or acetonitrile (ACN) are used. The reaction is carried out at temperatures between 0° C. and reflux. Preferably the reaction is carried out at room temperature. Preferably the organic base is triethylamine or N,N-diisopropylethylamine.




embedded image


The carboxylic acids (III) are commercially available or can be prepared from the corresponding esters (IV) (wherein RP is alkyl or benzyl). If RP is alkyl, esters (IV) may be cleaved using aqueous alkali metal hydroxides. Preferably lithium hydroxide, sodium hydroxide or potassium hydroxide (1-2 eq.) are employed. The reaction is typically carried out in mixtures of water and an organic solvent. Preferably the organic solvent is THF, methanol or acetonitrile. The reaction is carried out at temperatures between 0° C. and 100° C. Preferably the reaction is carried at room temperature. If RP is benzyl in (IV), then the ester may be cleaved using palladium on charcoal (0.001-1 eq.) as catalyst and hydrogen gas at temperatures between 0° C. and reflux. Preferably the reaction is carried out at room temperature. Typically, an organic solvent is employed. Preferably THF, methanol or ethanol are employed.


Compounds of the formula (IV) are commercially available or can be prepared by known methods. For example, the esters (IV) can be prepared according to methods described in Organometallics 2001, 20 (22), 4675-4682. For example, they can be prepared from the carboxylic acids (VI) and commercially available amines (V) using a base and a coupling reagent.




embedded image


Thus, compounds of formula (IV) can be synthesized from the corresponding carboxylic acids (1 eq.) using a coupling reagent (1-2 eq.), for example T3P (propanephosphonic acid anhydride) or HATU (O-(7-azabenzotriazole-1-yl)-N,N,N′,N′-tetramethyluronium-hexafluorphosphate), an organic base (1-3 eq.) and the amines (V) (1-3 eq.). The reaction is typically carried out in an organic solvent. Preferably an aprotic organic solvent is used. Most preferably tetrahydrofuran (THF), N,Ndimethylformamide (DMF) or acetonitrile (ACN) are used. The reaction is carried out at temperatures between 0° C. to refluxing temperatures. Preferably the reaction is carried out at room temperature. Preferably the organic base is triethylamine or N,N-diisopropylethylamine.




embedded image


Carboxylic acid (VI) may be prepared from the corresponding diester by selective cleavage of one ester group. If Ra is an alkyl ester, selective ester cleavage may be achieved using an aqueous base. Preferably an alkali metal hydroxide is used. Most preferably lithium hydroxide, sodium hydroxide or potassium hydroxide are used. The reaction is typically carried out in mixtures of water and an organic solvent. Preferably THF, methanol or acetonitrile are employed. The reaction is carried out at temperatures between 0° C. and 100° C., preferably at room temperature.


Alternatively, trimethyltin hydroxide (e.g. 1 eq.) in 1,2-dichlorethane at room temperature to reflux may be used (as described in Angew. Chem. Int. Ed, 2005, 44:1378-1382), preferably at reflux. If Ra is benzyl in (VII), then the ester may be cleaved using palladium on charcoal (0.001-1 eq.) as catalyst and hydrogen gas at temperatures between 0° C. and reflux. Preferably the reaction is carried out at room temperature. Typically, an organic solvent is employed. Preferably THF, methanol or ethanol are employed.


The diesters (VII) are either commercially available or can be prepared by standard methods of organic chemistry.




embedded image


Amines of the formula (XIII) can be prepared from the lactames (XIV), which are either commercially available or may be prepared by alkylation as described in Org. Process Res. Dev. 2018, 22, 337-343, and commercially available alcohols (XV) using thionyl chloride (2 eq.) as described in Tetrahedron Lett. 2001, 42, 1347-1350. The reaction is typically carried out in the coupling alcohols (XV) as the solvent. The reaction is carried out at temperatures between 0° C. to refluxing temperatures. Preferably the reaction is carried out at room temperature.


To widen the spectrum of action, the compounds of formula (I) may be mixed with many representatives of other herbicidal or growth-regulating active ingredient groups and then applied concomitantly. Suitable components for combinations are, for example, herbicides from the classes of the acetamides, amides, aryloxyphenoxypropionates, benzamides, benzofuran, benzoic acids, benzothiadiazinones, bipyridylium, carbamates, chloroacetamides, chlorocarboxylic acids, cyclohexanediones, dinitroanilines, dinitrophenol, diphenyl ether, glycines, imidazolinones, isoxazoles, isoxazolidinones, nitriles, N-phenylphthalimides, oxadiazoles, oxazolidinediones, oxyacetamides, phenoxycarboxylic acids, phenylcarbamates, phenylpyrazoles, phenylpyrazolines, phenylpyridazines, phosphinic acids, phosphoroamidates, phosphorodithioates, phthalamates, pyrazoles, pyridazinones, pyridines, pyridinecarboxylic acids, pyridinecarboxamides, pyrimidinediones, pyrimidinyl (thio)benzoates, quinolinecarboxylic acids, semicarbazones, sulfonylaminocarbonyltriazolinones, sulfonylureas, tetrazolinones, thiadiazoles, thiocarbamates, triazines, triazinones, triazoles, triazolinones, triazolocarboxamides, triazolopyrimidines, triketones, uracils, ureas.


It may furthermore be beneficial to apply the compounds of formula (I) alone or in combination with other herbicides, or else in the form of a mixture with other crop protection agents, for example together with agents for controlling pests or phytopathogenic fungi or bacteria. Also of interest is the miscibility with mineral salt solutions, which are employed for treating nutritional and trace element deficiencies. Other additives such as non-phytotoxic oils and oil concentrates may also be added.


In one embodiment of the present invention the combinations according to the present invention comprise at least one compound of formula (I) (compound A or component A) and at least one further active compound selected from herbicides B (compound B), preferably herbicides B of class b1) to b15), and safeners C(compound C).


In another embodiment of the present invention the combinations according to the present invention comprise at least one compound of formula (I) and at least one further active compound B (herbicide B).


Examples of herbicides B which can be used in combination with the compounds A of formula (I) according to the present invention are:


b1) from the group of the lipid biosynthesis inhibitors:


ACC-herbicides such as alloxydim, alloxydim-sodium, butroxydim, clethodim, clodinafop, clodinafop-propargyl, cycloxydim, cyhalofop, cyhalofop-butyl, diclofop, diclofop-methyl, fenoxaprop, fenoxaprop-ethyl, fenoxaprop-P, fenoxaprop-P-ethyl, fluazifop, fluazifop-butyl, fluazifop-P, fluazifop-P-butyl, haloxyfop, haloxyfop-methyl, haloxyfop-P, haloxyfop-P-methyl, metamifop, pinoxaden, profoxydim, propaquizafop, quizalofop, quizalofop-ethyl, quizalofop-tefuryl, quizalofop-P, quizalofop-P-ethyl, quizalofop-P-tefuryl, sethoxydim, tepraloxydim, tralkoxydim, 4-(4′-Chloro-4-cyclopropyl-2′-fluoro [1,1′-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3 (6H)-one (CAS 1312337-72-6); 4-(2′,4′-Dichloro-4-cyclopropyl [1,1′-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3 (6H)-one (CAS 1312337-45-3); 4-(4′-Chloro-4-ethyl-2′-fluoro [1,1′-biphenyl]-3-yl)-5-hydroxy-2,2,6,6-tetramethyl-2H-pyran-3 (6H)-one (CAS 1033757-93-5); 4-(2′,4′-Dichloro-4-ethyl [1,1′-biphenyl]-3-yl)-2,2,6,6-tetramethyl-2Hpyran-3,5 (4H,6H)-dione (CAS 1312340-84-3); 5-(Acetyloxy)-4-(4′-chloro-4-cyclopropyl-2′-fluoro [1,1′-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one (CAS 1312337-48-6); 5-(Acetyloxy)-4-(2′,4′-dichloro-4-cyclopropyl-[1,1′-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one; 5-(Acetyloxy)-4-(4′-chloro-4-ethyl-2′-fluoro [1,1′-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one (CAS 1312340-82-1); 5-(Acetyloxy)-4-(2′,4′-dichloro-4-ethyl [1,1′-biphenyl]-3-yl)-3,6-dihydro-2,2,6,6-tetramethyl-2H-pyran-3-one (CAS 1033760-55-2); 4-(4′-Chloro-4-cyclopropyl-2′-fluoro [1,1′-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester (CAS 1312337-51-1); 4-(2′,4′-Dichloro-4-cyclopropyl-[1,1′-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester; 4-(4′-Chloro-4-ethyl-2′-fluoro [1,1′-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester (CAS 1312340-83-2); 4-(2′,4′-Dichloro-4-ethyl [1,1′-biphenyl]-3-yl)-5,6-dihydro-2,2,6,6-tetramethyl-5-oxo-2H-pyran-3-yl carbonic acid methyl ester (CAS 1033760-58-5); and non ACC herbicides such as benfuresate, butylate, cycloate, dalapon, dimepiperate, EPTC, esprocarb, ethofumesate, flupropanate, molinate, orbencarb, pebulate, prosulfocarb, TCA, thiobencarb, tiocarbazil, triallate and vernolate;


b2) from the group of the ALS inhibitors:


sulfonylureas such as amidosulfuron, azimsulfuron, bensulfuron, bensulfuron-methyl, chlorimuron, chlorimuron-ethyl, chlorsulfuron, cinosulfuron, cyclosulfamuron, ethametsulfuron, ethametsulfuron-methyl, ethoxysulfuron, flazasulfuron, flucetosulfuron, flupyrsulfuron, flupyrsulfuron-methyl-sodium, foramsulfuron, halosulfuron, halosulfuron-methyl, imazosulfuron, iodosulfuron, iodosulfuron-methylsodium, iofensulfuron, iofensulfuron-sodium, mesosulfuron, metazosulfuron, metsulfuron, metsulfuron-methyl, nicosulfuron, orthosulfamuron, oxasulfuron, primisulfuron, primisulfuron-methyl, propyrisulfuron, prosulfuron, pyrazosulfuron, pyrazosulfuron-ethyl, rimsulfuron, sulfometuron, sulfometuron-methyl, sulfosulfuron, thifensulfuron, thifensulfuron-methyl, triasulfuron, tribenuron, tribenuron-methyl, trifloxysulfuron, triflusulfuron, triflusulfuron-methyl and tritosulfuron, imidazolinones such as imazamethabenz, imazamethabenz-methyl, imazamox, imazapic, imazapyr, imazaquin and imazethapyr, triazolopyrimidine herbicides and sulfonanilides such as cloransulam, cloransulam-methyl, diclosulam, flumetsulam, florasulam, metosulam, penoxsulam, pyrimisulfan and pyroxsulam, pyrimidinylbenzoates such as bispyribac, bispyribac-sodium, pyribenzoxim, pyriftalid, pyriminobac, pyriminobac-methyl, pyrithiobac, pyrithiobac-sodium, 4-[2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]phenyl]methyl]amino]-benzoic acid-1-methylethyl ester (CAS 420138-41-6), 4-[[2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]phenyl]methyl]amino]-benzoic acid propyl ester (CAS 420138-40-5), N-(4-bromophenyl)-2-[(4,6-dimethoxy-2-pyrimidinyl)oxy]benzenemethanamine (CAS 420138 Jan. 8), sulfonylaminocarbonyl-triazolinone herbicides such as flucarbazone, flucarbazonesodium, propoxycarbazone, propoxycarbazone-sodium, thiencarbazone and thiencarbazone-methyl; and triafamone;


among these, a preferred embodiment of the invention relates to those compositions comprising at least one imidazolinone herbicide;


b3) from the group of the photosynthesis inhibitors:


amicarbazone, inhibitors of the photosystem II, e.g. 1-(6-tert-butylpyrimidin-4-yl)-2-hydroxy-4-methoxy-3-methyl-2H-pyrrol-5-one (CAS 1654744-66-7), 1-(5-tertbutylisoxazol-3-yl)-2-hydroxy-4-methoxy-3-methyl-2H-pyrrol-5-one (CAS 1637455 Dec. 9), 1-(5-tert-butylisoxazol-3-yl)-4-chloro-2-hydroxy-3-methyl-2H-pyrrol-5-one (CAS 1637453-94-1), 1-(5-tert-butyl-1-methyl-pyrazol-3-yl)-4-chloro-2-hydroxy-3-methyl-2Hpyrrol-5-one (CAS 1654057-29-0), 1-(5-tert-butyl-1-methyl-pyrazol-3-yl)-3-chloro-2-hydroxy-4-methyl-2H-pyrrol-5-one (CAS 1654747-80-4), 4-hydroxy-1-methoxy-5-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one; (CAS 2023785-78-4), 4-hydroxy-1,5-dimethyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one (CAS 2023785-79-5), 5-ethoxy-4-hydroxy-1-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one (CAS 1701416-69-4), 4-hydroxy-1-methyl-3-[4-(trifluoromethyl)-2-pyridyl]imidazolidin-2-one (CAS 1708087-22-2), 4-hydroxy-1,5-dimethyl-3-[1-methyl-5-(trifluoromethyl) pyrazol-3-yl]imidazolidin-2-one (CAS 2023785-80-8), 1-(5-tertbutylisoxazol-3-yl)-4-ethoxy-5-hydroxy-3-methyl-imidazolidin-2-one (CAS 1844836-64-1), triazine herbicides, including of chlorotriazine, triazinones, triazindiones, methylthiotriazines and pyridazinones such as ametryn, atrazine, chloridazone, cyanazine, desmetryn, dimethametryn,hexazinone, metribuzin, prometon, prometryn, propazine, simazine, simetryn, terbumeton, terbuthylazin, terbutryn and trietazin, aryl urea such as chlorobromuron, chlorotoluron, chloroxuron, dimefuron, diuron, fluometuron, isoproturon, isouron, linuron, metamitron, methabenzthiazuron, metobenzuron, metoxuron, monolinuron, neburon, siduron, tebuthiuron and thiadiazuron, phenyl carbamates such as desmedipham, karbutilat, phenmedipham, phenmedipham-ethyl, nitrile herbicides such as bromofenoxim, bromoxynil and its salts and esters, ioxynil and its salts and esters, uraciles such as bromacil, lenacil and terbacil, and bentazon and bentazon-sodium, pyridate, pyridafol, pentanochlor and propanil and inhibitors of the photosystem I such as diquat, diquat-dibromide, paraquat, paraquat-dichloride and paraquat-dimetilsulfate. Among these, a preferred embodiment of the invention relates to those compositions comprising at least one aryl urea herbicide. Among these, likewise a preferred embodiment of the invention relates to those compositions comprising at least one triazine herbicide. Among these, likewise a preferred embodiment of the invention relates to those compositions comprising at least one nitrile herbicide;


b4) from the group of the protoporphyrinogen-IX oxidase inhibitors:


acifluorfen, acifluorfen-sodium, azafenidin, bencarbazone, benzfendizone, bifenox, butafenacil, carfentrazone, carfentrazone-ethyl, chlomethoxyfen, chlorphthalim, cinidon-ethyl, cyclopyranil, fluazolate, flufenpyr, flufenpyr-ethyl, flumiclorac, flumicloracpentyl, flumioxazin, fluoroglycofen, fluoroglycofen-ethyl, fluthiacet, fluthiacet-methyl, fomesafen, halosafen, lactofen, oxadiargyl, oxadiazon, oxyfluorfen, pentoxazone, profluazol, pyraclonil, pyraflufen, pyraflufen-ethyl, saflufenacil, sulfentrazone, thidiazimin, tiafenacil, trifludimoxazin, ethyl [3-[2-chloro-4-fluoro-5-(1-methyl-6-trifluoromethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-3-yl) phenoxy]-2-pyridyloxy]acetate (CAS 353292-31-6; S-3100), N-ethyl-3-(2,6-dichloro-4-trifluoromethylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 452098-92-9), N-tetrahydrofurfuryl-3-(2,6-dichloro-4-trifluoromethylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 915396-43-9), N-ethyl-3-(2-chloro-6-fluoro-4-trifluoromethylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 452099 May 7), N-tetrahydrofurfuryl-3-(2-chloro-6-fluoro-4-trifluoromethylphenoxy)-5-methyl-1H-pyrazole-1-carboxamide (CAS 452100 Mar. 7), 3-[7-fluoro-3-oxo-4-(prop-2-ynyl)-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl]-1,5-dimethyl-6-thioxo-[1,3,5]triazinan-2,4-dione (CAS 451484-50-7), 2-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-4,5,6,7-tetrahydro-isoindole-1,3-dione (CAS 1300118-96-0), 1-methyl-6-trifluoromethyl-3-(2,2,7-trifluoro-3-oxo-4-prop-2-ynyl-3,4-dihydro-2H-benzo[1,4]oxazin-6-yl)-1H-pyrimidine-2,4-dione (CAS 1304113-05-0), methyl (E)-4-[2-chloro-5-[4-chloro-5-(difluoromethoxy)-1 H-methyl-pyrazol-3-yl]-4-fluorophenoxy]-3-methoxy-but-2-enoate (CAS 948893-00-3), and 3-[7-chloro-5-fluoro-2-(trifluoromethyl)-1H-benzimidazol-4-yl]-1-methyl-6-(trifluoromethyl)-1H-pyrimidine-2,4-dione (CAS 212754 Feb. 4), 2-[2-chloro-5-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]-4-fluorophenoxy]-2-methoxy-acetic acid methyl ester (CAS 1970221-16-9), 2-[2-[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1 (2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy]-acetic acid methyl ester (CAS 2158274-96-3), 2-[2-[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1 (2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy]acetic acid ethyl ester (CAS 158274-50-9), methyl 2-[3-[2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]-4-fluoro-phenoxy]-2 -pyridyl]oxy]acetate (CAS 2271389-22-9), ethyl 2-[3-[2-chloro-5-[4-(difluoromethyl)-3-methyl-5-oxo-1,2,4-triazol-1-yl]-4-fluoro-phenoxy]-2-pyridyl]oxy]acetate (CAS 2230679-62-4), 2-[3-[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1 (2H)pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy]-acetic acid methyl ester (CAS 2158275-73-9), 2-[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1 (2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy]acetic acid ethyl ester (CAS 2158274-56-5), 2-[2-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1 (2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]phenoxy]-N-(methylsulfonyl)-acetamide (CAS 2158274-53-2), 2-[[3-[[3-chloro-6-[3,6-dihydro-3-methyl-2,6-dioxo-4-(trifluoromethyl)-1 (2H)-pyrimidinyl]-5-fluoro-2-pyridinyl]oxy]-2-pyridinyl]oxy]-N-(methylsulfonyl)-acetamide (CAS 2158276-22-1);


b5) from the group of the bleacher herbicides:


PDS inhibitors: beflubutamid, diflufenican, fluridone, flurochloridone, flurtamone, norflurazon, picolinafen, and 4-(3-trifluoromethylphenoxy)-2-(4-trifluoromethylphenyl)-pyrimidine (CAS 180608-33-7), HPPD inhibitors: benzobicyclon, benzofenap, bicyclopyrone, clomazone, fenquinotrione, isoxaflutole, mesotrione, oxotrione (CAS 1486617-21-3), pyrasulfotole, pyrazolynate, pyrazoxyfen, sulcotrione, tefuryltrione, tembotrione, tolpyralate, topramezone, bleacher, unknown target: aclonifen, amitrole flumeturon 2-chloro-3-methylsulfanyl-N-(1-methyltetrazol-5-yl)-4-(trifluoromethyl) benzamide (CAS 1361139-71-0), bixlozone and 2-(2,5-dichlorophenyl)methyl-4,4-dimethyl-3-isoxazolidinone (CAS 81778-66-7);


b6) from the group of the EPSP synthase inhibitors:


glyphosate, glyphosate-isopropylammonium, glyposate-potassium and glyphosatetrimesium (sulfosate);


b7) from the group of the glutamine synthase inhibitors:


bilanaphos (bialaphos), bilanaphos-sodium, glufosinate, glufosinate-P and glufosinateammonium;


b8) from the group of the DHP synthase inhibitors:


asulam;


b9) from the group of the mitosis inhibitors:


compounds of group K1: dinitroanilines such as benfluralin, butralin, dinitramine, ethalfluralin, fluchloralin, oryzalin, pendimethalin, prodiamine and trifluralin, phosphoramidates such as amiprophos, amiprophos-methyl, and butamiphos, benzoic acid herbicides such as chlorthal, chlorthal-dimethyl, pyridines such as dithiopyr and thiazopyr, benzamides such as propyzamide and tebutam; compounds of group K2: carbetamide, chlorpropham, flamprop, flamprop-isopropyl, flamprop-methyl, flampropM-isopropyl, flamprop-M-methyl and propham; among these, compounds of group K1, in particular dinitroanilines are preferred;


b10) from the group of the VLCFA inhibitors:


chloroacetamides such as acetochlor, alachlor, amidochlor, butachlor, dimethachlor, dimethenamid, dimethenamid-P, metazachlor, metolachlor, metolachlor-S, pethoxamid, pretilachlor, propachlor, propisochlor and thenylchlor, oxyacetanilides such as flufenacet and mefenacet, acetanilides such as diphenamid, naproanilide, napropamide and napropamide-M, tetrazolinones such fentrazamide, and other herbicides such as anilofos, cafenstrole, fenoxasulfone, ipfencarbazone, piperophos, pyroxasulfone and isoxazoline compounds of the formulae II.1, 11.2, 11.3, 11.4, 11.5, 11.6, 11.7, 11.8 and II.9




embedded image


embedded image




    • the isoxazoline compounds of the formula (II) are known in the art, e.g. from WO 2006/024820, WO 2006/037945, WO 2007/071900 and WO 2007/096576;

    • among the VLCFA inhibitors, preference is given to chloroacetamides and oxyacetamides;





b11) from the group of the cellulose biosynthesis inhibitors:


chlorthiamid, dichlobenil, flupoxam, indaziflam, isoxaben, triaziflam and 1-cyclohexyl-5-pentafluorphenyloxy-14-[1,2,4,6]thiatriazin-3-ylamine (CAS 175899 Jan. 1);


b12) from the group of the decoupler herbicides:


dinoseb, dinoterb and DNOC and its salts;


b13) from the group of the auxinic herbicides:


2,4-D and its salts and esters such as clacyfos, 2,4-DB and its salts and esters, aminocyclopyrachlor and its salts and esters, aminopyralid and its salts such as aminopyralid-dimethylammonium, aminopyralid-tris(2-hydroxypropyl) ammonium and its esters, benazolin, benazolin-ethyl, chloramben and its salts and esters, clomeprop, clopyralid and its salts and esters, dicamba and its salts and esters, dichlorprop and its salts and esters, dichlorprop-P and its salts and esters, flopyrauxifen, fluroxypyr, fluroxypyr-butometyl, fluroxypyr-meptyl, halauxifen and its salts and esters (CAS 943832-60-8); MCPA and its salts and esters, MCPA-thioethyl, MCPB and its salts and esters, mecoprop and its salts and esters, mecoprop-P and its salts and esters, picloram and its salts and esters, quinclorac, quinmerac, TBA (2,3,6) and its salts and esters, triclopyr and its salts and esters, florpyrauxifen, florpyrauxifen-benzyl (CAS 1390661-72-9) and 4-amino-3-chloro-5-fluoro-6-(7-fluoro-1H-indol-6-yl) picolinic acid (CAS 1629965-65-6);


b14) from the group of the auxin transport inhibitors: diflufenzopyr, diflufenzopyrsodium, naptalam and naptalam-sodium;


b15) from the group of the other herbicides: bromobutide, chlorflurenol, chlorflurenolmethyl, cinmethylin, cumyluron, cyclopyrimorate (CAS 499223-49-3) and its salts and esters, dalapon, dazomet, difenzoquat, difenzoquat-metilsulfate, dimethipin, DSMA, dymron, endothal and its salts, etobenzanid, flurenol, flurenol-butyl, flurprimidol, fosamine, fosamine-ammonium, indanofan, maleic hydrazide, mefluidide, metam, methiozolin, methyl azide, methyl bromide, methyl-dymron, methyl iodide, MSMA, oleic acid, oxaziclomefone, pelargonic acid, pyributicarb, quinoclamine tetflupyrolimet, and tridiphane.


Moreover, it may be useful to apply the compounds of formula (I) in combination with safeners. Safeners are chemical compounds which prevent or reduce damage on useful plants without having a major impact on the herbicidal action of the compounds of the formula (I) towards undesired vegetation. They can be applied either before sowings (e.g. on seed treatments, shoots or seedlings) or in the pre-emergence application or post-emergence application of the useful plant. The safeners and the compounds of formula (I) and optionally the herbicides B can be applied simultaneously or in succession.


In another embodiment of the present invention the combinations according to the present invention comprise at least one compound of formula (I) and at least one safener C(component C).


Examples of safeners are e.g. (quinolin-8-oxy) acetic acids, 1-phenyl-5-haloalkyl-1H-1,2,4-triazol-3-carboxylic acids, 1-phenyl-4,5-dihydro-5-alkyl-1H-pyrazol-3,5-dicarboxylic acids, 4,5-dihydro-5,5-diaryl-3-isoxazol carboxylic acids, dichloroacetamides, alpha-oximinophenylacetonitriles, acetophenonoximes, 4,6-dihalo-2-phenylpyrimidines, N-[4-(aminocarbonyl)phenyl]sulfonyl]-2-benzoic amides, 1,8-naphthalic anhydride, 2-halo-4-(haloalkyl)-5-thiazol carboxylic acids, phosphorthiolates and N-alkyl-O-phenylcarbamates and their agriculturally acceptable salts and their agriculturally acceptable derivatives such amides, esters, and thioesters, provided they have an acid group.


Examples of safener compounds C are benoxacor, cloquintocet, cyometrinil, cyprosulfamide, dichlormid, dicyclonon, dietholate, fenchlorazole, fenclorim, flurazole, fluxofenim, furilazole, isoxadifen, mefenpyr, mephenate, naphthalic anhydride, oxabetrinil, 4-(dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane (MON4660, CAS 71526 Jul. 3), 2,2,5-trimethyl-3-(dichloroacetyl)-1,3-oxazolidine (R-29148, CAS 52836-31-4), metcamifen and BPCMS (CAS 54091 Jun. 4).


The active compounds B of groups b1) to b15) and the active compounds C are known herbicides and safeners, see, for example, The Compendium of Pesticide Common Names (http://www.alanwood.net/pesticides/); Farm Chemicals Handbook 2000 volume 86, Meister Publishing Company, 2000; B. Hock, C. Fedtke, R. R. Schmidt, Herbizide [Herbicides], Georg Thieme Verlag, Stuttgart 1995; W. H. Ahrens, Herbicide Handbook, 7th edition, Weed Science Society of America, 1994; and K. K. Hatzios, Herbicide Handbook, Supplement for the 7th edition, Weed Science Society of America, 1998. 2,2,5-Trimethyl-3-(dichloroacetyl)-1,3-oxazolidine [CAS No. 52836-31-4] is also referred to as R-29148. 4-(Dichloroacetyl)-1-oxa-4-azaspiro[4.5]decane [CAS No. 71526 Jul. 3] is also referred to as AD-67 and MON 4660.


The assignment of the active compounds to the respective mechanisms of action is based on current knowledge. If several mechanisms of action apply to one active compound, this substance was only assigned to one mechanism of action.


The invention also relates to formulations comprising at least an auxiliary and at least one compound of formula (I) according to the invention.


A formulation comprises a pesticidally effective amount of a compound of formula (I). The term “effective amount” denotes an amount of the combination or of the compound of formula (I), which is sufficient for controlling undesired vegetation, especially for controlling undesired vegetation in crops (i.e. cultivated plants) and which does not result in a substantial damage to the treated crop plants. Such an amount can vary in a broad range and is dependent on various factors, such as the undesired vegetation to be controlled, the treated crop plants or material, the climatic conditions and the specific compound of formula (I) used.


The compounds of formula (I), their salts, amides, esters or thioesters can be converted into customary types of formulations, e.g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof. Examples for formulation types are suspensions (e.g. SC, OD, FS), emulsifiable concentrates (e.g. EC), emulsions (e.g. EW, EO, ES, ME), capsules (e.g. CS, ZC), pastes, pastilles, wettable powders or dusts (e.g. WP, SP, WS, DP, DS), pressings (e.g. BR, TB, DT), granules (e.g. WG, SG, GR, FG, GG, MG), insecticidal articles (e.g. LN), as well as gel formulations for the treatment of plant propagation materials such as seeds (e.g. GF). These and further formulation types are defined in the “Catalogue of pesticide formulation types and international coding system”, Technical Monograph No. 2,6th Ed. May 2008, CropLife International.


The formulations are prepared in a known manner, such as described by Mollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.


Suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfactants, dispersants, emulsifiers, wetting agents, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifiers and binders.


Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil fractions of medium to high boiling point, e.g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e.g. toluene, paraffin, tetrahydronaphthalene, alkylated naphthalenes; alcohols, e.g. ethanol, propanol, butanol, benzylalcohol, cyclohexanol; glycols; DMSO; ketones, e.g. cyclohexanone; esters, e.g. lactates, carbonates, fatty acid esters, gamma-butyrolactone; fatty acids; phosphonates; amines; amides, e.g. N-methylpyrrolidone, fatty acid dimethylamides; and mixtures thereof.


Suitable solid carriers or fillers are mineral earths, e.g. silicates, silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, e.g. cellulose, starch; fertilizers, e.g. ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of vegetable origin, e.g. cereal meal, tree bark meal, wood meal, nutshell meal, and mixtures thereof.


Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emulsifier, dispersant, solubilizer, wetter, penetration enhancer, protective colloid, or adjuvant. Examples of surfactants are listed in Mccutcheon's, Vol. 1: Emulsifiers & Detergents, Mccutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).


Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sulfates, phosphates, carboxylates, and mixtures thereof. Examples of sulfonates are alkylarylsulfonates, diphenylsulfonates, alpha-olefin sulfonates, lignine sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyland tridecylbenzenes, sulfonates of naphthalenes and alkylnaphthalenes, sulfosuccinates or sulfosuccinamates. Examples of sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols, or of fatty acid esters. Examples of phosphates are phosphate esters. Examples of carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol ethoxylates.


Suitable nonionic surfactants are alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents. Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide. Examples of N-substituted fatty acid amides are fatty acid glucamides or fatty acid alkanolamides. Examples of esters are fatty acid esters, glycerol esters or monoglycerides. Examples of sugar-based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters or alkylpolyglucosides. Examples of polymeric surfactants are home- or copolymers of vinylpyrrolidone, vinylalcohols, or vinylacetate.


Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants are alkylbetains and imidazolines. Suitable block polymers are block polymers of the A-B or A-B-A type comprising blocks of polyethylene oxide and polypropylene oxide, or of the A-B-C type comprising alkanol, polyethylene oxide and polypropylene oxide. Suitable polyelectrolytes are polyacids or polybases. Examples of polyacids are alkali salts of polyacrylic acid or polyacid comb polymers. Examples of polybases are polyvinylamines or polyethyleneamines.


Suitable adjuvants are compounds, which have a neglectable or even no pesticidal activity themselves, and which improve the biological performance of the compounds of formula (I) on the target. Examples are surfactants, mineral or vegetable oils, and other auxiliaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.


Suitable thickeners are polysaccharides (e.g. xanthan gum, carboxymethylcellulose), inorganic clays (organically modified or unmodified), polycarboxylates, and silicates.


Suitable bactericides are bronopol and isothiazolinone derivatives such as alkylisothiazolinones and benzisothiazolinones.


Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin.


Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids.


Suitable colorants (e.g. in red, blue, or green) are pigments of low water solubility and water-soluble dyes. Examples are inorganic colorants (e.g. iron oxide, titan oxide, iron hexacyanoferrate) and organic colorants (e.g. alizarin-, azo- and phthalocyanine colorants).


Suitable tackifiers or binders are polyvinylpyrrolidons, polyvinylacetates, polyvinyl alcohols, polyacrylates, biological or synthetic waxes, and cellulose ethers.


Examples for formulation types and their preparation are:

    • i) Water-soluble concentrates (SL, LS) 10-60 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C(component C) according to the invention and 5-15 wt % wetting agent (e.g. alcohol alkoxylates) are dissolved in water and/or in a water-soluble solvent (e.g. alcohols) ad 100 wt %. The active substance dissolves upon dilution with water.
    • ii) Dispersible concentrates (DC) 5-25 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C(component C) according to the invention and 1-10 wt % dispersant (e.g. polyvinylpyrrolidone) are dissolved in organic solvent (e.g. cyclohexanone) ad 100 wt %. Dilution with water gives a dispersion.
    • iii) Emulsifiable concentrates (EC) 15-70 wt % of compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C(component C) according to the invention and 5-10 wt % emulsifiers (e.g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in water-insoluble organic solvent (e.g. aromatic hydrocarbon) ad 100 wt %. Dilution with water gives an emulsion.
    • iv) Emulsions (EW, EO, ES) 5-40 wt % of compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C(component C) according to the invention and 1-10 wt % emulsifiers (e.g. calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in 20-40 wt % water-insoluble organic solvent (e.g. aromatic hydrocarbon). This mixture is introduced into water ad 100 wt % by means of an emulsifying machine and made into a homogeneous emulsion. Dilution with water gives an emulsion.
    • v) Suspensions (SC, OD, FS)


In an agitated ball mill, 20-60 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are comminuted with addition of 2-10 wt % dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate), 0,1-2 wt % thickener (e.g. xanthan gum) and water ad 100 wt % to give a fine active substance suspension. Dilution with water gives a stable suspension of the active substance. For FS type formulation up to 40 wt % binder (e.g. polyvinylalcohol) is added.

    • vi) Water-dispersible granules and water-soluble granules (WG, SG) 50-80 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C(component C) according to the invention are ground finely with addition of dispersants and wetting agents (e.g. sodium lignosulfonate and alcohol ethoxylate) ad 100 wt % and prepared as waterdispersible or water-soluble granules by means of technical appliances (e.g. extrusion, spray tower, fluidized bed). Dilution with water gives a stable dispersion or solution of the active substance.
    • vii) Water-dispersible powders and water-soluble powders (WP, SP, WS) 50-80 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C(component C) according to the invention are ground in a rotor-stator mill with addition of 1-5 wt % dispersants (e.g. sodium lignosulfonate), 1-3 wt % wetting agents (e.g. alcohol ethoxylate) and solid carrier (e.g. silica gel) ad 100 wt %. Dilution with water gives a stable dispersion or solution of the active substance.
    • viii) Gel (GW, GF)


In an agitated ball mill, 5-25 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention are comminuted with addition of 3-10 wt % dispersants (e.g. sodium lignosulfonate), 1-5 wt % thickener (e.g. carboxymethylcellulose) and water ad 100 wt % to give a fine suspension of the active substance. Dilution with water gives a stable suspension of the active substance.

    • iv) Microemulsion (ME)


5-20 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C(component C) according to the invention are added to 5-30 wt % organic solvent blend (e.g. fatty acid dimethylamide and cyclohexanone), 10-25 wt % surfactant blend (e.g. alcohol ethoxylate and arylphenol ethoxylate), and water ad 100%. This mixture is stirred for 1 h to produce spontaneously a thermodynamically stable microemulsion.

    • iv) Microcapsules (CS)


An oil phase comprising 5-50 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C (component C) according to the invention, 0-40 wt % water insoluble organic solvent (e.g. aromatic hydrocarbon), 2-15 wt % acrylic monomers (e.g. methylmethacrylate, methacrylic acid and a di- or triacrylate) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). Radical polymerization initiated by a radical initiator results in the formation of poly(meth)acrylate microcapsules. Alternatively, an oil phase comprising 5-50 wt % of a compound of formula (I) according to the invention, 0-40 wt % water insoluble organic solvent (e.g. aromatic hydrocarbon), and an isocyanate monomer (e.g. diphenylmethene-4,4′-diisocyanate) are dispersed into an aqueous solution of a protective colloid (e.g. polyvinyl alcohol). The addition of a polyamine (e.g. hexamethylenediamine) results in the formation of polyurea microcapsules. The monomers amount to 1-10 wt %. The wt % relate to the total CS formulation.

    • ix) Dustable powders (DP, DS)


1-10 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C(component C) according to the invention are ground finely and mixed intimately with solid carrier (e.g. finely divided kaolin) ad 100 wt %.

    • x) Granules (GR, FG)


0.5-30 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C(component C) according to the invention is ground finely and associated with solid carrier (e.g. silicate) ad 100 wt %. Granulation is achieved by extrusion, spray-drying or the fluidized bed.

    • xi) Ultra-low volume liquids (UL)


1-50 wt % of a compound of formula (I) or a combination comprising at least one compound of formula (I) (component A) and at least one further compound selected from the herbicidal compounds B (component B) and safeners C(component C) according to the invention are dissolved in organic solvent (e.g. aromatic hydrocarbon) ad 100 wt %.


The formulation types i) to xi) may optionally comprise further auxiliaries, such as 0,1-1 wt % bactericides, 5-15 wt % anti-freezing agents, 0,1-1 wt % anti-foaming agents, and 0,1-1 wt % colorants.


The formulations and/or combinations generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, and in particular between 0.5 and 75%, by weight of the compounds of formula (I).


The compounds of formula (I) are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).


Solutions for seed treatment (LS), suspoemulsions (SE), flowable concentrates (FS), powders for dry treatment (DS), water-dispersible powders for slurry treatment (WS), water-soluble powders (SS), emulsions(ES), emulsifiable concentrates (EC) and gels (GF) are usually employed for the purposes of treatment of plant propagation materials, particularly seeds. The formulations in question give, after two-to-tenfold dilution, active substance concentrations of from 0.01 to 60% by weight, preferably from 0.1 to 40% by weight, in the ready-to-use preparations. (nach unten verschoben)


Methods for applying compounds of formula (I), formulations and/or combinations thereof, on to plant propagation material, especially seeds, include dressing, coating, pelleting, dusting, soaking and in-furrow application methods of the propagation material. Preferably, compounds of formula (I), formulations and/or combinations thereof, respectively, are applied on to the plant propagation material by a method such that germination is not induced, e.g. by seed dressing, pelleting, coating and dusting.


Various types of oils, wetting agents, adjuvants, fertilizer, or micronutrients, and further pesticides (e.g. herbicides, insecticides, fungicides, growth regulators, safeners) may be added to the compounds of formula (I), the formulations and/or the combinations comprising them as premix or, if appropriate not until immediately prior to use (tank mix). These agents can be admixed with the formulations according to the invention in a weight ratio of 1:100 to 100:1, preferably 1:10 to 10:1.


The user applies the compounds of formula (I) according to the invention, the formulations and/or the combinations comprising them usually from a pre-dosage device, a knapsack sprayer, a spray tank, a spray plane, or an irrigation system. Usually, the formulation is made up with water, buffer, and/or further auxiliaries to the desired application concentration and the ready-to-use spray liquor or the formulation according to the invention is thus obtained. Usually, 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agricultural useful area.


According to one embodiment, either individual components of the formulation according to the invention or partially premixed components, e.g. components comprising compounds of formula (I) and optionally active substances from the groups B and/or C), may be mixed by the user in a spray tank and further auxiliaries and additives may be added, if appropriate.


In a further embodiment, individual components of the formulation according to the invention such as parts of a kit or parts of a binary or ternary mixture may be mixed by the user himself in a spray tank and further auxiliaries may be added, if appropriate.


In a further embodiment, either individual components of the formulation according to the invention or partially premixed components, e.g. components comprising compounds of formula (I) and optionally active substances from the groups B and/or C), can be applied jointly (e.g. after tank mix) or consecutively.


The compounds of formula (I), are suitable as herbicides. They are suitable as such, as an appropriate formulation or in combination with at least one further compound selected from the herbicidal active compounds B (component B) and safeners C(component C).


The compounds of formula (I), or the formulations and/or combinations comprising the compounds of formula (I), control undesired vegetation on non-crop areas very efficiently, especially at high rates of application. They act against broad-leaved weeds and grass weeds in crops such as wheat, rice, maize, soya and cotton without causing any significant damage to the crop plants. This effect is mainly observed at low rates of application.


The compounds of the invention are useful for controlling for example following weeds: Abutilon theophrasti (ABUTH), Alopercurus myosuroides (ALOMY), Amaranthus retro-flexus (AMARE), Apera spica-venti (APESV), Avena fatua (AVEFA), Digitaria sanguinalis (DIGSA), Echinocloa crus-galli (ECHCG), Lolium multiflorum (LOLMU) Setaria faberi (SETFA), Setaria viridis (SETVI), to name just a few representative examples.


The compounds of formula (I), or the formulations and/or the combinations comprising them, are applied to the plants mainly by spraying the leaves. Here, the application can be carried out using, for example, water as carrier by customary spraying techniques using spray liquor amounts of from about 100 to 1000 l/ha (for example from 300 to 400 l/ha). The compounds of formula (I), or the formulations and/or the combinations comprising them, may also be applied by the low-volume or the ultra-low-volume method, or in the form of microgranules.


Application of the compounds of formula (I), or the formulations and/or the combinations comprising them, can be done before, during and/or after, preferably during and/or after, the emergence of the undesired vegetation.


Application of the compounds of formula (I), or the formulations and/or the combinations can be carried out before or during sowing.


The compounds of formula (I), or the formulations and/or the combinations comprising them, can be applied pre-, post-emergence or pre-plant, or together with the seed of a crop plant. It is also possible to apply the compounds of formula (I), or the formulations and/or the combinations comprising them, by applying seed, pretreated with the compounds of formula (1), or the formulations and/or the combinations comprising them, of a crop plant. If the active ingredients are less well tolerated by certain crop plants, application techniques may be used in which the combinations are sprayed, with the aid of the spraying equipment, in such a way that as far as possible they do not come into contact with the leaves of the sensitive crop plants, while the active ingredients reach the leaves of undesired vegetation growing underneath, or the bare soil surface (postdirected, lay-by).


In a further embodiment, the compounds of formula (I), or the formulations and/or the combinations comprising them, can be applied by treating seed. The treatment of seeds comprises essentially all procedures familiar to the person skilled in the art (seed dressing, seed coating, seed dusting, seed soaking, seed film coating, seed multilayer coating, seed encrusting, seed dripping and seed pelleting) based on the compounds of formula (I), or the formulations and/or the combinations prepared therefrom. Here, the combinations can be applied diluted or undiluted.


The term “seed” comprises seed of all types, such as, for example, corns, seeds, fruits, tubers, seedlings and similar forms. Here, preferably, the term seed describes corns and seeds. The seed used can be seed of the crop plants mentioned above, but also the seed of transgenic plants or plants obtained by customary breeding methods.


When employed in plant protection, the amounts of active substances applied, i.e. the compounds of formula (I), component B and, if appropriate, component C without formulation auxiliaries, are, depending on the kind of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 0.9 kg per ha and in particular from 0.1 to 0.75 kg per ha.


In another embodiment of the invention, the application rate of the compounds of formula (I), component B and, if appropriate, component C, is from 0.001 to 3 kg/ha, preferably from 0.005 to 2.5 kg/ha and in particular from 0.01 to 2 kg/ha of active substance (a.s.).


In another preferred embodiment of the invention, the rates of application of the compounds of formula (I) according to the present invention (total amount of compounds of formula (I)) are from 0.1 g/ha to 3000 g/ha, preferably 10 g/ha to 1000 g/ha, depending on the control target, the season, the target plants and the growth stage.


In another preferred embodiment of the invention, the application rates of the compounds of formula (I) are in the range from 0.1 g/ha to 5000 g/ha and preferably in the range from 1 g/ha to 2500 g/ha or from 5 g/ha to 2000 g/ha.


In another preferred embodiment of the invention, the application rate of the compounds of formula (I) is 0.1 to 1000 g/ha, preferablyl to 750 g/ha, more preferably 5 to 500 g/ha.


The required application rates of herbicidal compounds B are generally in the range of from 0.0005 kg/ha to 2.5 kg/ha and preferably in the range of from 0.005 kg/ha to 2 kg/ha or 0.01 kg/ha to 1.5 kg/h of a.s.


The required application rates of safeners C are generally in the range of from 0.0005 kg/ha to 2.5 kg/ha and preferably in the range of from 0.005 kg/ha to 2 kg/ha or 0.01 kg/ha to 1.5 kg/h of a.s.


In treatment of plant propagation materials such as seeds, e.g. by dusting, coating or drenching seed, amounts of active substance of from 0.1 to 1000 g, preferably from 1 to 1000 g, more preferably from 1 to 100 g and most preferably from 5 to 100 g, per 100 kilogram of plant propagation material (preferably seeds) are generally required.


In another embodiment of the invention, to treat the seed, the amounts of active substances applied, i.e. the compounds of formula (I), component B and, if appropriate, component C are generally employed in amounts of from 0.001 to 10 kg per 100 kg of seed.


When used in the protection of materials or stored products, the amount of active substance applied depends on the kind of application area and on the desired effect.


Amounts customarily applied in the protection of materials are 0.001 g to 2 kg, preferably 0.005 g to 1 kg, of active substance per cubic meter of treated material.


In case of combinations according to the present invention it is immaterial whether the compounds of formula (I), and the further component B and/or the component C are formulated and applied jointly or separately.


In the case of separate application, it is of minor importance, in which order the application takes place. It is only necessary, that the compounds of formula (I), and the further component B and/or the component C are applied in a time frame that allows simultaneous action of the active ingredients on the plants, preferably within a time-frame of at most 14 days, in particular at most 7 days.


Depending on the application method in question, the compounds of formula (I), or the formulations and/or combinations comprising them, can additionally be employed in a further number of crop plants for eliminating undesired vegetation. Examples of suitable crops are the following:

    • Allium cepa, Ananas comosus, Arachis hypogaea, Asparagus officinalis, Avena sativa, Beta vulgaris spec. altissima, Beta vulgaris spec. rapa, Brassica napus var. napus, Brassica napus var. napobrassica, Brassica rapa var. silvestris, Brassica oleracea, Brassica nigra, Camellia sinensis, Carthamus tinctorius, Carya illinoinensis, Citrus limon, Citrus sinensis, Coffea arabica (Coffea canephora, Coffea liberica), Cucumis sativus, Cynodon dactylon, Daucus carota, Elaeis guineensis, Fragaria vesca, Glycine max, Gossypium hirsutum, (Gossypium arboreum, Gossypium herbaceum, Gossypium vitifolium), Helianthus annuus, Hevea brasiliensis, Hordeum vulgare, Humulus lupulus, Ipomoea batatas, Juglans regia, Lens culinaris, Linum usitatissimum, Lycopersicon lycopersicum, Malus spec., Manihot esculenta, Medicago sativa, Musa spec., Nicotiana tabacum (N.rustica), Olea europaea, Oryza sativa, Phaseolus lunatus, Phaseolus vulgaris, Picea abies, Pinus spec., Pistacia vera, Pisum sativum, Prunus avium, Prunus persica, Pyrus communis, Prunus armeniaca, Prunus cerasus, Prunus dulcis and Prunus domestica, Ribes sylvestre, Ricinus communis, Saccharum officinarum, Secale cereale, Sinapis alba, Solanum tuberosum, Sorghum bicolor (s. vulgare), Theobroma cacao, Trifolium pratense, Triticum aestivum, Triticale, Triticum durum, Vicia faba, Vitis vinifera and Zea mays.
    • Preferred crops are Arachis hypogaea, Beta vulgaris spec. altissima, Brassica napus var. napus, Brassica oleracea, Citrus limon, Citrus sinensis, Coffea arabica (Coffea canephora, Coffea liberica), Cynodon dactylon, Glycine max, Gossypium hirsutum, (Gossypium arboreum, Gossypium herbaceum, Gossypium vitifolium), Helianthus annuus, Hordeum vulgare, Juglans regia, Lens culinaris, Linum usitatissimum, Lycopersicon lycopersicum, Malus spec., Medicago sativa, Nicotiana tabacum (N.rustica), Olea europaea, Oryza sativa, Phaseolus lunatus, Phaseolus vulgaris, Pistacia vera, Pisum sativum, Prunus dulcis, Saccharum officinarum, Secale cereale, Solanum tuberosum, Sorghum bicolor (s. vulgare), Triticale, Triticum aestivum, Triticum durum, Vicia faba, Vitis vinifera and Zea mays.


Especially preferred crops are crops of cereals, corn, soybeans, rice, oilseed rape, cotton, potatoes, peanuts or permanent crops.


The compounds of formula (I) according to the invention, or the formulations and/or combinations comprising them, can also be used in crops which have been modified by mutagenesis or genetic engineering in order to provide a new trait to a plant or to modify an already present trait.


The term “crops” as used herein includes also (crop) plants which have been modified by mutagenesis or genetic engineering in order to provide a new trait to a plant or to modify an already present trait.


Mutagenesis includes techniques of random mutagenesis using X-rays or mutagenic chemicals, but also techniques of targeted mutagenesis, in order to create mutations at a specific locus of a plant genome. Targeted mutagenesis techniques frequently use oligonucleotides or proteins like CRISPR/Cas, zinc-finger nucleases, TALENs or meganucleases to achieve the targeting effect.


Genetic engineering usually uses recombinant DNA techniques to create modifications in a plant genome which under natural circumstances cannot readily be obtained by cross breeding, mutagenesis or natural recombination. Typically, one or more genes are integrated into the genome of a plant in order to add a trait or improve a trait. These integrated genes are also referred to as transgenes in the art, while plant comprising such transgenes are referred to as transgenic plants. The process of plant transformation usually produces several transformation events, which differ in the genomic locus in which a transgene has been integrated. Plants comprising a specific transgene on a specific genomic locus are usually described as comprising a specific “event”, which is referred to by a specific event name. Traits which have been introduced in plants or have been modified include in particular herbicide tolerance, insect resistance, increased yield and tolerance to abiotic conditions, like drought.


Herbicide tolerance has been created by using mutagenesis as well as using genetic engineering. Plants which have been rendered tolerant to acetolactate synthase (ALS) inhibitor herbicides by conventional methods of mutagenesis and breeding comprise plant varieties commercially available under the name Clearfield®. However, most of the herbicide tolerance traits have been created via the use of transgenes.


Herbicide tolerance has been created to glyphosate, glufosinate, 2,4-D, dicamba, oxynil herbicides, like bromoxynil and ioxynil, sulfonylurea herbicides, ALS inhibitor herbicides and 4-hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors, like isoxaflutole and mesotrione.


Transgenes which have been used to provide herbicide tolerance traits comprise: for tolerance to glyphosate: cp4 epsps, epsps grg23ace5, mepsps, 2mepsps, gat4601, gat4621 and goxv247, for tolerance to glufosinate: pat and bar, for tolerance to 2,4-D: aad-1 and aad-12, for tolerance to dicamba: dmo, for tolerance to oxynil herbicies: bxn, for tolerance to sulfonylurea herbicides: zm-hra, csr1-2, gm-hra, S4-HrA, for tolerance to ALS inhibitor herbicides: csr1-2, for tolerance to HPPD inhibitor herbicides: hppdPF, W336 and avhppd-03.


Transgenic corn events comprising herbicide tolerance genes are for example, but not excluding others, DAS40278, MON801, MON802, MON809, MON810, MON832, MON87411, MON87419, MON87427, MON88017, MON89034, NK603, GA21, MZHGOJG, HCEM485, VCO-Ø1981-5, 676, 678, 680, 33121, 4114, 59122, 98140, Bt10, Bt176, CBH-351, DBT418, DLL25, MS3, MS6, MZIR098, T25, TC1507 and TC6275.


Transgenic soybean events comprising herbicide tolerance genes are for example, but not excluding others, GTS 40-3-2, MON87705, MON87708, MON87712, MON87769, MON89788, A2704-12, A2704-21, A5547-127, A5547-35, DP356043, DAS44406-6, DAS68416-4, DAS-81419-2, GU262, SYHTØH2, W62, W98, FG72 and CV127.


Transgenic cotton events comprising herbicide tolerance genes are for example, but not excluding others, 19-51a, 31707, 42317, 81910, 281-24-236, 3006-210-23, BXN10211, BXN10215, BXN10222, BXN 10224, MON1445, MON1698, MON88701, MON88913, GHB119, GHB614, LLCotton25, T303-3 and T304-40.


Transgenic canola events comprising herbicide tolerance genes are for example, but not excluding others, MON88302, HCR-1, HCN10, HCN28, HCN92, MS1, MS8, PHY14, PHY23, PHY35, PHY36, RF1, RF2 and RF3.


Insect resistance has mainly been created by transferring bacterial genes for insecticidal proteins to plants. Transgenes which have most frequently been used are toxin genes of Bacillus spec. and synthetic variants thereof, like crylA, crylAb, crylAb-Ac, crylAc, crylA.105, crylF, crylFa2, cry2Ab2, cry2Ae, mcry3A, ecry3.1Ab, cry3Bb1, cry34Ab1, cry35Ab1, cry9C, vip3A (a), vip3Aa20. However, also genes of plant origin have been transferred to other plants. In particular genes coding for protease inhibitors, like CpTI and pinll. A further approach uses transgenes in order to produce double stranded RNA in plants to target and downregulate insect genes. An example for such a transgene is dvsnf7.


Transgenic corn events comprising genes for insecticidal proteins or double stranded RNA are for example, but not excluding others, Bt10, Bt11, Bt176, MON801, MON802, MON809, MON810, MON863, MON87411, MON88017, MON89034, 33121, 4114, 5307, 59122, TC1507, TC6275, CBH-351, MIR162, DBT418 and MZIR098.


Transgenic soybean events comprising genes for insecticidal proteins are for example, but not excluding others, MON87701, MON87751 and DAS-81419.


Transgenic cotton events comprising genes for insecticidal proteins are for example, but not excluding others, SGK321, MON531, MON757, MON1076, MON15985, 31707, 31803, 31807, 31808, 42317, BNLA-601, Event1, COT67B, COT102, T303-3, T304-40, GFM CrylA, GK12, MLS 9124, 281-24-236, 3006-210-23, GHB119 and SGK321. Increased yield has been created by increasing ear biomass using the transgene athb17, being present in corn event MON87403, or by enhancing photosynthesis using the transgene bbx32, being present in the soybean event MON87712.


Crops comprising a modified oil content have been created by using the transgenes: gm-fad2-1, Pj.D6D, Nc.Fad3, fad2-1A and fatb1-A. Soybean events comprising at least one of these genes are: 260-05, MON87705 and MON87769.


Tolerance to abiotic conditions, in particular to tolerance to drought, has been created by using the transgene cspB, comprised by the corn event MON87460 and by using the transgene Hahb-4, comprised by soybean event IND-ØØ410-5.


Traits are frequently combined by combining genes in a transformation event or by combining different events during the breeding process. Preferred combination of traits are herbicide tolerance to different groups of herbicides, insect tolerance to different kind of insects, in particular tolerance to lepidopteran and coleopteran insects, herbicide tolerance with one or several types of insect resistance, herbicide tolerance with increased yield as well as a combination of herbicide tolerance and tolerance to abiotic conditions.


Plants comprising singular or stacked traits as well as the genes and events providing these traits are well known in the art. For example, detailed information as to the mutagenized or integrated genes and the respective events are available from websites of the organizations “International Service for the Acquisition of Agri-biotech Applications (ISAAA)” (http://www.isaaa.org/gmapprovaldatabase) and the “Center for Environmental Risk Assessment (CERA)” (http://cera-gmc.org/GMCropDatabase), as well as in patent applications, like EP3028573 and WO2017/011288.


The use of the compounds of formula (I) or formulations or combinations comprising them according to the invention on crops may result in effects which are specific to a crop comprising a certain gene or event. These effects might involve changes in growth behavior or changed resistance to biotic or abiotic stress factors. Such effects may in particular comprise enhanced yield, enhanced resistance or tolerance to insects, nematodes, fungal, bacterial, mycoplasma, viral or viroid pathogens as well as early vigor, early or delayed ripening, cold or heat tolerance as well as changed amino acid or fatty acid spectrum or content.


Furthermore, plants are also covered that contain by the use of recombinant DNA techniques a modified amount of ingredients or new ingredients, specifically to improve raw material production, e.g., potatoes that produce increased amounts of amylopectin (e.g. Amflora® potato, BASF SE, Germany).


Furthermore, it has been found that the compounds of formula (I) according to the invention, or the formulations and/or combinations comprising them, are also suitable for the defoliation and/or desiccation of plant parts of crops such as cotton, potato, oilseed rape, sunflower, soybean or field beans, in particular cotton. In this regard, formulations and/or combinations for the desiccation and/or defoliation of crops, processes for preparing these formulations and/or combinations and methods for desiccating and/or defoliating plants using the compounds of formula (I) have been found.


As desiccants, the compounds of formula (I) are particularly suitable for desiccating the above-ground parts of crop plants such as potato, oilseed rape, sunflower and soybean, but also cereals. This makes possible the fully mechanical harvesting of these important crop plants.


Also of economic interest is to facilitate harvesting, which is made possible by concentrating within a certain period of time the dehiscence, or reduction of adhesion to the tree, in citrus fruit, olives and other species and varieties of pernicious fruit, stone fruit and nuts. The same mechanism, i.e. the promotion of the development of abscission tissue between fruit part or leaf part and shoot part of the plants is also essential for the controlled defoliation of useful plants, in particular cotton.


Moreover, a shortening of the time interval in which the individual cotton plants mature leads to an increased fiber quality after harvesting.


A Synthesis Examples

Chemical bonds, drawn as bars in chemical formulae, indicate the relative stereochemistry on the ring system.


Example 1: Synthesis of Methyl (3S)-3-[3-(3-Chloroanilino)-2,2-Dimethyl-3-Oxopropanoyl]Amino]Butanoate



embedded image


1.1 Lithium 3-ethoxy-2,2-dimethyl-3-oxo-propanoate:




embedded image


Diethyl 2,2-dimethylpropanedioate (20.0 g; 106 mmol) was dissolved in a mixture of THF (50 mL) and water (50 mL). Lithium hydroxide (2.55 g; 106 mmol) was added in portions. The reaction mixture was stirred at room temperature for 60 hours. The solution was concentrated in vacuo and dried in vacuum drying cabinet over night at 50° C. to give the crude product (9.90 g) which was used without further purification for the next step.


1.2 Ethyl 3-(3-chloroanilino)-2,2-dimethyl-3-oxo-propanoate:




embedded image


A mixture of 3-chloroaniline (1.84 g; 14.5 mmol; 1.2 eq), an aliquot of the crude lithium salt of 3-ethoxy-2,2-dimethyl-3-oxo-propanoate (2.00 g; 12.0 mmol; 1 eq) and triethylamine (3.66 g; 36.1 mmol; 3 eq) in THF (20 mL) was treated with n-propanephosphonic acid anhydride (13.0 g; 20.5 mmol; 1.7 eq; 50% solution in ethyl acetate; T3P; CAS [68957-94-8]) and stirred overnight at room temperature. Water (30 mL) was added, and the reaction mixture extracted with ethyl acetate. The organic solution was washed with aqueous hydrochloric acid solution (1 M) and water, dried over sodium sulfate and concentrated in vacuo to give crude ethyl 3-(3-chloroanilino)-2,2-dimethyl-3-oxopropanoate (3.10 g) which was again used for the next step without further purification.


1.3 3-(3-Chloroanilino)-2,2-dimethyl-3-oxo-propanoic acid:




embedded image


Crude ethyl 3-(3-chloroanilino)-2,2-dimethyl-3-oxo-propanoate (3.10 g; 11.5 mmol) was dissolved in a mixture of THF (20 mL) and water (20 mL). Lithium hydroxide (0.551 g; 23.0 mmol; 2 eq) was added in portions. The reaction mixture was stirred at room temperature for 3 hours. The THF was evaporated in vacuo and the slurry was treated with methyl tert-butyl ether and the resulting two phases were separated. The aqueous solution was adjusted to ca. pH 1 with concentrated hydrochloric acid solution. The product 3-(3-chloroanilino)-2,2-dimethyl-3-oxo-propanoic acid precipitated overnight and was filtered. (0.80 g; 29% yield).



1H NMR: (400 MHz; DMSO) δ=12.7 (br s, 1H), 9.65 (s, 1H), 7.85 (s, 1H), 7.55 (d, 1H), 7.30 (t, 1H), 7.10 (d, 1H), 1.40 (s, 6H)


1.4 Methyl (3S)-3-[3-(3-chloroanilino)-2,2-dimethyl-3-oxo-propanoyl]amino]butanoate




embedded image


To a solution of 3-(3-chloroanilino)-2,2-dimethyl-3-oxo-propanoic acid (250 mg, 1.03 mmol) in dimethylformamide (DMF, 5 ml) methyl (3S)-3-aminobutanoate (Shomoalanine) hydrochloride (194 mg, 1.19 mmol) was added. To the resulting solution was added HATU (2-(7-aza-1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate, CAS [148893 Oct. 1]), (452 mg, 1.19 mmol) and then diisopropylethylamine (257 mg, 2.07 mmol)). The resulting reaction mixture was stirred at room temperature for a few hours. Water and ethyl acetate were added. The ethyl acetate phase was washed with saturated sodium chloride solution and the solvent evaporated under reduced pressure. The crude product was purified by reversed phase chromatography using acetonitrile/water as eluent. This gave 190 mg (54%) of the product. 1H NMR: (400 MHZ, CDCl3) d=9.55 (s, 1H), 7.75 (s, 1H), 7.4 (d, 1H), 7.25 (t, 1H), 7.1 (d, 1H), 6.95 (1 H), 4.35 (m, 1H), 3.7 (s, 3H), 2.55 (q, 2H), 1.55 (s, 6H), 1.25 (d, 3H).


In analogy to the examples described above, the following compounds of formula (I), wherein R1, R2, R6 and R9 are hydrogen and R3, R4, R5, R7, R8 and X-Y (depicted together with the nitrogen atom to which-X-Y is bound to show the stereochemistry) are compiled in Table 1, were prepared, starting from commercially available diesters and using commercially available amines:




embedded image
















TABLE 1





No.
R3
R4
R5
R7
R8
N*— X—Y
LC-MS







I.1.
Cl
H
Cl
CH3
CH3


embedded image


375.1





I.2.
Cl
H
Cl
CH3
CH3


embedded image


398.9





I.3.
Cl
H
Cl
CH3
CH3


embedded image


388.9





I.4.
I
H
H
CH3
CH3


embedded image


456.9





I.5.
I
H
H
CH3
CH3


embedded image


432.8





I.6.
I
H
H
CH3
CH3


embedded image


446.9





I.7.
Et
H
H
CH3
CH3


embedded image


359.3





I.8.
Et
H
H
CH3
CH3


embedded image


335.1





I.9.
OCF3
H
H
CH3
CH3


embedded image


415.1





I.10.
OCF3
H
H
CH3
CH3


embedded image


390.9





I.11.
OCF3
H
H
CH3
CH3


embedded image


405.1





I.12.
F
H
H
CH3
CH3


embedded image


349.1





I.13.
F
H
H
CH3
CH3


embedded image


325.1





I.14.
F
H
H
CH3
CH3


embedded image


339.1





I.15.
Cl
H
H
CH3
CH3


embedded image


364.9





I.16.
Cl
H
H
CH3
CH3


embedded image


340.9





I.17.
Cl
H
F
CH3
CH3


embedded image


359.9





I.18.
Cl
H
F
CH3
CH3


embedded image


383.0





I.19.
Et
H
H
CH3
CH3


embedded image


349.1





I.20.
F
H
F
CH3
CH3


embedded image


357.0





I.21.
F
H
F
CH3
CH3


embedded image


343.1





I.22.
Cl
H
H
CH3
CH3


embedded image


355.0





I.23.
Cl
H
F
CH3
CH3


embedded image


373.0





I.24.
F
H
F
CH3
CH3


embedded image


367.0





I.25.
Cl
H
H
CH2CH3
CH2CH3


embedded image


393.1





I.26.
Cl
H
F
CH2CH3
CH2CH3


embedded image


401.2





I.27.
Cl
H
H
CH2CH3
CH2CH3


embedded image


369.1





I.28.
Cl
H
F
CH2CH3
CH2CH3


embedded image


387.2





I.29.
F
H
H
CH2CH3
CH2CH3


embedded image


377.2





I.30.
F
H
H
CH2CH3
CH2CH3


embedded image


367.2





I.31.
Cl
H
H
CH2CH3
CH2CH3


embedded image


383.1





I.32.
F
H
F
CH2CH3
CH2CH3


embedded image


385.3





I.33.
F
H
F
CH2CH3
CH2CH3


embedded image


395.2





I.34.
F
H
F
CH2CH3
CH2CH3


embedded image


371.1





I.35.
Cl
H
F
CH2CH3
CH2CH3


embedded image


411.1





I.36.
Cl
H
Cl
CH2CH3
CH2CH3


embedded image


427.1





I.37.
Cl
H
Cl
CH2CH3
CH2CH3


embedded image


403.1





I.38.
Cl
H
Cl
CH2CH3
CH2CH3


embedded image


417.1





I.39.
Cl
H
Cl
CH3
CH(CH3)2


embedded image


427.2





I.40.
Cl
H
Cl
CH3
CH(CH3)2


embedded image


403.2





I.41.
Cl
H
Cl
CH3
CH(CH3)2


embedded image


417.2





I.42.
Cl
H
H
CH2CH3
CH2CH3


embedded image


355.2





I.43.
F
H
H
CH2CH3
CH2CH3


embedded image


339.2





I.44.
F
H
F
CH2CH3
CH2CH3


embedded image


371.2





I.45.
F
H
F
CH2CH3
CH2CH3


embedded image


381.2





I.46.
Cl
H
H
CH2CH3
CH2CH3


embedded image


379.2





I.47.
F
H
F
CH2CH3
CH2CH3


embedded image


357.1





I.48.
Cl
H
Cl
CH2CH3
CH2CH3


embedded image


389.1





I.49.
Cl
H
Cl
CH2CH3
CH2CH3


embedded image


425.1





I.50.
Cl
H
Cl
CH2CH3
CH2CH3


embedded image


413.1





I.51.
F
H
F
CH3
CH(CH3)2


embedded image


395.1





I.52.
F
H
F
CH3
CH(CH3)2


embedded image


384.8





I.53.
F
H
F
CH3
CH(CH3)2


embedded image


371.0





I.54.
Cl
H
Cl
CH3
CH(CH3)2


embedded image


413.1





I.55.
Cl
H
Cl
CH3
CH(CH3)2


embedded image


389.1





I.56.
Cl
H
Cl
CH3
CH(CH3)2


embedded image


425.1





I.57.
F
H
F
CH3
CH2CH3


embedded image


356.9





I.58.
F
H
F
CH3
CH2CH3


embedded image


381.2





I.59.
F
H
H
CH3
CH2CH3


embedded image


363.2





I.60.
F
H
H
CH3
CH2CH3


embedded image


339.2





I.61.
F
H
H
CH3
CH2CH3


embedded image


353.2





I.62.
F
H
F
CH3
CH2CH3


embedded image


371.1





I.63.
Cl
H
Cl
CH3
CH2CH3


embedded image


412.8





I.64.
Cl
H
Cl
CH3
CH2CH3


embedded image


388.8





I.65.
Cl
H
Cl
CH3
CH2CH3


embedded image


402.8





I.66.
Cl
H
F
CH3
CH2CH3


embedded image


397.2





I.67.
Cl
H
F
CH3
CH2CH3


embedded image


373.2





I.68.
Cl
H
F
CH3
CH2CH3


embedded image


387.2





I.69.
F
H
F
CH3
n-Pr


embedded image


395.0





I.70.
F
H
F
CH3
n-Pr


embedded image


385.2





I.71.
F
H
F
CH3
n-Pr


embedded image


371.2





I.72.
Cl
H
H
CH3
CH2CH3


embedded image


379.1





I.73.
Cl
H
H
CH3
CH2CH3


embedded image


355.1





I.74.
Cl
H
H
CH3
CH2CH3


embedded image


369.1





I.75.
Cl
H
Cl
CH3
n-Pr


embedded image


427.2





I.76.
Cl
H
Cl
CH3
n-Pr


embedded image


403.2





I.77.
Cl
H
Cl
CH3
n-Pr


embedded image


417.2





I.78.
Cl
H
F
CH3
CH3


embedded image


369.0





I.79.
OCF3
H
H
CH3
CH3


embedded image


401.1





I.80.
Cl
H
Cl
CH3
CH3


embedded image


385.0





n-Pr = n-propyl


B Biological examples






The herbicidal activity of the compounds of formula (I) was demonstrated by the following greenhouse experiments:


The culture containers used were plastic flowerpots containing loamy sand with approximately 3.0% of humus as the substrate. The seeds of the test plants were sown separately for each species.


For the pre-emergence treatment, the active ingredients, which had been suspended or emulsified in water, were applied directly after sowing by means of finely distributing nozzles. The containers were irrigated gently to promote germination and growth and subsequently covered with transparent plastic hoods until the test plants had rooted. This cover caused uniform germination of the test plants, unless this had been impaired by the active ingredients.


For the post-emergence treatment, the test plants were first grown to a height of 3 to 15 cm, depending on the plant habit, and only then treated with the active ingredients which had been suspended or emulsified in water. For this purpose, the test plants were either sown directly and grown in the same containers, or they were first grown separately as seedlings and transplanted into the test containers a few days prior to treatment.


Depending on the species, the test plants were kept at 10-25° C. or 20-35° C., respectively.


The test period extended over 2 to 4 weeks. During this time, the test plants were tended, and their response to the individual treatments was evaluated.


Evaluation was carried out using a scale from 0 to 100. 100 means no emergence of the test plants, or complete destruction of at least the aerial moieties, and 0 means no damage, or normal course of growth. A good herbicidal activity is given at values of 70 to <90 and a very good herbicidal activity is given at values of 90 to 100.


The test plants used in the greenhouse experiments were of the following species:
















Bayer code
Scientific name









ABUTH

Abutilon theophrasti




ALOMY

Alopercurus myosuroides




AMARE

Amaranthus retroflexus




APESV

Apera spica-venti




AVEFA

Avena fatua




DIGSA

Digitaria sanguinalis




ECHCG

Echinocloa crus-galli




LOLMU

Lolium multiflorum




SETFA

Setaria faberi




SETVI

Setaria viridis











At an application rate of 0.250 kg/ha, applied by the pre-emergence method:

    • compound 1.19 showed good herbicidal activity against ABUTH
    • compounds 1.2, 1.9, 1. 17 showed good herbicidal activity against AMARE.
    • compounds 1.24, 1.78 showed very good herbicidal activity against DIGSA
    • compound 1.79 showed good herbicidal activity against DIGSA
    • compounds 1.9, 1.15, 1.18 showed very good herbicidal activity against ECHCG
    • compounds 1.2, 1.12 showed good herbicidal activity against ECHCG.
    • compounds 1.24, 1.78, 1.79 showed very good herbicidal activity against LOLMU
    • compound 1.80 showed good herbicidal activity against LOLMU.
    • compounds 1.2, 1.7, 1.9, 1.18, 1.20 showed very good herbicidal activity against SETFA.
    • compounds 1.12, 1.16, 1. 19 showed good herbicidal activity against SETFA
    • compound 1.24 showed very good herbicidal activity against SETVI
    • compound 1.78 showed very good herbicidal activity against SETVI


At an application rate of 0.250 kg/ha, applied by the post-emergence method:

    • compounds 1.2, 1.9, 1.18 showed very good herbicidal activity against ABUTH.
    • compounds 1.4 showed good herbicidal activity against ABUTH.
    • compounds 1.2, 1.4, 1.15, 1.18, 1.19, 1.22, 1.78, 1.79, 1.80 showed very good herbicidal activity against ALOMY
    • compounds 1.3, 1.6, 1.10, 1.11, 1.12, 1.14, 1.16, 1.21, 1.24 showed good herbicidal activity against ALOMY.
    • compounds 1.15, 1.78, 1.79, 1.80 showed very good herbicidal activity against AMARE
    • compounds 1.3, 1.12 showed good herbicidal activity against AMARE
    • compounds 1.3, 1.9, 1.19, 1.21, 1.22, 1.24, 1.79, 1.80 showed very good herbicidal activity against AVEFA.
    • compounds 1.5, 1.6, 1.10, 1.11, 1.14, 1.16, 1.17, 1.20 showed good herbicidal activity against AVEFA.
    • compounds 1.2, 1.4, 1.9, 1.12, 1.15, 1.18, 1.24, 1.78 showed very good herbicidal activity against ECHCG
    • compounds 1.20, 1.23 showed good herbicidal activity against ECHCG
    • compounds 1.20, 1.22, 1.23 showed good herbicidal activity against SETVI


At an application rate of 0.500 kg/ha, applied by the pre-emergence method:

    • compounds 1.1 showed very good herbicidal activity against APESV
    • compounds 1.1 showed good herbicidal activity against ABUTH


At an application rate of 0.500 kg/ha, applied by the post-emergence method:

    • compounds 1.1 showed very good herbicidal activity against ALOMY
    • compounds 1.1 showed very good herbicidal activity against AVEFA.
    • compounds 1.1 showed very good herbicidal activity against SETVI

Claims
  • 1. A compound of formula (I)
  • 2. The compound as claimed in claim 1, wherein one, two, three, or all four of the following conditions (a), (b), (c), and (d) apply:(a) R1 is hydrogen; and R9 is hydrogen;(b) R2 is hydrogen, halogen, or (C1-C3)-alkyl; and R6 is hydrogen, halogen, or (C1-C3)-alkyl;(c) R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, or (C1-C3)-haloalkoxy; and R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, or (C1-C3)-haloalkoxy;(d) R4 is hydrogen or halogen.
  • 3. The compound as claimed in claim 1, wherein one, two, three, or all four of the following conditions (a), (b), (c), and (d) apply: (a) R1 is hydrogen; and R9 is hydrogen;(b) R2 is hydrogen; and R6 is hydrogen;(c) R3 is halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, or (C1-C3); and R5 is hydrogen or halogen;(d) R4 is hydrogen.
  • 4. The compound as claimed in claim 1, wherein: R7 and R8, independently of each other, are (C1-C6)-alkyl or (C2-C6)-alkenyl.
  • 5. The compound as claimed in claim 4, wherein: R7 and R8, independently of each other, are (C1-C4)-alkyl.
  • 6. The compound as claimed in claim 5, wherein R7 and R8 are both methyl.
  • 7. The compound as claimed in claim 1, wherein the substituents have the following meaning: X is a bond; andY is Z;whereZ is a three-, four-, five-, or six-membered saturated, partly unsaturated or fully unsaturated carbocyclic ring, except phenyl, which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O),Ra, SO2NRbRa, SO2NRbCORe, CORD, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORlRl, and C(Rb)═NORe, and where the carbon ring atoms bear n oxo groups; orZ is a three-, four-, five-, or six-membered saturated, partly unsaturated or fully unsaturated heterocyclic ring containing one or two oxygen atoms as ring members, where the ring is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O),Ra, SO2NRbRa, SO2NRbCORe, CORD, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORlRl, and C(Rb)═NORe, and where the carbon ring atoms bear n oxo groups.
  • 8. The compound as claimed in claim 7, where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl.
  • 9. The compound as claimed in claim 1, wherein the substituents have the following meanings: X is a divalent unit (X1), where R10 and R11 are as defined in claim 1;Y is (C1-C8)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, S(O),Ra, SO2NRbRa, SO2NRbCORe, CORD, CONReS(O)Ra, CONReSO2Ra, CONRb1SO2NRb2Rb3, NRbRe, NRbCORe, NRbCONReRe, NRbCO2Re, NRbSO2Re, NRb1SO2NRb2Re, OCONRbRe, OCSNRbRe, PORlRl and C(Rb)═NORe.
  • 10. The compound as claimed in claim 9, wherein Y is (C1-C4)-alkyl which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C4)-alkyl.
  • 11. The compound as claimed in claim 1, wherein p is 1 or 2.
  • 12. The compound as claimed in claim 1, wherein the substituents have the following meaning: R1 hydrogen;R2 is hydrogen or halogen;R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, or (C1-C3)-haloalkoxy;R4 is hydrogen or halogen;R5 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, or (C1-C3)-haloalkoxy;R6 is hydrogen;R7 and R8, independently of each other, are (C1-C6)-alkyl;R9 hydrogen; andx is a bond; and Y is Z; where Z is a five- or six-membered saturated or partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl; orX is a divalent unit (X1), where R10 and R11 are independently of each other hydrogen or (C1-C6)-alkyl; and Y is (C1-C4)-alkyl which is substituted by p radicals selected from the group consisting of CO2Re, CONRbRh, CONReS(O)Ra, CONReSO2Ra, and CONRb1SO2NRb2Rb3, whereRe in CO2Re is hydrogen, (C1-C6)-alkyl which optionally has a cyano substituent; (C2-C4)-alkynyl or phenyl-(C1-C3)-alkyl;Rb in CONRbRh is hydrogen or (C1-C3)-alkyl;Rh in CONRbRh is (C1-C3)-alkoxy;Re in CONReS(O)Ra is hydrogen or (C1-C3)-alkyl;Ra in CONReS(O)Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;Re in CONReSO2Ra is hydrogen or (C1-C3)-alkyl;Ra in CONReSO2Ra is (C1-C6)-alkyl or (C1-C3)-haloalkyl;in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;Rb2 in CONRb1SO2NRb2Rb3 is hydrogen or (C1-C3)-alkyl;Rb3 in CONRb1SO2NRb2Rb3 is (C—C6)-alkyl; orRb2 and Rb3, together with the nitrogen atom they are bound to, form a saturated 5- or 6-membered N-bound heterocyclic ring; andp is 1 or 2.
  • 13. The compound as claimed in claim 12, where the substituents have the following meaning: R hydrogen;R2 is hydrogen;R3 is hydrogen, halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy, or (C1-C3)-haloalkoxy;R4 is hydrogen;R5 is hydrogen or halogen;R6 is hydrogen;R7 and R8, independently of each other, are (C1-C4)-alkyl;R9 hydrogen; andX is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl; orX is a divalent unit (X1), where R10 and R11 are independently of each other hydrogen or methyl; and Y is (C1-C4)-alkyl which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C6)-alkyl; andp is 1.
  • 14. The compound as claimed in claim 13, where the substituents have the following meaning: R hydrogen;R2 is hydrogen;R3 is halogen, (C1-C3)-alkyl, (C1-C3)-haloalkyl, (C1-C3)-alkoxy or (C1-C3)-haloalkoxy;R4 is hydrogen;R5 is hydrogen or halogen;R6 is hydrogen;R7 and R8 are methyl;R9 hydrogen; andX is a bond; and Y is Z; where Z is a five-membered partly unsaturated carbocyclic ring which is substituted by p radicals CO2Re, where Re is hydrogen or (C1-C4)-alkyl; orX is a divalent unit (X1), where one of R10 and R11 is hydrogen and the other is methyl; and Y is (C1-C4)-alkyl which is substituted by p radicals CO2Re, where Re is (C1-C4)-alkyl; andp is 1.
  • 15. The compound as claimed in claim 1, wherein-X-Y form together a group of the formula (XY1) or (XY2)
  • 16. The compound as claimed in claim 15, where RA is hydrogen or methyl; andRB, RC, RD, RE, and RF are hydrogen; orRA and RE, together with the carbon atoms they are bound to, form a 5- or 6-membered saturated or partly unsaturated carbocyclic ring; andRB, RC, RD_and RF are hydrogen; orRA and RE, together with the carbon atoms they are bound to, form a 5- or 6-membered saturated or partly unsaturated heterocyclic ring containing one oxygen atom as ring member; andRB, RC, RD and RF are hydrogen; andRe is hydrogen or (C1-C4)-alkyl.
  • 17. A composition comprising at least one compound as claimed in claim 1, and at least one auxiliary, which is customary for formulating crop protection compounds.
  • 18. The composition as claimed in claim 17 comprising a further herbicide.
  • 19. (canceled)
  • 20. A method for controlling unwanted vegetation which comprises contacting an herbicidally effective amount of at least one compound as claimed in claim 1, with a plant, its seed and/or its habitat.
Priority Claims (1)
Number Date Country Kind
21193044.1 Aug 2021 EP regional
PCT Information
Filing Document Filing Date Country Kind
PCT/EP2022/073602 8/24/2022 WO